
















































Crohn’s! disease! (CD)! has! a! distinct! feature! of!mesenteric! adipose!



















mesenteric!AT! (mean=29,!SD=20)! than!control! (mean=19,!SD=12).!
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Hypoxia! inducible! factorR1! (HIF1)! staining! was! higher! in! CD!
mesenteric! AT! (n=22,! 67%)! than! control! (n=18,! 22%)! (Χ2(2)=11.2,!
p<0.01).! RTRPCR! array! confirmed! that! 47! (56%)! of! the! angiogenic!
genes!were!>2Rfolds!downRregulated!in!CD!mesenteric!AT.!Correlation!
matrix! showed! significantly! more! negative! correlations! in! CD!






pg/mg,!SD=43)! and! (mean=57!pg/mg,!SD=43)! respectively.! InRvitro!
secretion!of!IL6!and!VEGF!was!similar!in!CD!and!control!AT.!Vascular!





CD! mesenteric! AT! demonstrated! dysregulated! angiogenesis! and!































through! the! development! of! this! work! and! provided! continued!
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chronic,! progressive! and! potentially! disabling.! Indeed,! patients!with!
CD!can!suffer!from!a!wide!spectrum!of!symptoms!including:!recurrent!
abdominal! painK! diarrhoeaK! blood! in! the! stoolK!mouth! soresK! loss! of!
appetiteK!weight!lossK!fatigueK!and!!arthralgia!(Mekhjian!et!al.,!1979a).!
Furthermore,!complications! from!CD!including:! intestinal!structuring,!
obstruction! and! perforationK! intraabdominal! and! perianal! sepsisK!
visceral!fistulation!and!damage!to!other!abdominal!and!pelvic!organs,!
which!all!can!lead!to!significant!morbidity!and!mortality!(Schwartz!et!
al.,! 2002,! Morson! and! LockhartRMummery,! 1959).! Although! the!








that! approximately! 90%! of! patients’! death! were! either! directly! or!
probably!related!to!CD!(Weterman!et!al.,!1990).!The!causes!of!death!
were! due! to! postoperative! complicationsK! or! patients! developing!







Thus,! there! are! farRreaching! socioeconomic! implications! of! CD,! for!
example,! the! overall! annual! incidence! of! hospital! admission! is!
estimated! to! be! over! 20%! (Mekhjian! et! al.,! 1979b).! In! the!UK,! the!
overall!annual!cost!to!care!for!any!patient!with!CD!was!estimated!to!
be!approximately!£6000.!The!annual!cost!for!those!in!remission!and!
relapse! was! approximately! £1800! and! £10,000! per! patient!
respectively! (Miles! et! al.,! 2014).! ! Yet,! the! overburden! of! surgical!
interventions! for! the! treatment! of! CD! is! a! common! recourse.! It! is!
estimated! that! between! 70%! and! 90%! of! patients! with! CD! would!
require! surgical! treatment! during! their! lifetime! (CaninREndres! et! al.,!
1999).!Beyond!the!suffering!of! these!patients!and!their! families!and!
the!burden!on!health!care!provision,!CD!affects!the!young!generation!
of! patients! at! the! time! they! are! economically! and! socially! most!
productive.!The!peak!incidence!is!amongst!the!youngest!members!of!
the! society,! with! age! of! onset! ranging! between! 10! and! 40! years!
(Mekhjian!et!al.,!1979b,!PeyrinRBiroulet!et!al.,!2010).!Despite!all! the!
compelling! facts! indicating! the! need! to! prevent,! and! treat! CD,! the!
progress! in! finding!a!cure! is! far! from!grasp.! In! fact,! there! is!humble!
progress!made!over!the!past!three!decades,!which!has!not!concluded!
a! cause! or! identified! an! effective! cure.! Therefore,! further!




One! of! the! important! pathological! features! of! CD! is! observed! in! a!
neighboring!anatomical! structure!called! the!mesentery1.! It! is!mainly!
constituted! of! adipose! tissue! (AT),! attaches! the! bowel! to! the!
abdominal! wall! and! homes! its! blood! supply.! Macroscopically,! it! is!
remarkably!thickened,!particularly,!at!the!level!of!the!bowel!affected!by!






reported! in!CD!(Addison,!1983).!Thus,! fat!wrapping! is!considered!a!
pathognomonic! phenomenon! to! CD.! The! compelling! question! is!
whether! the! mesentery! can! be! an! active! contributor! to! CD!
pathogenesis?! And! whether! this! phenomena! plays! a! role! in! the!
development! and! perpetuation! of! CD?! In! order! to! answer! this!
question,! several! research! studies! have! been! dedicated! to!
characterise!CD!mesentery!(PeyrinRBiroulet!et!al.,!2007,!Sheehan!et!
al.,!1992,!Kredel!et!al.,!2013).!Although!these!studies!and!others!have!









Siegmund,! 2014),! the! mesentery! in! CD! is! an! inflammatory! and!
expanding!tissue!mass.!To!survive!this!expansion,!new!blood!vessels!
are!required!to!ensure!oxygenation,!nutrition!and!disposal!of!metabolic!
products.! ! This! is! achieved! by! a! process! called! angiogenesis2:! the!
development! of! new! blood! vessels! form! preRexisting! blood! vessels!
(Folkman,! 1971).! Angiogenesis! is! considered! a! hallmark! of!




pathogenesis! of! CD.! Further! understanding! of! angiogenic!
mechanisms! may! unravel! diagnostic,! therapeutic! and! prognostic!
targets.!
!
The! overall! aim! of! this! thesis! is! to! characterise! the! angiogenic!
mechanisms!in!CD!mesentery.!The!objectives!can!be!summarised!in!
the!following:!1)!to!describe!the!angiogenic!gene!expression!profile!in!
CD! mesenteric! ATK! 2)! to! assess! the! level! of! angiogenic! protein!

























and!Eastern!Europe! (Lakatos! et! al.,! 2011).! This! data! suggests! the!





CD! (Mayberry! et! al.,! 2013).! In! Europe,! the! incidence! rates! for! CD!











Thus,! a! wellRdesigned! methodological! study! conducted! by! the!
Epidemiological! Committee! (EpiCom)! (Burisch! et! al.,! 2014a)! has!
included! 31! centres! from! 23! European! countries.! The! EpiCom!
reported! 2:1! WestREast! gradient! of! IBD! incidence! rate! in! Europe!





personRyears! (Ng! et! al.,! 2013).! ! The! high! incidence! of! CD! in! the!
Australian! and! Western! European! population! considering! their!
common! racial! origin! and! a! similar! life! style! may! support! the!
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In! terms! of! racial! origin,! a! good! example! that! has! been! studied!
extensively! in! the! literature! is! the! increased!risk!of!CD!amongst! the!
Jewish!population!(Yang!et!al.,!1993).!Subsequently,!several!studies!
have! described! heterogeneity! among! the! different! Jewish! historical!
ethnic! groups! (Zlotogora! et! al.,! 1990,! Abu! Freha! et! al.,! 2015).!
Specifically,! American! or! European! Ashkenazi! Jews! have! a!
significantly!increased!incidence!and!prevalence!of!CD!in!comparison!
to!Sephardic!or!Oriental!Jews!(BarRGil!Shitrit!et!al.,!2015,!Zvidi!et!al.,!
2009).! In! the! context! of! a! North! Mediterranean! racial! origin! of!





population! studied.! In! an!Asian! population! including,!China,! Japan,!!
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some!showed!a!slight!preponderance! in! females! (Vind!et!al.,!2006,!
Bernstein!et!al.,!2006).!Female!predominance!was!also!higher!in!the!
Jewish! population!with! a! female! to!male! ratio! of! 1.1:1! (Zvidi! et! al.,!
2009).! These! gender! differences! appear! to! be! dependent! on! the!
population!studied,!the!significance!of!which!is!unclear.!However,! in!
terms!of!female!preponderancy!in!a!Western!population,!this!could!be!






















Genetically,! the! candidate! genes! found! to! be! implicated! in!CD! are!
mainly! involved! in! coding! for! the! regulation! of! the! immune! and!
inflammatory!processes!(Mathew!and!Lewis,!2004).!This! is!a!cause!
for! intolerance! to! bowel! microflora.! For! example,! the! susceptible!
genes! linked! to! CD,! such! as! nucleotideRbinding! oligomerization!
domain!(NOD)!receptors!and!TollRlike!receptors!(TLR)!are!involved!in!
pattern!recognition!and!loss!of!tolerance!to!the!commensal!microflora!
(Arseneau! et! al.,! 2007).! However,! gene! association! does! not! fully!
explain!the!aetiology!of!CD,!since!NOD!genes!for!example!account!for!
only!20%!of!CD!cases!(Shanahan,!2002).!It!is!therefore!believed!that!
the! aetiology! of! CD! is! multiRfactorial! and! may! be! determined! by!
environmental! exposures.! For! example,! evidence! from! a! metaR
analysis!suggested!a!positive!association!between!smoking!and!CD!
with!odds!ratio!(OR)!of!1.76!(Mahid!et!al.,!2006).!In!terms!of!diet,!the!














To! identify! therapeutic! targets,! research! into!CD!aimed! to! describe!
inflammatory!pathways!that!drive!the!chronic!inflammation.!Currently,!
multiple! and! possibly! independent! pathways! have! been! explained.!
Two!main!pathways!mediated!by!TRhelper!(Th)!1!and!Th17!cells!have!
been! explained.! The! antigen! presenting! cells! (APC),! possibly!
pathologically!reacting!to!normal!flora,!activate!Th1!and!Th17!cells!by!
interleukins! (IL)! 12! and! IL6,! IL1β! and! IL23! respectively! (Figure! 2).!
Initially,!Th1!cells!activated!by!IL12!were!believed!to!distinctly!mediate!
the!pathogenesis!in!CD.!However,!the!role!of!Th17!mainly!activated!
by! IL!23!dominated! the!scene.! Interestingly,! IL12!and! IL23!share!a!
common!p40!subunit!and!therefore!have!an!interchangeable!effect!on!
activating!Th1!and!Th17.!Further!research!has!subsequently!showed!
that! Th17! remains! activated! in! a! milieu! where! L12! and! IL23! are!
blocked.! In! turn,! IL6!and!tumor!growth! factorRβ!(TGFβ)!can!activate!








Similar! to! other! autoimmune! disorders,! CD! has! a! heterogeneous!
immune!response!(Cho!and!Feldman,!2015).!It!appears!that!more!than!
a! single! inflammatory! pathway! drives! the! inflammation.! This! line! of!
thought! is! reinforced! by! the! different! therapeutic! response! to!
monoclonal! antibodies! designed! to! target! distinct! levels! of!




of! their! first! attack,! and! not! in! those! with! longRstanding! disease!
(Kugathasan! et! al.,! 2007).! Zorzi! et! al! demonstrated! a! significant!






















Th1,!Th2!and!Th17!are!active! in!all! the!stages!of! the!disease,!Th1!
activity!is!predominant!in!the!early!stages,!while!Th17!takes!the!lead!











Angiogenesis! is! the!process!at!which! the! interaction!of! several! cell!
types!and!mediators!creates!a!specific!microenvironment!that!leads!to!
the! formation! of! new! capillaries! from! preRexisting! blood! vessels!
(Conway!et!al.,!2001,!Folkman,!1985).!Physiologically,!angiogenesis!
is!an!essential!component!of!organ!growth!and!development!(Ribatti!
et! al.,! 1991).! Furthermore,! integral! healing! mechanisms! are!
dependent!on!a!balanced!angiogenic! response! typically! intertwined!
with! an! appropriate! inflammatory! response! (Gurtner! et! al.,! 2008).!
Wound! healing! is! a! prime! example:! first! stage! is! characterised!
inflammation! (Grose! and! Werner,! 2004)K! followed! by! new! tissue!
formation! and! angiogenesis! (Werner! and!Grose,! 2003)K! and! finally!




intracellular! signaling! pathways! of! a! large! diversity! of! cells.! These!
homeostatic!mechanisms!are!impaired!in!chronic!disease.!!
!




(Danese! et! al.,! 2006,! Carmeliet,! 2005).! As! inflammation! evolves,!
vessels!expand! to!supply!nutrients! that!sustain! the!accumulation!of!
activated! immune! cells.! In! the! chronic! phase,! local! immune! cells!
overproduce! endothelial! cell! growth! factors,! which! subsequently!
promote! the!expansion!of!capillary!networks! (Carmeliet,!2005).!The!
infiltration!of!macrophages!and!lymphocytes!in!chronic! inflammatory!
disorders! and! the! constant! tissue! damage! and! repair! occur!
concurrently! resulting! in! the! newly! formed! vessels! to! become!
permanent!(Szekanecz!and!Koch,!2004).!The!anatomical!expansion!




Although! the! involvement!of!vasculature! in!CD!has!been!known! for!
more! than! four! decades! (Bacaner,! 1966,! Brahme! and! Lindström,!
1970),!the!angiogenic!mechanisms!are!still!poorly!understood.!!In!CD,!
there! is! a! continuous! deep! ulceration! and! regeneration,! for! which!













previously! identified! at! the! level! of! bowel! mucosa! (Knutson! et! al.,!
1968).! Histologically,! small! intramucosal! haemorrhagic! lesions! are!
seen! early! in! the! disease! development! and! before! inflammatory!
changes! occur! (Sankey! et! al.,! 1993).! Evidence! of! early! vascular!
damage!was!also!demonstrated!by!“summit”!lesions,!with!plumes!of!
fibrin!and!loss!of!superficial!epithelial!cells.!Furthermore,!disruption!of!
the! collagen! IV! in! the! basement! membrane! of! mucosal! layer!
capillaries,!and!extravasation!of!red!blood!cells!and!fibrinogen!into!the!
surrounding! lamina! propria!was! seen! in! 17%!of! a! cohort! of! 35!CD!
patients! (Sankey! et! al.,! 1993).! In! another! cohort! of! 7! CD! patients,!
patchy!epithelial!necrosis! in! the!absence!of!acute! inflammation!was!
reported!as!early!features!of!the!disease!in!2!patients!(Dourmashkin!
et! al.,! 1983).! Wakefield! et& al! suggested! that! vascular! damage!
precedes!mucosal! inflammation! in!CD!patients!when! they!observed!
occlusion!of!the!arteries!supplying!the!affected!bowel!(Wakefield!et!al.,!
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1989).! Although! the! authors! in! these! studies! concluded! that! these!
findings!are!indicative!of!early!vascular!changes!that!are!unlikely!to!be!




characteristic! “fluorescent! spots”,! which! histologically! relate! to!
vasodilatation.! Approximately! 80%! of! the! biopsies! taken! from! the!
fluorescent! spots! showed! vascular! involvement! as! well! as!
inflammatory!changes.!It! is!possible!that!this! isolated!report!has!not!
detected!changes!early!enough!and!therefore!the!vast!majority!of!the!
vascular! changes! are! associated! with! inflammatory! response.!
Furthermore,! a! better! designed! and! larger! sample! size! study! used!
magnifying! colonoscopy! and! biopsy! of! early! “red! halo! appearance”!
lesions! concluded! that! capillary! disruption! precedes! inflammation!
(Fujimura!et! al.,! 1996).! Therefore,! it! is! reasonable! to! conclude! that!
microvascular! changes! are! present! in! the! early! stages! of! CD,!
however,!further!studies!are!required!to!conclude!that!these!changes!
precede! or! cause! inflammation.! In! depth! understanding! of! these!
microvascular!changes!and!the!mechanisms!at!which!they!contribute!











recent! studies! demonstrated! the! frequent! presence! of! mucosal!
capillary!microthrombi!(Dhillon!et!al.,!1992,!Wakefield!et!al.,!1991a).!!
Mucosal! capillary! thrombi! are! also! seen! in! other! forms! of! colitis!
including!infective!colitis!and!are!mainly!formed!of!platelets!(Mathan!




which! is!activated!by! thrombin! to! form! factor!XIIIA! (McDonagh!and!
McDonagh,!1975).!!
!
During! this! process,! stabilised! fibrin! is! formed,! and! that! is! the! final!
event!in!the!coagulation!of!blood.!Therefore,!the!presence!of!XIIIA!in!
the! capillary! microthrombi! of! CD! suggests! that! these! are! true!
microvascular! thrombi.! Keeping! in! mind! that! mucosal! capillary!
microthrombi!are!the!diagnostic!morphological!features!of!ischaemia,!
disseminated! intravascular! coagulation,! and! pseudomembranous!
colitis! (Whitehead,! 1971),! and! that! these! changes! have! only!















et! al.,! 2003).! In! comparison,! the! prevalence! of! CD! in! the! general!
population! in! a! similar! population! is! approximately! 0.2%! (Lapidus,!
2006,!Hall!et!al.,!1985).!A! recent!systematic! review!of! the! literature!
and! a! case! series! confirmed! a! high! incidence! of! vasculitis! in! IBD!
patients! (67%,! 167/260)! (Sy! et! al.,! 2016).! There! were! three! most!
common! types! of! vasculitis! in! IBD! including:! Takayasu! arthritisK!
cutaneous! vasculitis! and! antiRneutrophilic! cytoplasmic! antibodiesR
associated!vasculitis.!The!diagnosis!of!IBD!was!made!before!that!of!
vasculitis!in!most!cases.!Furthermore,!a!hallmark!of!Takayasu!arteritis!








CD! and! features! of! vasculitis! (Dowling! et! al.,! 2008).! Indeed,! the!
gastrointestinal! bleeding! and! perforation! of! patients! with! Behçet’s!
syndrome!increases!its!overall!morbidity!and!mortality!(Hatemi!et!al.,!
2016).! Both! conditions! share! IL23R,! IL10! and! TLR8! genetic!
susceptibility! (OrtizRFernández! et! al.,! 2015).! These! mediators! are!
heavily! involved! in! the! regulation! of! innate! immune! response!
(Trinchieri! and! Sher,! 2007,! Gautier! et! al.,! 2005,! Napolitani! et! al.,!
2005).!!Furthermore,!the!response!rate!to!immunosuppressive!therapy!
and!antiRTNF!agents!in!both!conditions!is!similar!!(Tanida!et!al.,!2015,!
Hatemi!et!al.,!2015).!Fecal!calprotectin! level! is!also!high! in!patients!









the! reason! for! the! association! between! vasculitis! and! CD.! Further!





Angiogenesis! is! mediated! by! several! factors,! some! of! which! are!
proangiogenic! and! others! are! antiangiogenic! (Bouïs! et! al.,! 2006).!
Impeccable!balance!of!the!expression!of!these!factors!is!required!to!
maintain! an! appropriate! angiogenic! response! (Kwiatkowski! et! al.,!
2013).! ! One! of! the! most! important! proangiogenic! factors! in!
pathological! angiogenesis! is! vascular! endothelial! growth! factor!
(VEGF)!(Pousa!et!al.,!2008b).!
!
There! are! seven! different! isoforms! of! VEGF! including:! VEGFRAK!
VEGFRBK!VEGFRCK!VEGFRDK!VEGFREK!VEGFRFK!and!placental!growth!
factor!(PlGF)!(Toi!et!al.,!2001).!VEGF!isoforms!exhibit!their!action!on!
the! cells! by! binding! to! three! cell! membrane! receptors! VEGFRR1,!
VEGFRR2,!and!VEGFRR3!(Ferrara!et!al.,!2003).!Specifically,!VEGFRA!
promotes! angiogenesis! by! increasing! vascular! permeability,! and!
inducing! endothelial! cells! (EC)! proliferation,! migration! and!
differentiation.!VEGFRA!stimulates!the!production!of!proinflammatory!
cytokines! by! activating! nuclear! factor! !B! (NF!B)! and! increasing!
adhesion!of!leukocytes!to!vascular!endothelium!and!monocytes!(Toi!
et!al.,!2001).!The!level!of!VEGF!was!found!to!be!significantly!higher!in!







of! VEGF! in! the! supernatant! of! cultured! mucosal! biopsies! was!
significantly!higher! than!controls! (Griga!et!al.,!1999b).! In!a!different!
report! the! secretion! of! VEGF! by! the! peripheral! blood!mononuclear!
cells!was!significantly!higher!in!CD!patients!than!controls!(Griga!et!al.,!
1999a).! Further! work! by! the! same! group! demonstrated! that! VEGF!
expression!is!significantly!higher!in!CD!patients!inflamed!endoscopic!
biopsies! in! comparison! to! nonRinflamed! mucosa! of! same! patients!
(Griga!et!al.,!2002).!More!recently,!Alkim!et&al&confirmed!significantly!
higher! expression! of! VEGF! and! increased! microvascular! density!
(MVD)!in!CD!and!UC!mucosal!biopsies!than!healthy!controls!(Alkim!et!




between! the! groups! (Kapsoritakis! et! al.,! 2003).! Although! the! latter!









and! as! has! been! hypothesised! in! section! 1.3.1.,! and! illustrated! in!
Figure!1.3.!of!this!chapter!cytokine!expression!may!differ!depending!













Other! angiogenic! growth! factors!were! investigated! in!CD! including:!
basic!fibroblast!growth!factor!(bFGF)K!hepatocyte!growth!factor!(HGF)K!
and! transforming! growth! factor! beta! (TGFR").! bFGF! triggers! vessel!
formation! by! promoting! the! growth! and! differentiation! of! vascular!






bFGF! in! the! process! of! transmural! fibrogenesis.! HGF! is! a!
proangiogenic! factor! that! stimulates! endothelial! cells! mitogenesis,!
motility!and!extracellular!matrix!invasion!(Van!Belle!et!al.,!1998).!There!
were! conflicting! reports! about! the! serum! level! of! HGF! in! CD.! In! a!
cohort! of! 60! patients! with! CD! Srivastava! et& al& found! a! significant!
elevation! in! the! serum! level! of! HGF! in! comparison! to! patients!
presenting!with!function!and!benign!bowel!disorders!(Srivastava!et!al.,!















al.,! 2004).! However,! individually! they! have! been! shown! to! exhibit!







the! levels!of! thrombospondins! (TSPs),! a!wellRknown!antiangiogenic!
factor,! in!CD!patients!were! inconsistent! in! the! literature.!Alkim!et&al!
reported!higher! level!of!TSPR1!expression! in!mucosal!biopsies!of!a!
cohort! of! 14! patients!with!CD! in! comparison! to! 11!healthy! controls!
(Alkim!et!al.,!2012).!On! the!other!hand,!Wejman!et&al! found!similar!
expression! of! TSPR1! in! surgical! specimens! of! 38! CD! patients! in!
comparison! to! controls! (Wejman! et! al.,! 2013).! It! is! noticeable! in! a!
repeated!pattern!that!the!tissue!expression!level!of!angiogenic!factors!
differ! depending!on! the! specimens!used! for! analysis.!For! example,!
when! surgical! specimens! obtained! from! surgical! resections,! no!
significant!increase!in!the!level!of!expression!is!observed.!However,!
when! the! samples! are! retrieved! from! patients! endoscopically,!
significant!differences!are!observed.!This!has!also!been!seen!when!
the! level! of! VEGF! was! assessed! (see! above).! Several! potential!
reasons! may! explain! this! difference.! Firstly,! patients! who! are!
undergoing! surgical! resection! have! usually! failed! optimal! medical!
therapy! and! the! disease! is! at! its! late! stage.! Whereas! endoscopic!
specimens!are!usually!retrieved!from!patients!at!an!early!stage!of!the!
disease.! Secondly,! surgical! specimens! are! taken! from! nonRliving!


















whether!CD! is!proangiogenic!whereby! these! factors!perpetuate! the!
disease?!And!therefore!could!angiogenesis!be!targeted!for!therapy?!
The!answer!remains!unclearK!it!is!difficult!to!conclude!whether!CD!is!
characterised! by! up! or! down! regulation! of! angiogenesis.! Indeed,!









and! a! potential! therapeutic! target.! Hence,! the! use! of! angiogenic!
modulators!may!be!beneficial!in!the!treatment!of!CD.!Mesalamine,!for!
example! while! given! as! an! antiRinflammatory! has! an! angiogenic!
modulatory! role.! Deng! et& al& shown! that! mesalamine! establishes!
angiogenic! balance! by! reducing! angiostatin! and! endostatin! and!
induced!TNFR#!and!MMPR9!activity!in!experimental!colitis!(Deng!et!al.,!
2009).! Furthermore,! antiRTNF! drugs,! such! as! infliximab,! currently!
considered!an!effective! therapy! for! the! treatment! of!CD!have!been!




Nevertheless,! specific! antiangiogenic! therapy! for! CD! is! yet! to! be!
discovered.!The!use!of!Bevacizumab,!a!monoclonal!antibody!against!
VEGF,! for! the! treatment! of! CD! has! been! hindered! by! its! reported!
serious!side!effect,!such!as!reducing!wound!healing,!anastomotic!leak!
and!intestinal!perforation!(Adenis!et!al.,!2007).!Furthermore,!lessons!
have!been! learnt! from!the!use!of! tyrosine!kinase! inhibitors,!such!as!
sunitinib! and! sorafenib,! which! inhibit! angiogenesis! by! blocking!
VEGFR1,!VEGFR2!and!VEGFR3.!When!these!drugs!were!used!for!
the! treatment! of! hepatocellular! and! renal! cell! carcinoma! they! have!
caused!relapse!of!CD!(Danese,!2011).!They!also!cause!CD!relapse!in!
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patients! being! treated! for! renal! cell! carcinoma,! even! when! reR
challenged!a!second!relapse!occurred!(BoersRSonderen!et!al.,!2014).!!
!
Another! promising! antiangiogenic! therapy! that! was! used! for! the!
treatment!of!CD!is!antiR#4Rintegrins!monoclonal!antibodies!including:!
natalizuma!and!vedolizumab.!!#4Rintegrins!were!initially!discovered!on!
lymphocytes,! but! have! subsequently! been! reported! on! angiogenic!
endothelial!cells!(Vanderslice!et!al.,!1998).!Integrins!are!the!principle!
adhesion! receptors! used! by! endothelial! cells! to! interact! with! their!
extracellular! environment! and! play! a! crucial! role! in! regulating!
endothelial! cell! proliferation,! migration! and! survival! (Stupack! and!
Cheresh,! 2004).! By! blocking! #4Rintegrins! angiogenesis! can! be!
inhibited! (Calzada! et! al.,! 2004,! Koch! et! al.,! 1995).! A! recent! metaR
analysis!on!the!use!of!natalizuma!and!vedolizumab!for!the!treatment!
of! CD! including! 8! randomised! clinical! trials! concluded! that! these!
antiangiogenic!and!antiRinflammatory!drugs!are!effective! in! inducing!
and! maintaining! remission! in! CD! patients! (Chandar! et! al.,! 2015).!
However,! the! rare! but! fatal! risk! of! a! progressive! multifocal!
leukoencephalopathy!(PML)!is!a!major!concern!(Hunt!and!Giovannoni,!















PDGF! nor! angiogenic! factors,! such! as! AngiopoietinR2! (AngR2)! and!
epidermal!growth!factor!receptor!(EGFR)!were!significantly!different!to!
control.! ! More! importantly,! this! treatment! strategy! also! failed! to!
decrease!the!desired!outcome!of!MVD!or!inflammation!(Knod!et!al.,!
2016b).!It!appears!that!additional!angiogenic!pathways!are!activated!
when! certain! pathways! are! blocked.! These! mechanisms! require!
further! understanding,! in! order! to! design! a!multiple! pathway! target!
strategy! that! mediates! an! appropriate! angiogenic! response! in!









fold! of! the! peritoneum! which! attaches! the! bowel! to! the! posterior!
abdominal!wall!(Culligan!et!al.,!2014).!It!is!formed!of!AT!surrounding!
the!major!vessels!and!their!branches!that!carry!the!blood!supply!to!the!








fibrosis,! inflammation,! thickened! lymphatic! vessels,! infiltration! of!
stromal! cells,! perineuronal! chronic! inflammation,! engorged! vessels,!





















wrapping! was! only! identified! in! patients! with! CD! (Sheehan! et! al.,!
1992).! Thus,! the! uniqueness! of! fat! wrapping! to! CD! and! the! high!










lesions,!particularly! transmural! inflammation,! it! is!also!recognised!at!
early!stages!of! the!disease!and!without!apparent!bowel! lesion.!This!
may! suggest! that! mesenteric! AT! is! implicated! in! the! early!
aetiopathogenesis!of!CD.!The!first!description!of!CD!by!Crohn!in!1932!
implies! the!possibility!of!early!mesenteric! involvement!(Crohn!et!al.,!







Desreumaux! et& al! (Desreumaux! et! al.,! 1999)! demonstrated! a!
significantly!greater!ratio!of!intraRabdominal!fat!to!total!abdominal!fat!
in!CD!patients!in!comparison!to!control.!Although!ShelleyRFraser!et&al!
demonstrated! a! strong! correlation! between! fat! wrapping! and!
transmural! inflammation,! in! the! form!of! lymphoid!aggregates,! using!
intraoperative!endoscopy,!Smedh!et&al!identified!fat!wrapping!in!14%!
of! CD! patients! who! had!macroscopically! healthy! intestinal! mucosa!
(Smedh! et! al.,! 1993).! Therefore,! the! accumulation! of! fat! in! the!
mesentery!of!patients!with!CD!appears!to!be!an!early!event!and!not!






in! the! mesentery! of! CD! patients?”! The! current! knowledge!
demonstrates! that! adipocytes! have! metabolic! and! immunologic!
functions! and! not! only! energy! storage! as! was! believed! previously.!
Specifically,!mesenteric!AT!in!CD!patients!was!found!to!over!express!
proR! and! antiRinflammatory! chemokines,! adipokines! and! other!
cytokines.! Increase! expression! of! leptin! and! adiponectin!mRNA! as!
well! as! their! proteins! are! reported! in! hypertrophied!CD!mesenteric!
tissue! (Barbier! et! al.,! 2003,!Yamamoto!et! al.,! 2005).!Similarly,! proR
inflammatory!cytokines!such!as,! interleukin!6!(IL6),! tumour!necrosis!





to! differentiate! into! macrophages! with! antimicrobial! activities!




be! due! to! an! assumption! that! it! is! a! result! of! the! transmural!
inflammation.!However,!as!demonstrated!above!the!literature!does!not!
fully! support! this! assumption! and! complete! understanding! of! the!
58""






As! described! above! the! mesentery! homes! the! blood! vessels! that!
supply! the! bowel! with! oxygen! and! nutrients! and! dispose! of! waiste!
products.! Thus,! the! association! of! changes!mesenteric! vasculature!
and! CD! is! not! a! surprise.! Indeed,! patients! with! CD! had! reduced!







al.,! 2004).! Furthermore,! Ludwig! et& al! demonstrated! a! significant!
correlation!between!the!velocity!of!blood!flow!in!the!SMA,!which!is!an!








altered!mesenteric!vasculature! in!CD,!which! is!useful! for!diagnostic!
purposes,! these! studies! suggest! that! a! potential! difference! in! the!







proangiogenic! cytokines,! mesenteric! AT! in! CD! expresses! VEGF!
(Schaffler!et!al.,!2006),!TNFR#!(Desreumaux!et!al.,!1999),!IL6!(Zulian!
et! al.,! 2013)! and! IL1R"! (Hotamisligil! et! al.,! 1993)! at! higher! rates! in!
comparison!to!controls!(Table!1.1.).!It!has!been!shown!that!adipocyte!












VEGF! Proangiogenic! Similar! (Schaffler!et!al.,!2006)!
TNF^#! Proangiogenic! High! (Desreumaux!et!al.,!1999)!
IL6! Proangiogenic! High! (Zulian!et!al.,!2013)!










the! inflammatory! mechanisms! of! CD! have! been! intensively!
investigated,! its! angiogenic! effect! remains! poorly! understood.!
However,! in! cancer,! TNFR#! has! a! strong! proangiogenic! effect! by!
inducing! neovascularization! (Tertil! et! al.,! 2014).! Similarly,! the!
overexpression!of!IL6!in!the!mesentery!of!CD!is!also!associated!with!
elevated! levels! in! the! serum! (Bertin! et! al.,! 2010).! Several! studies!
suggested!that!adipocytes!are!responsible!for!approximately!30%!of!
the!total!level!of!circulating!IL6!(Park!et!al.,!2005).!In!fact,!the!serum!
level! of! IL6! is! a! potential! marker! for! the! prediction! of! the! disease!
activity!(Reinisch!et!al.,!1999).!Patients!in!remission!have!low!levels!in!
comparison! to!patients! in! relapse! (Van!Kemseke!et! al.,! 2000).!The!
angiogenic!role!of!IL6!in!CD!has!not!been!investigated.!However,!IL6!
is! a! potent! proangiogenic! cytokine.! It! enhances! angiogenesis! and!
tubule!formation!(Hashizume!et!al.,!2009).!!
!
Specifically,! IL6! up! regulates!VEGF! production.! In! vitro! IL6! treated!
adipocytes! secreted! significantly! high! levels! of! VEGF! (Rega! et! al.,!
2007).!Only!one!study!to!date!investigated!the!level!of!VEGF!secretion!




















Adiponectin! has! been! known! for! its! antiRinflammatory! properties!
(Trujillo! and! Scherer,! 2005),! also! shown! to! induce! angiogenesis! in!
endothelial! cells! via!AMPRactivated!protein! kinaseRendothelial! nitricR
oxide!synthase!(AMPKReNOS)!pathway!(Ouchi!et!al.,!2004).!Although!
antiangiogenic!potential!of!adiponectin!has!been!explored! in!cancer!
therapy! (Man! et! al.,! 2010),! its! role! in! angiogenesis! appears! to! be!
critical.!For!example,!low!adiponectin!level!(hypoadiponectinemia)!is!
an!independent!risk!factor!for!endothelial!dysfunction!and!modulating!
vessel! wall! health! (Okui! et! al.,! 2008).! The! serum! concentration! of!
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concertation! of! adiponectin! was! similar! in! comparison! to! controls!







Leptin! is!an!adipokine! that! is! involved! in!appetite! regulation,! fertility!
and! bone! metabolism! (Ahima! and! Flier,! 2000b).! Yet,! one! of! the!




proinflammatory! cytokines! (Lord! et! al.,! 1998).! Specifically! leptin!
stimulates!the!development!of!Th1!phenotype,!such!as!IFNR$,!TNFR#,!
IL6!and!IL1!rather!than!Th2!phenotype!(Lord,!2002).!In!angiogenesis,!
leptin! is! a! proangiogenic! adipokines! induces! endothelial! cell!
proliferation! and! stimulates! the! expression! of! matrix!
metalloproteinases!(MMPs)!(Park!et!al.,!2001).!In!CD!mesenteric!AT!
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leptin! is! up! regulated! in! the! in! comparison! to! colon! cancer! and!
diverticular! disease! (Barbier! et! al.,! 2003,! Paul! et! al.,! 2006b).!
Interestingly,! leptin! has! a! direct! effect! on! mucin! production! and!
increase! colonic! tight! junction! permeability! (El! Homsi! et! al.,! 2007,!
Plaisancie!et!al.,!2006,!Le!Dréan!et!al.,!2014),!which!contributes!to!the!
integrity!of!the!intestinal!barrier!(Hardwick!et!al.,!2001).!Hence!leptin!







and! impact! this! may! have! progression,! ! the! need! to! further!
characterise! the! mesentery! has! become! apparent.! The! intimate!
relationship! between! angiogenesis! and! inflammation! is! also!
undisputable.!For!example,!major!inflammatory!cytokines,!such!as!IL6,!
TNFR#,! and! IL1R",! known! for! their! profound! involvement! in! CD!
pathogenesis!are!also!angiogenic!factors.!!
!
The! phenomenon! of! fat! wrapping! is! shaped! by! the! expansion! of!
mesenteric! AT.! Like! any! expanding! tissue,! the!mesentery! requires!
new!blood!vessels! to!support! the! inflammatory!mass.! It! is! therefore!
perceivable! to! assume! an! active! angiogenic! element! to! the! fat!
wrapping!phenomena.!To!date,!there!is!only!one!study!in!the!literature!
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The! hypothesis! of! this! work! is! that! angiogenic! mechanisms! in! CD!

































































ethical! approval! and! the! design! for! the! five! experiments! that! were!







Patients! undergoing! bowel! resection! involving! the! ileocaecal!




and! the! theatreRoperation! list.! Patients! were! approached! prior! to!







2.! Patients!with! the!diagnosis!of! IBD!or!any!other!benign!bowel!














Ethical! approval! was! obtained! from! The! National! Research! Ethics!
Service!Committee!(LondonRHampstead)!(10/H0722/69)!and!the!Joint!











the! time! of! surgery! and! included:! ileocaecal! mesenteric,! omental,!
subcutaneous!AT!from!CD!and!controls!and!wrapping!mesenteric!AT!





in! formaldehyde! for! histopathological! analysis.! All! samples! were!
immediately!transported!to!the!laboratory.!
!
Blood! samples!were! centrifuged! (3000! rpm,15!minutes,! 25oC),! the!
serum! was! collected! aliquoted! and! stored! at! R80! oC! until! analysis.!
Tissue!samples!aliquoted!immediately!upon!excision!from!the!patient,!
labeled! and! stored! at! R80! oC.! AT! transported! in! cellgro! (Cellgro,!


















Then! the! slides! were! plunged! into! water! and! counterstained! with!






antigen! retrieval.!Several! primary!antibodies!were!used! to! quantify,!
inflammation,! fibrosis,! microvascular! density! and! the! level! of!
angiogenic! factors! includingK! hypoxia! inducible! factor! (HIF)R1#K! and!
vascular!endothelial!growth!factor!(VEGF).!The!primary!antibodies!that!
were!used!are:!CD68!(clone!PGRM1,!Dako),!α3!chain!of! the!human!




Dilution! of! the! primary! antibodies! was! done! as! per! manufactures’!




PBS/T,! and! the! respective! secondary! antibodies! were! added.! A!
biotinylated! goat! vs.! mouse! secondary! antibody! (Jackson! Immuno!
Research! Labs,! West! Grove! PA)! was! applied! for! 15! minutes! and!
followed!by!Elite!ABC!reagent!(Vector!Labs,!Burlingame,!CA)!for!20!
min.!The!amplification!reagent!from!the!Catalyzed!Signal!Amplification!



















2.! Granulomata! were! defined! as! identifiable! macrophage! cellR
related! lesions! counted! for! the! entire! area! studied! at! 100x!
magnification!











vessel! density! counted! (Chalkley,! 1943).! Vessel! architecture!
(tortuosity,!calibre!changes)!was!also!assessed!in!an!ordinal!manner!
as!absent,!mild,!moderate!and!severe!(Thornton!and!Solomon,!2002).!
Sections! were! stained! with! CD31,! and! CD34! antibodies! to! assess!
vascular! density,! morphology! and! vascular! alterations.! Angiogenic!
























This! was! pipetted! carefully! and! transferred! into! a! new! eppendorf.!
Equal!volume!of!100%! isopropanol!was!added! to! the!RNA!solution!
and!mixed!gently.!The!sample!was!then!incubated!at!R20!oC!for!several!
hoursK! a! minimum! of! 2! hours! was! allowed.! After! another! round! of!





nucleaseRfree!water! (Chomczynski! and!Sacchi,! 1987,!Chomczynski!
and!Sacchi,!2006).!!
!
The! purity! and! concentration! of! total! RNA! were! determined!
spectrophotometrically!(NanoDropR1000!Spectrophotometer,!Thermo!
Scientific,! USA).! The! concentration! of! RNA! was! measured! as!
absorbance! at! 260! nm.! The! purity! was! determined! by! the! ratios!
between!260!nm!and!280!nm!(260/280)!and!between!260!nm!and!230!











transcription! mix! (5x! Buffer! BC3,! Control! P2,! RE3! Reverse!











PCR!array! plates!were! carried! out! according! to! the!manufacturer’s!
instructions!!(Qiagen!Ltd,!UK).!In!brief,!RT2!SYBR!Green!Mastermix!
was!centrifuged!for!10R15!seconds!before!being!mixed!with!the!cDNA!
and!RNaseRfree!water! to! create!a! total! volume!of! 1300!µl! for! each!
reaction.! A! total! volume! of! 10!µl! of! the!PCR! components!mix!was!
added!to!each!well!in!the!RT2!Profiler!and!Custom!RT2!Profiler!Arrays!
plates.! ! Cycling! condition! for! PCR! was! one! cycle! at! 95! oC! for! 10!
minutes! to! activate! HotStart! DNA! Taq! Polymerase,! followed! by! 40!
cycles!at!95!oC!for!15!seconds!each,!and!finally!one!cycle!60!oC!in!ABI!
Prism! 7900HT! Sequence! Detection! System! (Applied! Biosystems,!
UK).!
!
Web! based! data! analysis! aided! by! Microsoft! excel! spreadsheet!
containing!algorithms!provided!by! the!manufacturer! to!calculate! the!
ΔΔCt! (Qiagen! Ltd,! UK).! Furthermore,! foldRchanges! were! calculated!
using! the! same! web! based! analysis! as! recommended! by! the!








measure! the! tissue! expression! of! IL6! and! VEGF.! Secondly,! the!
capacity!of!tissue!to!secrete!these!proteins!was!measured!using!tissue!









Assay! (Novagen,! EMD!Chemicals,! CA,!USA).! Briefly,! the! standard!
curve!was!built!by!using!diluted!bovine!serum!albumin!as!the!standard!
(SigmaRAldrich,! UK,! concentration:! 0,! 25,! 125,! 250,! 500,! and! 1000!
µg/ml).!25!µl!standards!and!samples!were!loaded!into!a!96Rwell!plate!
followed! by! 200! µl! BCA! working! reagent! (1! portion! of! 4%! Cupric!
Sulfate!plus!50!portions!of!BCA!solution).!The!plate!was!incubated!at!
37!oC!for!30!minutes.!Cu2+!was!reduced!to!Cu1+!by!protein!in!alkaline!









and! incubated! in! 500! µl! Cellgro! serumRfree! media! (Mediatech!
Manassas,!VA)!with!5%!penicillinRstreptomycin!for!a!total!of!36!hours!
(37! oC,! 95%! O2,! 5%! CO2).! Following! incubation,! the! medium! was!







ATK! 2)! explant! AT! culture! supernatantK! and! 3)! serum.! The!
concentration! of! ILR6! was! measured! using! Quantikine! Human! ILR6!
ELISA! Kit! (R&D! Systems,! Minneapolis,! MN,! USA)! and! VEGF!
measured!using! the!Quantikine!Human!VEGF!Immunoassay!ELISA!
kit! (R&D! Systems,! Inc.! Minneapolis,! MN,! USA)! according! to!
manufacture!protocol.!Explained!here!briefly,! the!standard!solutions!
for!standard!curve!were!first!prepared!by!diluting!down!the!standard!





ensuring! complete! removal! of! liquid! between! each! wash! using!
aspirating!and!blotting!against!a!clean!paper! towel.!Then!conjugate!
was!added!to!each!well,!covering!with!adhesive!strip!and!incubated!
for!one!hour!at! room! temperature.!After! the! second! incubation,! the!















the! immunofluorescent! staining! performed! to! demonstrate! that! the!













with! vascular! endothelial! growth! factors! and! hydrocortisone! (VWR!
International!Ltd,!UK).!The!plate!is!incubated!at!37!oC,!95%!O2,!and!
5%!CO2.!Every!alternative!day!100μl!of!the!media!was!changed.!Live!














On! day! 12,! AT! explants! embedded! in! Matrigel! were! fixed! in! 4%!
formaldehyde!and!stained!with!primary!mouse!antihuman!antibodies!
to! the! following:! antiRalpha! smooth! muscle! actin! antibody! (VWR!
International! Ltd,! UK)K! and! endothelial! marker! antiReNOS! antibody!
(SigmaRaldrich,! UK).! In! brief,! formaldehyde! was! removed! and! the!
matrigel!culture!was!permeabilise!with!a!mixture!of!PBS,!CaCl2,!MgCl2!
and!0.25%!Triton!XR100! for! 15!minutes!at! room! temperature! twice.!
Block!using!1!drop!of!2x!casein!buffer!per!well!was!then!added!for!30!













Figure! 2.2.! Immunofluorescent! staining! of! matrigel! assay! vascular!









most! important! findings! as! appropriate.! Variables! were! tested! for!
normality! of! distribution! when! applicable! using! D’AgostinoRPearson!




For! continuous! variables,! paired! tRtest,! unpaired! tRtest,! ANOVA,!


























Patients’ characteristics and 
postoperative outcome 
!








Despite! the! effectiveness! of! medical! therapy,! and! in! particular! the!
progress! achieved! in! the! potency! of! biological! immunomodulatory!
drug! treatments! ! over! the! past! decade! (Cummings! et! al.,! 2008),!
surgical!treatment!for!CD!remains!an!important!option!(Scarpa!et!al.,!
2015).! It! is! estimated! that! 70R90%! of! CD! patients! will! still! require!
surgery!at!some!point!in!their!lives!notwithstanding!medical!treatment!
(CaninREndres!et!al.,!1999,!Mekhjian!et!al.,!1979b).!There!are!several!
indications! for! surgery! in! CD! patients,! including! acute! and! chronic!
complications,! such! as! toxic! colitis,! megacolon,! perforation,!
haemorrhage,! fistula,! obstruction,! stricture,! carcinoma! and! in! those!
who!failed!medical!therapy.!!
!
All! the! patients! who! participated! in! this! study! underwent! surgical!
resection,!and!excised! tissues!were!used! for! specific! investigations!
described!in!this!thesis.!!!Due!to!the!diversity!of!indications!for!surgical!
resection! in!CD!and! the! different! diagnoses! for! controls,! there! is! a!
potential! for! clinical! and! pathological! heterogeneity! of! the! study!
participants.! Therefore,! it! is! important! to! accurately! define! patients’!
characteristics.!This!will!allow!the!identification!of!confounding!factors!









chapter! is! divided! into! three! main! sections:! 1)! preoperative!





This! section! addresses:! 1)! basic! characteristics! describing! age,!
gender,! race,! body! mass! index! (BMI),! American! Society! of!





Table! 3.1! summarises! patients’! demographics! and! preoperative!
details.!The!age!was!similar!between!CD!(mean=34!years,!SD=16)!
and! control! (mean=39! years,! SD=16).! There! were! similar! ratios! of!
males! and! females! in! the! two! groups:! disease! group! included! 10!
(43%)!males! and! 13! (57%)! femalesK! and! control! group! included! 6!






origin! in! the! disease! group.! The! difference! in! ratios! between! the!
groups!was!statistically!significant!(X2(2)=6.5,!p<0.05)!(Figure!3.1).!BMI!
was! similar! between! CD! (mean=24,! SD=6)! and! control! (mean=24,!
SD=5)!patients.!Patients!also!had!similar!ASA!score:! there!were!19!
(83%)!and!12!(86%)!patients!with!ASA!score!of!II,!in!the!disease!and!




blood! levels! were! significantly! (p<0.05)! higher! in! the! disease!
(mean=54! mg/L,! SD=66)! than! control! (mean=17! mg/L,! SD=25)!
patients!(Figure!3.2).!Haemoglobin!(mean=13!g/L,!SD=2)!and!WCC!










































































































































































Urea:!(mmol/L)!! 4.9!(1.7)! 4.6!(6)! 0.85!
Creatinine:!(μmol/L)! 66!(23)! 76!(19)! 0.22!
EGFR:!
(mls/min/1.73m2)! 86!(9.8)! 79!(12)! 0.08!
Sodium:!(mmol/L)! 139!(4)! 140!(2.5)! 0.38!
Potassium:!(mmol/L)! 4.3!(0.5)! 4!(0.4)! 0.06!
Calcium!(total):!
(mmol/L)! 2.3!(0.2)! 2.3!(0.2)! R!
Albumen:!(g/L)! 40!(9)! 40!(8)! 0.7!















in! the! disease! group! (n=20,! 87%)! than! in! the! control! (n=4,! 29%)!
(X2(1)=13,! p<0.001)! (Figure! 3.3).! Table! 3.3! summarises! the!
immunosuppressive! therapy! in! CD! and! control! groups.! Of! the! 20!
patients!with!CD!on! immunosuppressive! therapy!12! (60%)!were!on!
combination! of! two! or! more! immunosuppressive! therapy! including:!





immunosuppressive! therapy!were!on!a! combination!of! three!drugs:!
azathioprine,! infliximab! and!methotrexate.! The! other! three! patients!
































































The! overwhelming! majority! of! CD! patients! were! diagnosed! with!
ileocaecal! disease! (n=20,! 87%).! The! remaining! 3! patients! had! the!
disease! affecting! the! ileocolonicK! isolated! colonicK! and! isolated!
terminal!ileum!respectively!(Table!3.1).!In!the!control!group,!there!were!
5! patients! diagnosed! with! functional! colonic! disease! and! required!
subtotal!colectomy:!3!of!which!were!diagnosed!with!EDS,!and!2!with!
chronic! constipation.! Furthermore,! there! were! 4! patients! with!








in! CD! patients! (n=23).! Active! chronic! transmural! inflammation! was!
described!in!21!(91%)!bowel!tissue!samples.!The!remainder!2!(9%)!of!

















































UC.!This! is! important! to!characterise!as!patients!with!UC!can!have!
similar!biochemical!markers!as!CD.!However,!UC!is!not!know!to!affect!
the! mesentery.! The! diagnosis! of! UC,! was! confirmed! on! the!
pathological! specimens! to! be! severe! active! in! 3! patients! and!
moderately! active! in! 2! patients.! All! colonic! samples! showed! focal!
active! inflammation! in! the! form! of! cryptitis! and! occasional! crypt!



































































Figure! 3.6.! Significant! correlation! between! Crohn’s! Disease! Activity! Index!
(CDAI)!(n=23)!and!various!biochemical!markers.!White!cell!count!significantly!
positively!correlates!with!CDAI!(A).!Neutrophils!count!significantly!positively!
correlates! with! CDAI! (B).! Haemoglobin! blood! level! significantly! negatively!





Figure! 3.7.! Significant! positive! correlation!was! found! between! the! disease!
activity! on! the! histological! specimen! of! the! bowel! and! Crohn’s! Disease!
Activity!Index!(CDAI)!score!

























Except! for! CRP,! all! other! variables! including! WCC,! neutrophils,!
haemoglobin,!haematocrit!and!CDAI!were!normally!distributed!when!
tested! for! normality! using! KolmogorovRSimirnov! and! ShapiroRWilk!
tests.!Univariate!linear!logistic!regression!analysis!was!performed!on!
individual! independent! variables! including:! WCC,! neutrophils,!
haemoglobin!and!haematocrit.!CDAI!was!considered!the!dependent!
variable.!The!model!produced!statistically!significant!coefficients!for!all!
the! variables! (Table! 3.6).! This!means! that! a! unit! increase! in!WCC!
(x109/L)!can!predict!an!increase!of!CDAI!by!15.5!points.!Similarly,!a!
unit!increase!in!the!neutrophils!count!(x109/L)!or!CRP!(mg/dL)!serum!






Except! for! the! CRP! level,! multivariate! linear! regression! of! WCC,!
neutrophils,!haemoglobin,!and!haematocrit!to!predict!CDAI!produced!









Table! 3.6.! Univariate! and! multivariate! linear! regression! analysis! to! predict! the!
likelihood!of!CDAI!score!!
! Univariate! Multivariate!




WCC! 15.5! [2.7,28]! 0.02! R! R! R!
Neutrophils! 16.2! [2.5,30]! 0.02! R! R! R!
CRP! 0.8! [0.1,1.5]! 0.03! 0.5! [R0.2,1.3]! 0.15!
Haemoglobin! R47.5! [R85,R10]! 0.01! R! R! R!










correlated!with!CDAI! (Section! 3.2.3.1! and!Figure! 3.7).! This! section!
aims! to! construct! a! model! that! can! predict! the! severity! of! bowel!
inflammation! from! preoperative! variables.! Although! the! dependent!
variable! of! CD! pathological! severity! is! ordinal,! represented! by:! 10!




remission! pathological! diagnosis.! Binary! rather! than! ordinal! logistic!
regression!analysis!was!used! for!easier! interpretation!of! the! results!
and! because! patients! with! severe! disease! represented! the! highest!
ratio,!almost!half!of!the!CD!patients’!population.!!
!
Univariate! analysis! of! WCC,! neutrophils,! CRP,! haemoglobin,!
haematocrit,!and!CDAI!was!performed!to!predict!the!severity!of!bowel!
disease!on!pathology!and!demonstrated!a! significant! odds! ratio! for!
CDAI!(OR=1.02,!95%!CI![1,1.04],!p<0.05).!This!suggests!that!for!every!
unit! increase! in! the! CDAI! the! likelihood! of! the! patient! to! have!
pathologically!severe!bowel!disease!increases!by!2%.!The!odds!ratio!






CDAI,! there! is! 3%! increase! in! the! likelihood! of! the! patient! having!
pathologically!severe!bowel!disease.!The!odds!ratio!for!other!variables!
remain! statistically! insignificant! (Table!3.7).!On! the!univariate!CDAI!
can!predict!pathologically!severe!bowel!and!nonRsevere!bowel!disease!
in! 92%! and! 90%! of! the! patients! respectively.! Similarly,! in! the!







! OR! 95%!CI! p!value! OR! 95%!CI! p!value!
WCC!! 1.18! [1,1.5]! 0.17! 1.27! [0.1,36]! 0.89!
Neutrophils!! 1.18! [1,1.5]! 0.19! 0.70! [0.02,20]! 0.83!
CRP!!! 1.02! [0.99,1! 0.17! 1.00! [1,1.1]! 0.99!
Haemoglobin!!! 0.55! [0.3,1.1]! 0.10! 1.38! [0.1,49]! 0.86!
Haematocrit!!! 0.80! [0.63,1]! 0.08! 0.85! [0.24,3]! 0.81!












performed! in! 13! (53%)! and! 10! (71%)! of! CD! and! control! patients!
respectively.!A!total!of!5!(22%)!patients!in!the!CD!group!and!3!(21%)!
patients! in! the! control! group! had! their! resection! completed!
laparoscopically4.!Furthermore,!5!(22%)!of!CD!patients!and!1!(7%)!of!

























































Table! 3.9! summarises! postoperative! details! including! the! length! of!
hospital!stay,!postoperative!complications,!readmission!rate,!and!CD!
recurrence! rate.!The! time!of! follow!up! ranged! from!approximately!6!
months!to!3!years.!The!median!hospital!stay!for!the!CD!patients!was!
shorter! (median=9! days,! range:! 4,! 64)! than! the! control! group!
(median=13! days,! range:! 3,! 36),! however! the! difference! was! not!
statistically! significant! (p=0.67).! Two! patients! from! the! CD! group!
suffered!from!postRoperative!wound!infection,!one!of!which!required!a!
negative! pressure! wound! therapy! (NPWT)! (vacuum! dressing)5! for!
treatment!and!the!other!resolved!with!conservative!management.!One!







relapse.! None! of! the! patients! who! were! readmitted! in! the! disease!
group! required! surgery.! Two! patients! from! the! control! group! were!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!
5! NegativeRpressure! wound! therapy! (NPWT)! is! a! therapeutic! technique! using!






The! recurrence! rate!was! reported! in!5! (22%)!of! the!disease!group.!
Three!of!which!were!proven!on! repeat!colposcopy!and!pathological!
specimens.! The! remainder! two! complained! of! symptoms! of!




















The! objectives! were! to! identify! potential! differences! between! the!
patients!that!might!have!been!a!cause!for!biases,!such!as!age,!gender,!
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comparable! in! terms! of! their! age,! gender,! BMI,! ASA! score,! WCC!
count,!haemoglobin,!haematocrit,!and!albumen!levels.!However,!there!
were!significantly!more!Caucasian!patients,!higher!CRP! levels,!and!
more! frequent! immunosuppressive! treatment! in! the! disease! group.!
These!differences!will!be!considered!when!interpreting!the!results!of!
the!subsequent!experiments,!such!as!gene!and!protein!expression.!
The! results! also! confirmed! that! CDAI,! relevant! to! CD! patients,!
significantly! positively! correlated! with! the! disease! activity! on!
histopathology,! WCC,! and! neutrophils! counts.! On! the! other! hand,!








CD! from! other! chronic! gastrointestinal! conditions.! A! study! from! St!
Bartholomew’s!Hospital,!London!(Beattie!et!al.,!1995)! found! that!26!
(100%)!of!the!patients!diagnosed!with!CD!had!increased!CRP!levels!
as! compared!with! those!who!had!polyps!or! children!with!otherwise!
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normal! investigations.! Similar! findings!were! demonstrated! almost! a!
decade! before! that,! by! Shine! et! al! at! St! Mark’s! hospital,! London!
investigating!chronic!abdominal!pain!in!82!patients,!out!of!which!all!of!
CD!patients!had!increased!CRP!as!compared!with!normal!CRP!levels!





Another!significant! finding! is! that!majority!of!CD!patients!are!from!a!
Caucasian!racial!origin,!which!is!consistent!with!previous!research.!In!
an!epidemiological!report!including!554!patients!with!CD,!485!(87%)!
and! 53! (10%)! were! from! Caucasian! and! African! American! racial!
origins!respectively! (Kanaan!et!al.,!2012).! Indeed,!populationRbased!









As!would!be!expected! in! the!era!of!advanced!medical! therapy,! the!
majority! of! patients! with! CD! were! treated! with! immunosuppressive!
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therapy.! The! ratio! of! patients! treated! with! immunosuppressive!
medication!was!significantly!higher! in!the!CD!patients.!Furthermore,!
multiple! immunosuppressive! therapy! including,!
azathioprine/mercaptopurine! and! methotrexate! in! combination! with!
steroids! were! used! to! treat! most! patients! with! moderately! active!
localized!ileocaecal!disease.!In!the!CD!group,!antiRTNF!therapy!was!
used! to! treat! patients! with! steroid! refractory! and! those! who! were!
steroid!dependent.!This!line!of!treatment!is!consistent!with!the!current!
European! evidenceRbased! consensus! on! the! diagnosis! and!
management!of!CD!(Dignass!et!al.,!2010).!Also,!patients!in!the!control!
group! suffering! from! UC! were! on! optimal! medical! therapy! as!
recommended! by! the! European! evidenceRbased! consensus! on! the!
diagnosis! and! management! of! UC! (Dignass! et! al.,! 2012).!
Immunosuppressive! therapy! can! alter! cellular! gene! expression,!
therefore!the!significant!increase!in!the!ratio!of!patients!with!CD!who!




This! study! also! demonstrated! a! significant! positive! correlation!
between!CDAI!and! the! levels!of!CRP,!WCC!and!neutrophils!count.!
Several!studies!in!the!literature!reported!a!positive!correlation!between!
CRP! levels!and!CD!activity.!Those! comparable! studies!based! their!




between! CDAI! and! the! CRP! levels! (r=0.3)! (Karoui! et! al.,! 2007).!
Correlation!that!is!similar!but!stronger!was!demonstrated!in!this!study!
(r=0.45).! The! reason! for! a! stronger! correlation! in! this! study! can!be!
explained!by!the!higher!percentage!of!patients!with!severe!disease,!


















CRP,! haemoglobin,! and! haematocrit! were! significant! predictors! of!
CDAI.!In!a!univariate!linear!regression!analysis,!these!variables!can!
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predict! CDAI! with! significant! coefficient! values.! Previously,! similar!
studies! predicted! CDAI! from! a! more! simplified! clinical! score,! the!
HarveyRBradshaw!score.!This!produced!a!27!unit!increase!in!the!CDAI!
for!every!unit!increase!in!HarveyRBradshaw!score!(Best,!2006).!A!more!
recent! prospective! clinical! trial! that! employ! similar! methods! as!
predictors!of!relapse!after!cessation!of!biological! therapy! in!patients!
with! steroid! free! clinical! remission! is! the! STORI! trial! (Louis! et! al.,!
2012).! They! identified! risk! factors! for! CD! relapse! including:! male!
genderK! absence! of! surgical! resectionK! WCC! >6x109K! haemoglobin!
level!≤145!g/LK!CRP!level!≥5!mg/LK!and!calprotectin!level!≥300!µg/g.!





despite! negating! multicollinearity,! the! model! was! not! statistically!
significant.!This!may!be!limited!by!the!small!sample!size!used!in!this!
study,!however!further!work!may!be!powered!and!if!achieves!statistical!
significance! could! be! a! novel! method! to! validate! CDAI! with! more!












Another! interesting! finding! was! the! significant! positive! correlation!
found! between! CDAI! and! the! severity! of! CD! in! the! pathological!
specimen.!Other! studies!have! found!significant! correlation!between!
CDAI!and!endoscopic!findings!(Cellier!et!al.,!1994),!MRI!(Florie!et!al.,!
2006),! CT! enteroclysis! (Chiorean! et! al.,! 2007),! and! histopathology!
(Geboes!et!al.,!2005,!Tielbeek!et!al.,!2014).!In!this!study,!univariate!
and!multivariate! analysis! of!WCC,! neutrophils,! CRP,! haemoglobin,!
haematocrit!and!CDAI!were!modeled!to!predict!the!histopathological!
disease!severity.!CDAI!was!the!only!significant!predictor!of!the!disease!
severity! at! the! bowel! level,! emphasising! the! significant! positive!
correlation! between! the! histological! severity! of! the! disease! and!
patients! symptoms!and! signs.!Other! authors! used! similar! statistical!
methods!to!predict!the!need!for!biological!therapy!(Molnar!et!al.,!2013).!
The!ability!to!establish!the!likelihood!of!the!final!histology!of!patients!





The! incidence! of! anaemia! in! CD! ranges! between! 7%! to! 74%!
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depending! on! disease! severity! (Gasche! et! al.,! 1997).! Although! the!
haemoglobin!level!was!similar!between!CD!and!controls!in!this!study,!
it! is! observed! that! as! disease! activity! increases! the! level! of!
haemoglobin! decreases.! This! negative! correlation! was! statistically!


















The!methods! in! this!section!are!strengthened!by! the!objectivity!and!
accuracy!of!the!data.!The!clinical!information!was!anonymised!at!the!
time! of! analysis.! Variables,! such! as! biochemical! blood! levels! were!
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performed! in! the! hospital! laboratory! for! clinical! purposes,! which! is!
known!for!its!high!standard.!Subjective!measures,!such!as!CDAI!are!
validated! and! largely! used! in! clinical! trials.! To! ensure! that! the!
questionnaire!was!accurate!and! the!questions!were!well! explained,!
this!was!completed!by!a!clinician!(ME).!Pathological!disease!activity!
and! diagnosis! were! interpreted! by! a! qualified! consultant! pathology!
consultant! (Dr!RodriguezRJusto).! The! sample! size,!was! powered! at!
80%! for! all! outcome! measures! and! the! statistical! methods! were!
appropriately!applied!to!data!analysis.!!
!
Despite! the! strengths! described! above,! some! limitations! were!
unavoidable.!These!include:!lack!of!healthy!controlK!potential!selection!
and! inclusion! biasesK! and! lack! of! blinding! particularly! regarding!






consent! for! the!study,!however,! these!patients!do!not! represent! the!
entire! population! of! CD,! such! as! those! who! do! not! require! bowel!




In! conclusion,! CD! patients! included! in! this! study! have! similar!
characteristics!to!the!control!group,!but!are!significantly!more!likely!to!
be! from! a! Caucasian! racial! background! and! have! higher! rate! of!




















mesenteric adipose tissue in 
Crohn’s disease patients 
!
4.! Histopathology and immunohistochemistry of mesenteric adipose 


















et! al.,! 2000),! there! are! no! dedicated! studies! to! characterise!
angiogenesis!in!CD!mesentery.!In!this!thesis,!it!was!hypothesised!that!





response.! Secondly,! to! assess! the! vascular! morphology! in! CD!





Therefore,! this! chapter! presents! the! following! results:! tissue!
inflammation,! fibrosis,! vascular! morphology,! HIF1! staining,! VEGF!








Chapter! 3! (Table! 3.1.).! There! is! a! discrepancy! in! the! number! of!
patients!used!in!subsequent!experiments,!reflecting!the!suitability!and!
availability!of! tissue!samples.!Analyses!were!carried!out!on!disease!










were!classified!as!disease! R! [14! (16%)!wrapping!AT,!and!19! (21%)!
ileocaecal! mesenteric! disease! AT]K! 57! (63%)! were! classified! as!
controls! R! [10! (11%)! ileocaecal! mesenteric! control! AT,! 15! (16%)!
omental! disease!AT,! 15! (16%)! subcutaneous! disease!AT,! 9! (10%)!
omental!control!AT,!and!8!(9%)!subcutaneous!control!AT]!(Figure!4.1).!
Methods! used! to! determine! tissue! characteristics! and! associations!
included:!tissue!immunohistochemistry,!which!has!been!described!in!






from!Crohn’s! disease! patients! (grey,! d.)! and! from! control! patients!









































































To! achieve! histological! characterisation! of! the! disease! tissues,!
comparison! was! initially! made! between! all! types! of! AT.! Further!






There! was! significantly! higher! ratio! of! tissue! inflammation! in! the!
disease!group!compared!to!control.!Mild!inflammation!was!identified!
in! 16! (48%)! and! 11! (19%)! of! the! disease! and! control! tissues!
respectively.!Moderate!inflammation!identified!in!3!(10%)!and!1!(2%)!
of! the! disease! and! control! tissues! respectively! (Table! 4.1).! This!
difference!was!statistically!significant!(X2(2)=12.7,!p<0.01)!(Figure!4.2:!
A,!B!and!C).!Furthermore,!there!was!also!statistical!differences!in!the!
presence! and! degree! of! inflammation! between! different! types! of!
tissues.!In!the!AT!from!CD!patients,!wrapping,!ileocaecal!mesenteric,!
omental! and! subcutaneous! AT! demonstrated! 8! (57%),! 8! (42%),! 8!
(53%)!and!2! (13%),!mild! inflammation! respectively.!CD!patients!AT!
also! demonstrated! moderate! inflammation! in! wrapping! 1! (7%),!
ileocaecal!mesenteric! 2! (11%),! and!omental! 1! (7%).!There!was!no!
moderate!significant!inflammation!in!AT!harvested!from!control!!
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None! Mild! Moderate! None! Mild! Moderate!
Inflammation!**! 14!(42%)! 16!(48%)! 3!(10%)! 45!(79%)! 11!(19%)! 1!(2%)!
Fibrosis! 23!(70%)! 6!(18%)! 4!(12%)! 45!(79%)! 11!(19%)! 1!(2%)!
! Absent! Present! Absent! Present!
Vessel!








HIF1**! 11!(33%)! 13!(40%)! 9!(27%)! 39!(68%)! 13!(23%)! 5!(9%)!
! Negative! Positive! Negative! Positive!






































































































































































































































































None! Mild! Moderate! Total!
Wrapping!AT! 5!(36%)! 8!(57%))! 1!(7%)! 14!
Ileocaecal!mesenteric!AT!d.! 9!(47%)! 8!(42%)! 2!(11%)! 19!
Ileocaecal!mesenteric!AT!c.! 10!(100%)! 0! 0! 10!
Omental!AT!d.! 6!(40%)! 8!(53%)! 1!(7%)! 15!
Omental!AT!c.! 8!(89%)! 1!(11%)! 0! 9!
Subcutaneous!AT!d.! 13!(87%)! 2!(13%)! 0! 15!
Subcutaneous!AT!c.! 8!(100%)! 0! 0! 8!







group! is! represented! by! the! wrapping! mesentery! and! the! ileocaecal!
mesentery!from!Crohn’s!disease!(CD)!patients.!Other!AT!are!control!group,!














































































There!was! no! statistical! difference! found! in! tissue! fibrosis! between!
disease!and!the!control!groups!(Χ2(2)=4.30,!p=!0.11).!Furthermore,!the!






Normal! Mild! Moderate! Total!
Wrapping!AT! 10!(71%)! 3!(22%))! 1!(7%)! 14!
Ileocaecal!
mesenteric!AT!d.! 13!(68%)! 3!(16%)! 3!(16%)! 19!
Ileocaecal!
mesenteric!AT!c.! 8!(80%)! 2!(20%)! 0! 10!
Omental!AT!d.! 11!(73%)! 4!(27%)! 0! 15!
Omental!AT!c.! 7!(78%)! 2!(22%)! 0! 9!
Subcutaneous!AT!d.! 11!(73%)! 3!(20%)! 1!(7%)! 15!
Subcutaneous!AT!c.! 8!(100%)! 0! 0! 8!






Vessel! tortuosity!was!present! in!4!(12%)!and!1!(2%)!of! the!disease!
and! control! AT! respectively! (Table! 4.1).! This! increase! in! vascular!
tortuosity!was!statistically!significant!(Χ2(1)=4.3,!p<0.05)!(Figure!4.2:!D,!
E,!and!F).!However,!when!comparison!was!made!to!different!type!of!









Wrapping!AT! 12!(86%)! 2!(14%)! 14!
Ileocaecal!mesenteric!AT!d.! 17!(90%)! 2!(10%)! 19!
Ileocaecal!mesenteric!AT!c.! 10!(100%)! 0! 10!
Omental!AT!d.! 14!(93%)! 1!(7%)! 15!
Omental!AT!c.! 9!(100%)! 0! 9!
Subcutaneous!AT!d.! 15!(100)! 0! 15!
Subcutaneous!AT!c.! 8!(100%)! 0! 8!






HIF1! staining! was! significantly! higher! in! the! disease! AT! than! in!
controls! (Table!4.1).!Wrapping!and! ileocaecal!mesenteric!AT! in!CD!
patients!demonstrated!13!(40%)!and!9!(27%)!weak!and!strong!HIF1!
staining! respectively,! which! was! significantly! higher! than! controls!
(Figure!4.2:!G,!H,!and!I).!Comparing!different!types!of!depot!regardless!
of!the!disease!state!demonstrated!weak!staining!in!4!(29%)!wrapping!














Negative! Weak! Strong! Total!
Wrapping!AT! 3!(21%)! 4!(29%)! 7!(50%)! 14!
Ileocaecal!mesenteric!AT!d.! 8!(42%)! 9!(47%)! 2!(11%)! 19!
Ileocaecal!mesenteric!AT!c.! 8!(80%)! 2!(20%)! 0! 10!
Omental!AT!d.! 7!(47%)! 3!(20%)! 5!(33%)! 15!
Omental!AT!c.! 7!(78%)! 2!(22%)! 0! 9!
Subcutaneous!AT!d.! 9!(60%)! 6!(40%)! 0! 15!
Subcutaneous!AT!c.! 8!(100%)! 0! 0! 8!







Figure! 4.4.!Hypoxia! Inducible! Factor^1! (HIF1)! staining! in! different! type! of!





























































































Wrapping!AT! 1(7%)! 13!(93%)! 14!
Ileocaecal!mesenteric!AT!d.! 1(5%)! 18!(95%)! 19!
Ileocaecal!mesenteric!AT!c.! 0! 10!(100%)! 10!
Omental!AT!d.! 1(7%)! 14!(93%)! 15!
Omental!AT!c.! 1(11%)! 8!(89%)! 9!
Subcutaneous!AT!d.! 0! 15!(100%)! 15!
Subcutaneous!AT!c.! 0! 8!(100%)! 8!






There! was! a! significant! difference! in! the! levels! of! MVD! between!
disease! and! control! AT! (Table! 4.1).! Disease! AT! has! significantly!
(p<0.01)!higher!MVD!(mean=29,!SD=20)!than!control!AT!(mean=19,!
SD=12)!(Figure!4.2:!J,!K,!and!L).!There!was!also!a!significant!(p<0.01)!









! Mean!(SD,!SEM)! Median!(range)! Total!
Wrapping!AT! 27.6!(15.3,!4.1)! 23.5!(11R62)! 14!
Ileocaecal!mesenteric!AT!d.! 29.6!(23.3,!5.3)! 21!(13R102)! 19!
Ileocaecal!mesenteric!AT!c.! 13.3!(5.8,!1.8)! 11!(7R26)! 10!
Omental!AT!d.! 30.4!(15,!3.9)! 28!(11R62)! 15!
Omental!AT!c.! 16.6!(9.2,!3.1)! 15!(6R32)! 9!
Subcutaneous!AT!d.! 17.5!(8.1,!2.1)! 16!(7R33)! 15!
Subcutaneous!AT!c.! 12.5!(5.6,!2)! 10.5!(7R23)! 8!



































































   
   
   
   
























Table! 4.8! summarises! the! Pearson! Correlation! (r)! of! associations!
between!the!histological!characteristics!of!the!different!types!of!depot.!
This!included:!inflammation,!fibrosis,!vessel!tortuosity,!assessment!of!
tissue! staining! for! angiogenic! factors! (HIF1! and! VEGF),! and!MVD.!
There! was! a! strong! association! between! these! characteristics:!
particularly!MVD!was!positively!correlated!with!inflammation,!fibrosis,!






























































Inflammation! was! significantly! positively! correlated! with! fibrosis!
(r=0.53),! HIF1! staining! (r=0.66),! VEGF! staining! (r=0.26)! and! MVD!
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(r=0.65)! (Figure! 4.7,! A).! No! association! was! found! between!
inflammation!and!vessel!tortuosity.!Furthermore,!association!of!ordinal!
categories! was! tested! by! Pearson! ChiRsquare.! This! included!
inflammation!and!fibrosis,!vessel!tortuosity,!HIF1!staining,!and!VEGF!





Figure! 4.7.!Correlation!between!microvascular!density! (MVD,!Y! axis)! and!







Fibrosis!was! significantly! positively! correlated!with! vessel! tortuosity!
(r=0.21),! HIF1! staining! (r=0.26),! VEGF! staining! (r=0.30),! and!MVD!
(r=0.53)!(Figure!4.7,!B).!Significant!association!between!fibrosis!and!
vessels! tortuosity! (X2(2)=6.4,! p<0.05),! as! well! as! VEGF! staining!
(X2(2)=12.2,!p<0.01)!was!demonstrated!when!using!ordinal!Pearson!
ChiRsquare! test.! Using! the! latter! test,! there! was! no! significant!






Vessel! tortuosity! was! significantly! positively! correlated! with! HIF1!
staining! (r=0.33)! and!MVD! (r=0.22)! (Figure! 4.7,! C).! There! was! no!







HIF1! staining! was! significantly! positively! correlated! with! VEGF!
staining!(r=0.33)!and!MVD!(r=0.50)!(Figure!4.7,!D).!Similarly,!VEGF!
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staining! was! significantly! positively! correlated! with! MVD! (r=0.37)!
(Figure!4.7,!E).!Ordinal!data!Pearson!ChiRsquare!test!also!suggested!










CD! patients.! Specifically,! this! set! of! experiments! was! designed! to!
study! inflammation,! fibrosis,! vascular! morphology,! HIF1! staining,!
VEGF!staining!and!MVD,!in!freshly!harvested!tissues.!The!tissue!was!
immediately! fixed! in! formaldehyde! to! preserve! its! characteristics,!
aiming! to! investigate! whether! the! angiogenic! features! were!
dysregulated,!resulting!in!a!pathological!microvasculature.!This!study!





AT! had! significantly! more! inflammation! and! vessel! tortuosity.! The!
strength! of!HIF1! staining,! a! proRangiogenic! factor,!was! significantly!
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higher!in!CD!mesenteric!AT!in!comparison!to!control.!MVD!was!also!
significantly! higher! in! the! test! group.! Despite! the! presence! of!
inflammation!and!the!increase!in!MVD,!the!level!of!VEGF!staining,!a!
potent! proRangiogenic! factor,! was! not! increased.! Yet,! there! was! a!
significant!positive!correlation!between!MVD!and!other!characteristics!
including:!inflammation,!fibrosis,!vessels!tortuosity,!HIF1!staining,!and!
VEGF!staining.!This! finding! suggests! that! inflammation! significantly!
correlated! with! increased! angiogenesity! (Figure! 4.7).! MVD! was!
significantly!positively!correlated!with!an!increase!in!the!frequency!of!
vessel! tortuosity.! Unlike! the! upRregulated! angiogenesis! that! takes!
place! in! physiological! healing! mechanisms,! the! upRregulated!
angiogenesis! in! CD! mesenteric! AT! is! likely! to! be! unbalanced.! In!
wound!repair!for!example,!newly!formed!blood!vessels!participate!in!
provisional! granulation! tissue! formation! and! provide! nutrition! and!
oxygen!to!the!growing!tissues!(Li!et!al.,!2003).!Thus,!when!the!wound!
has!healed!and!the!tissue!is!adequately!perfused,!vessels!that!are!no!
longer! needed! die! by! apoptosis! (Greenhalgh,! 1998).! ! This! did! not!
appear! to!be! the!case! in!CD!mesentery,!suggesting!a!dysregulated!
angiogenic! response.! Clinically,! it! is! relevant! to! understand! the!
angiogenic! response,! particularly! when! considering! antiRangiogenic!
therapy!for!the!treatment!of!CD!patients!(Chandar!et!al.,!2015).!!
!






that! the! abnormal! mesenteric! tissue,! particularly! the! wrapping!







mesenteric! AT).! This! may! be! explained! by! the! fact! that! the! vast!
majority!of!CD!patients! in!this!study!were!diagnosed!with! ileocaecal!
Crohn’s.!The!pathological! diagnosis!of!CD!specimens! including! the!
wrapping!mesentery!were!summarised!in!chapter!3.!The!results!of!the!
pathological!diagnosis!stated!in!chapter!3!and!this!study!are!consistent!
with! that! described! by! Crohn’s! approximately! a! century! ago.! ! The!
mesentery! is! thickened,! edematous! and! contains! numerous! large!




harvested! from!CD!patients! (Borley!et!al.,!2000).!Depending!on! the!
stage!of!the!disease,!these!changes!varied!considerably,!from!mild!to!
severe! inflammation.! Other! reports! also! described! a! more! severe!
inflammation! in! the!mesentery! that!has!most!proximity! to! the!bowel!
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(Desreumaux! et! al.,! 1999).! The! findings! in! this! study! are! unique!
because!they!correlated!these!pathological!features!to!increased!MVD!
and!associated!abnormal!tortuous!vessels.!This!further!confirms!the!




group,! this! cohort! included! specimens! from! the! omental! and!
subcutaneous!AT!of!CD!patients!for!comparison!as!well.!Initially!the!
comparison!was!performed!between! the! test! group!and! the! control!
group! and! subsequently! comparison! between! all! tissue! type! was!
undertaken.!This!was!to!obtain!a!comprehensive!view!of!the!difference!
between!CD! and! nonRCD,! as!well! as! differences! between! different!
types! of! AT.! Thus,! patients! with! CD! demonstrated! increased!
inflammatory! changes! in! both! omental! and! subcutaneous! AT.! This!
may! partly! explain! the! extraRintestinal! manifestations! of! CD.! In! a!
retrospective! study! of! 448! IBD! patients,! Aghazadeh! et! al.! reported!
extraRintestinal!manifestations! in! approximately! 40%!of!CD!patients!
involving!most!of!the!body!systems!particularly!the!skin!(Aghazadeh!
et! al.,! 2005).! Inflammatory! changes! in! the! subcutaneous! AT! may!






similar! ratio! of! fibrosis! in! CD! and! control.! Nevertheles,! this! study!
demonstrated!that!fibrosis!in!AT!was!positively!significantly!correlated!
with! inflammation,! vessels! tortuosity,!HIF1!and!VEGF!staining,! and!
MVD.! This! may! suggest! an! interplay! between! the! mechanisms! of!
chronic! inflammation! and! angiogenesis! (Kreuger! and! Phillipson,!
2016).!A!possible!explanation!to!the!similar!ratio!of!fibrosis!between!




in! the!context!of! chronic! tissue!disease.!Fibrosis!has!been!strongly!
associated!with! chronic! inflammatory! diseases! (Ueha! et! al.,! 2012).!
Previous!investigation!of!the!mesenteric!AT!in!CD!found!a!significant!
correlation! between! bowel! mucosal! ulceration,! transmural!




blood! flow! to! the! bowel.! At! this! level,! exchange! of! gas,! solute! and!
hormones! between! blood! and! tissue! occurs.! Furthermore,! the!
microvasculature!entertains!the!highest!regenerative!capacity!and!is!




CD! description,! few! reports! briefly! mentioned! vascular! changes! in!















suggested! that! CD! is! mediated! by! multifocal! gastrointestinal!
ischaemia! (Wakefield! et! al.,! 1989).! Vessel! tortuosity! is! also! part! of!
systemic!diseases!(Amemiya!and!Bhutto,!2001)!and!it!could!be!that!
this! may! be! a! part! of! the! extraRintestinal! manifestation! of! CD.!








consumed! by! the! mitochondria! (Rolfe! and! Brown,! 1997).! As! a!
compensatory! mechanism! HIF1! becomes! activated! (Semenza! and!
Wang,!1992).! It! is!now!clear! that!HIF1!accumulation!stimulates! the!
transcription! of! proangiogenic! factors! including! VEGF! (Semenza,!
2003,!Semenza,!2009).!In!CD!bowel!specimens!HIF1!and!not!VEGF!
was!overexpressed! (Giatromanolaki!et!al.,!2003).!This! is!consistent!
with! the! results! in! this! experiment.! The! lack! of!VEGF! in!CD!bowel!




were! collected.! Anaesthetic! agents! such! as! nitrous! oxide! can!
redistribute!oxygen!toward!all!compartments!outside!mitochondria!and!
activate! HIF! hydroxylase! (Hagen! et! al.,! 2003).! Consequently,!
hydroxylases!do!not!register!hypoxia!and!HIF1!is!inactivated!(Taylor,!
2008).! The! other! explanation! could! be! that! the! angiogenic!
mechanisms!in!this!group!of!patients!are!dysregulated!and!the!vessels!
tortuosity! and! high!MVD! is! propagated! by! other! angiogenic! factors!
than!VEGF.!For!example,!AT!angiogenesis!can!be!promoted!by!Leptin!
and!HIF1!(Wator!et!al.,!2008).!Furthermore,!similar!to!AT!in!obesity,!
angiogenesis! in! inflamed!wrapping!and! ileocaecal!mesenteric!AT!of!







in! neoplastic! angiogenesis! (Yin! et! al.,! 2005).! Furthermore,! the!
correlation! between! increased! MVD! and! arteriolar! stenosis! in! CD!
intestinal! tissue! has! been! demonstrated! (Wakefield! et! al.,! 1991b).!
Limited! tissue! flow! due! to! arteriolar! stenosis! could! account! for!
increased! MVD! in! the! wrapping! and! ileocaecal! AT! in! this! cohort!
(Koerselman!et!al.,!2003).!It!is!unclear!whether!increased!MVD!in!the!
disease!AT!samples!is!related!to!chronic!inflammation!or!to!arteriolar!




The! strength! of! this! study! lies! mainly! in! characterising! freshly!
harvested!AT! from! the!mesentery! of!CD!patients.!Unlike! gene!and!
protein!expression!studies!described! in! the!subsequent!chapters,! in!
this! experiment! tissues! were! fixed! immediately! in! formaldehyde! in!
order! to!preserve! the! features!of! tissues!at! the! time!of!harvest!and!
negate!any!bias!that!may!result! from!sample!processing!(Carson!et!
al.,! 1973).! The!methods! are! well! established! and! the! results! were!
accurately! interpreted! by! two! blinded! researchers:! Dr! Manuel!









Despite! the! strengths! of! this! study! there! are! some! unavoidable!
limitations.! The! short! duration! of! the! study! as! well! as! the! small!
proportion!of!CD!patients!requiring!surgical!resection,!restrict!sample!









In! conclusion,! wrapping! and! ileocaecal! mesenteric! AT! from! CD!
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nucleus! through! the! cytoplasm,! picked!up!by! the! ribosomes,!which!
translate!the!information!code!into!amino!acid!sequence!that!makes!
up! proteins! (Palade,! 1975,!Morisaki! et! al.,! 2016).! Cells! respond! to!
environmental!cues!and!synthesise!proteins!with!precise!timing!and!
specific!molecular! functions! (Sonenberg!and!Hinnebusch,! 2009).! In!
particular! to! this! thesis,! angiogenic! gene! expression! studies! will!
characterise! the! mesenteric! AT! in! CD! at! a! molecular! level.! The!
hypothesis! of! a! dysregulated! angiogenic! balance! that! drives! the!













sample! size.! The! chapter! has! been! divided! into! two! sections:! 1)!















ileocaecal! mesenteric! AT! from! 8! nonRCD! patients.! Patients!
characteristics!are!detailed! in! chapter! 3.!Table!5.1! summarises! the!
characteristics!of!the!16!patients!included!in!this!study.!Briefly,!CD!and!
control!patients!were!similar!in!age,!gender,!BMI,!and!ASA!score.!Out!
of! a! total! of! 8!patients! in! the!CD!group,! 7! (87%)!were! treated!with!
immunosuppressive! therapy! including! steroids! and! antiRTNF!
monoclonal! antibodies.! In! the! control! group! there! were! 3! (37%)!
patients! with! a! diagnosis! of! UC! who! were! treated! with!
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immunosuppressive!therapy!at!the!time!of!surgery!including!steroids.!











































dendrogram! in!order! to!demonstrate! the!strength!of! fold! regulation,!
and!group!together!genes!with!similar!expression!patterns!.!Secondly,!
the!quantitative!method!using!2^(RAvg.(Delta(CT))!was!employed! to!








calculated! to! identify!upregulated!and!downregulated!genes.!A! total!
number! of! 47! (56%)! demonstrated! two! or! moreRfold! decrease! in!
comparison!to!control!(Figure!5.1).!The!heat!map!is!colour!coded!and!
shows! the! genes’! expression! fold! regulation.! For! example,! gene!




a! hierarchical! clustering! model! to! group! the! genes! based! on! their!
expression! in! tissues!(Figure!5.1,!C).!For!example,!as!shown!in! the!
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dendrogram,! CXCL6! and! VEGFC! share! common! gene! expression!
pattern.! This! pattern! is! then! similar! to! VEGFA,! HIF1A,! CTGF! and!
SERPINF1.!Both!groups!are!then!grouped!with!FLT1!and!so!on.!The!
clustergram!also!groups!genes!that!are!similar!by!colour!coding,!noted!

































































































































































































































































































































The! strength! of! correlations,! whether! positive! or! negative,! was!
examined! by! inference! statistics.! Because,! r! values! can! only! lie!
between!(0!to!1)!if!positive,!and!(R1!to!0)!if!negative,!it!is!not!possible!
to!generate!confidence! intervals!and!using! tRtest!was! inappropriate.!
Instead,!Fissure!transformation!of!the!r!values!to!z!scores!was!used!to!
test!the!average!strength!of!correlations.!The!mean!of!the!z!score!for!




mean! of! the! z! score! ! for! the! negative! correlation! demonstrated!
statistically!significantly!(p<0.0001)!stronger!correlation!in!the!disease!
group!(mean=R0.3,!SD:!0.2K!median=0.3,!range:!R.08,!!R0.007)!than!in!

















































































































































































































































































































































































































































































































































































































































































































































































































in& fold& regulation.&Gene&name&and&a& summary&of& its& angiogenic& function.&Proangiogenic& (++).&
Positively&or&negative&angiogenesis&regulator&(+).&Antiangiogenic&(BB).&





















































in& fold& regulation.&Gene&name&and&a& summary&of& its& angiogenic& function.&Proangiogenic& (++).&
Positively&or&negative&angiogenesis&regulator&(+).&Antiangiogenic&(BB).&





















































EFNA1'(++)' Ephrin)A1'' Endothelial'cell'migration.' (Song'et'al.,'2013)'
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Table&5.2.&Angiogenic&genes&with&2&or&more&decrease&in&fold&regulation,&and&1&or&more&increase&
in& fold& regulation.&Gene&name&and&a& summary&of& its& angiogenic& function.&Proangiogenic& (++).&
Positively&or&negative&angiogenesis&regulator&(+).&Antiangiogenic&(BB).&
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their! functional! ability! to! maintain! angiogenic! balance,! a! literature!
search! was! conducted! using! PubMed! database! to! establish! the!




into! three! categories! (Ribatti! et! al.,! 2007):! 1)! proangiogenic! group,!
those!which!promote!angiogenesisH!2)!positive!or!negative!angiogenic!
regulator:! those! that! positively! or! negatively! regulate! rather! than!
promote!angiogenesisH!and!3)!antiangiogenic:!those!with!functions!that!















classified! as! proangiogenic.! Genes! with! proangiogenic! function!

















Individual! gene! expression! was! quantified! by! calculating! the! 2^(?
Avg.(Delta(Ct))! for! levels! comparison.! Antiangiogenic! gene!
expression!was!lower!in!the!disease!group!than!controls!(Figure!5.4,!
A).!!However,!the!only!statistically!significant!level!was!observed!for!
CXCL9.! The! expression! of! CXCL9! was! statistically! significantly!
(p<0.05)! lower! in! the! disease! tissue! (mean=0.05,! SD:! 0.12H!
median=0.004,! range:! 0.0002,! 0.4)! than! in! the! control! tissue!
(mean=0.21,!SD:0.4H!median=0.07,!range:!0.002,!1.2).!
!
Although! not! statistically! significant,! the! gene! expression! levels! of!




5.4,! C).! Specifically,! CXCL5! and! EFNA1! were! downregulated! with!
statistically! significant! 2^(?Avg.(Delta(Ct))! values.! The! gene!
expression!level!of!CXCL5!was!statistically!significantly!(p<0.05)!lower!
in!the!disease!tissue!(mean=0.002,!SD:!0.003H!median=0.0003,!range:!
0.0001,! 0.011)! than! in! the! control! tissue! (mean=0.03,! SD:! 0.07H!
median=0.002,! range:! 0.0003,! 0.2).! The! gene! expression! level! of!

















This! section! will! explain! the! difference! in! ratios! between! pro?! and!
antiangiogenic! genes.! To! measure! whether! the! ratios! of! gene!
expression! levels! differ! between! disease! and! control.! The! gene!




























































































































































In! the! disease! tissue,! COL3A3! and! IL6! genes! expression! was!













Although!IL6!gene!expression!were!higher! in! the!control!group,! this!
did!not!reach!statistical!significance.!The!mean!for!IL6!level!in!the!test!
group!(mean=7,!SD=26)!was!lower!than!the!controls!(mean=31,!SD=!













COL4A3% 4.4!(8)! 2.6!(6)! 0.43!
CXCL9% 1.2!(5.7)! 0.1!(0.4)! 0.67!
IL6% 7!(27)! 31!(147)! 0.76!
MMP2% 0.3!(0.7)! 0.1!(0.1)! 0.4!
SERPINF1% 4.4!(8)! 2.6!(6)! 0.42!


























IL6/COL4A3% 404!(716)! 1154!(2468)! 0.3!
IL6/CXCL9% 69!(114)! 169!(416)! 0.15!
IL6/SERPINF1% 1!(1.6)! 11!(37)! 0.13!
MMP2/COL4A3% 136!(174)! 303!(874)! 0.85!
MMP2/CXCL9% 19!(30)! 21!(35)! 0.94!
MMP2/SERPINF1% 0.4!(0.4)! 0.8!(1.5)! 0.61!
VEGFA/COL4A3% 211!(246)! 384!(563)! 0.73!
VEGFA/CXCL9% 35!(52)! 61!(117)! 0.87!



























































































































































































































































































































































previously! in! this! thesis,! where! it! was! demonstrated! that! the!
mesenteric! AT! in! CD! patients! have! higher! MVD! and! more! vessel!
tortuosity,! this! set! of! experiments! aims! to! discover! whether! the!
angiogenic!balance!in!CD!patients!is!different!to!control.!By!assessing!
the! expression! of! genes! involved! in! human! angiogenesis! the!
objectives! were! to! assess! their! levels,! correlations! and! ratios! in!





downregulated! in! comparison! to! control.! The! correlations! between!
angiogenic!genes!were!significantly!different!between!the!disease!and!




Semenza,! 2003,! Semenza,! 2009).! Impaired! correlation! between!
genes!may!potentially!result!in!angiogenic!dysregulation.!In!fact,!this!
is!an!important!indicator!that!angiogenic!mechanisms!in!CD!mesentery!
may! differ! from! control.! Furthermore,! in! the! angiogenic! gene! array!
experiment,! the! proportion! of! proangiogenic! to! antiangiogenic! gene!
expression! were! significantly! different.! In! the! validation! gene!
expression! experiment,! although! antiangiogenic! factors! were!
relatively!higher!in!the!disease!patients,!these!genes!were!lower!when!
the!ratio!of!pro?!and!antiangiogenic!genes!was!performed.!However,!it!
is!difficult! to!conclude! these! results!as! the!validation!study! failed! to!




of! CD! (Carmeliet,! 2003),! detailed! information! about! the! angiogenic!
mechanisms!in!the!inflamed!bowel!and!specifically!in!the!mesentery!is!
essentially! non?existent! (Laroux! and! Grisham,! 2001,! Hatoum! and!
Binion,!2005).!Currently,!there!are!no!published!studies!dedicated!to!
characterise!angiogenic!gene!expression!in!the!mesenteric!AT!in!CD.!
However,! few! studies! have! demonstrated! an! association! between!
angiogenesis! and! CD! in! the! bowel! specimens! of! CD! patients.!
Recently,!Knod!et%al.!!demonstrated!a!significant!increase!in!VEGFB!
and!CD!bowel! specimen! (Knod! et! al.,! 2016a).! The! levels! for! other!







including! VEGF! and! IL6! were! downregulated.! The! apparent!
disagreement! in! gene! regulation! may! be! accountable! as! follows.!
Firstly,!angiogenic!gene!expression!in!the!mesentery!is!different!to!that!
presented! in! bowel! specimens.! Secondly,! the! multiple!
immunosuppressive!drugs!used!to!treat!the!patients!in!this!study,!may!
have! altered! the! gene! expression! profile.! Keeping! in!mind! that! the!
population!investigated!by!Knod!et%al.!are!paediatirc!patients!with!CD,!
who!may!have!a!different!gene!expression!profile!to!adult!patients,!and!
are! less! likely! to! be! chronically! treated! with! multiple!
immunosuppressive!therapy.!Lastly,!the!disease!activity!in!the!cohort!
of!patients!recruited!to!this!study!have!less!CDAI!in!comparison!to!the!
patients! investigated!by!Knod!et% al% (Knod%et% al.,% 2013,%Knod%et% al.,%
2016a).!!
%
The! finding! of! downregulated! angiogenesis! in! this! study! is! also!
inconsistent!with!previous!research!investigating!angiogenic!factors!in!
CD!bowel!specimens.!Danese!et%al.!described!upregulated!angiogenic!
factors! including! VEGF,! TNF,! bFGF,! and! IL8! in! the! intestinal!





that! may! have! changed! their! gene! expression! profile! due! to! their!
proliferative!state.!In!comparison,!this!study!looked!at!mesenteric!AT!
samples,! that! were! snap! frozen.! Therefore,! there! are! two! obvious!
explanations!that!can!be!counted!for!this!difference.!Firstly,!mesenteric!
AT!may!have!a!different!angiogenic!profile!in!comparison!to!the!bowel!
epithelium.! Secondly,! fresh! frozen! tissue! may! have! a! different!
angiogenic!profile!to!cells!in!culture!(vitro!environment),!as!explained!
above.!It!could!be!argued,!the!findings!in!this!study!are!more!accurate!
as! freshly! harvested,! snap! frozen! tissue! are! a! more! genuine!
representation!of!gene!expression!profile.!!
!
One! of! the!most! interesting! findings! in! this! study! is! the! significant!
difference! in! angiogenic! gene! correlations! found! between! CD! and!
control.!In!CD!mesenteric!AT!(test!group)!there!were!significantly!less!
positive! correlations! between! angiogenic! genes! and! on! average!
weaker!correlation!coefficients!(r).!Furthermore,!the!CD!mesenteric!AT!




supporting! this! study’s! main! hypothesis.! ! For! example,! VEGF! and!
VEGF!receptors,!are!positively!correlated!and!upregulated!in!response!
to! hypoxic! conditions! (Tuder! et! al.,! 1995,! Dvorak,! 2005).! Thus,! for!
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study! both! VEGFR1! and! VEGFR2! are! significantly! positively!
correlated!with!VEGFA!gene!expression.!Similarly,!the!expression!of!
VEGF! is! significantly! positively! correlated! with! the! expression! of!
MMP2!and!MMP9!in!human!glioblastomas!(Munaut!et!al.,!2003).! In!
this!study,!although!the!level!of!MMP2!was!positively!correlated!with!
VEGF! in! disease! and! control! tissue,! MMP9! was! only! positively!
correlated! with! VEGF! in! the! control! tissue! and! not! in! the! disease!
tissue.!!Other!angiogenic!factors!such!as!FGFR,!TGFA,!and!ERBB2!
were!significantly!strongly!correlated!with! the! level!of!VEGFA!in! the!
control! tissue,! but! negatively! correlated! in! the! disease! tissue.!!
Although!more!detailed!studies!are!required!to!highlight!the!functional!




in! this! experiment,! angiogenic! genes! were! classified! into! three!
categories:! 1)! those! that! promote! angiogenesis! (proangiogenic)H! 2)!
those!with!either!positive!or!negative!angiogenic!regulatory!functionH!
and! 3)! those! that! inhibit! angiogenesis! (antiangiogenic).! A! literature!
review!was! conducted! to! confirm! the! current! concluded! function! of!
each!gene.! In!order! to! investigate! the!angiogenic!balance!between!
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pro?!and!antiangiogenic!gene!expression,!ratios!of!individual!pro?!and!
antiangiogenic! genes! were! calculated! and! compared.! Statistically!
significant!differences!were!found!in!the!ratios!of!VEGFA!to!CXCL9,!
indicating!that!although!CXCL9!gene!expression!was!down!regulated!




effects! on! VEGF?stimulated! endothelial! cells! by! reducing! VEGFR2!
(KDA),! phospholipase! Cγ! (PLCγ),! and! exracellular! signal?regulated!




fibrosis! (Keane! et! al.,! 1999).! The! antiangiogenic! and! antfibrotic!
function! of! CXCL9! is! confirmed! to! be! mainly! through! reducing!
endothelial!cell!activation!rather!than!anti?inflammatory!(Sahin!et!al.,!
2012).! The! angiogenic! balance!with! relatively! higher! proangiogenic!
function,! may! explain! the! increase! MVD! reported! in! the!
immunohistochemistry!in!chapter!4!(Section!4.3.5).!Functionally,!these!
findings!support!the!hypothesis!of!this!thesis!that!angiogenesis!in!CD!






On! the! other! hand,! although! the! expression! of! the! antiangiogenic!
factor!THBS1!(Tolsma!et!al.,!1993)!was!lower!in!CD!mesenteric!AT!in!
comparison! to! control,! the! ratio! of! VEGFC! (a! strong! proangiogenic!
factor)! to! THBS1! demonstrated! a! relatively! higher! expression! of!
THBS1! in! the! disease! tissue.! Although! not! statistically! significant,!
THBS1!expression!level!is!also!higher!in!the!disease!tissue!relative!to!
VEGFA.! The! mechanisms! for! which! THBS1,! also! known! as!
thrombospondin! 1,! in! relation! to!VEGF!are!mediated! by! interacting!
with!CD36!on!the!endothelial!cell!membrane!(Dawson!et!al.,!1997).!
This!appears!to!inhibit!the!migration!and!apoptosis!of!endothelial!cells!
(Iruela?Arispe!et!al.,!1999).! In!view!of! the!gene!correlation! findings,!











PCR! quality! controls!were! optimal.! The! data!were! analysed! in! two!
different!validated!methods:!quantitative!and!relative.!The!construction!
of! a! correlation!matrix! to! demonstrate! differences! between!multiple!
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angiogenic!genes!and! illustrate! their! relationship! to!each!other!may!
explain! the! dysregulated! function! in! angiogenesis.! Comparison!
between! disease! and! control! in! the! correlation! matrix! showed!
significant! differences.! Furthermore,! the! comparison! based! on! the!
angiogenic!gene!functions!and!the!ratio!between!proangiogenic!and!














and! exploring! the! mechanismal! pathways! of! gene! function! are!
required!to!build!up!and!validate!these!findings.!On!a!larger!sample!
size,! structural! equation!modeling! to! correlate! structure! analysis! of!
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to! the! mechanisms! of! angiogenesis! in! the! mesenteric! AT! of! CD!
patients.! In! particular,! this! experiment! will! focus! on! two! potent!
proantiogneic!cytokines:!IL6!and!VEGFA.!These!two!cytokines!have!
been! selected! because! they! were! down! regulated! and! positively!
significantly!correlated! in! the!disease! tissue! in! the!gene!expression!
experiments.!Although!their!signaling!pathway!will!not!be!the!focus!of!
this! chapter,! it! is! important! to! demonstrate! their! similarity! in!
mechanism! of! action! through! STAT! and! ERK! pathways.! This! is! to!








al.,! 2003).! The! activation! of!ERK1/2! and!STAT3! pathways! activate!
endothelial! cell! proliferation,! migration! and! microvascular! tube!
formation!(Yahata!et!al.,!2003,!Deo!et!al.,!2002).!!
!
Similarly,!VEGFA! isoforms!bind!with!high?affinity! to!VEGFR1! (Flt?1)!
(de!Vries!et!al.,!1992,!Seetharam!et!al.,!1995)!and!VEGFR2!(KDR)!!!
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(Terman!et! al.,! 1991,! Terman!et! al.,! 1992).!VEGFR2!mediates! cell!




and! differentiation! (Zhuge! et! al.,! 2005,! Wang! et! al.,! 2016).!
Furthermore,! VEGFR2! mediates! the! activation! of! STAT3! pathway!
(Bartoli!et!al.,!2000,!Bartoli!et!al.,!2003).!Therefore,!deficiency!in!either!
cytokines,! IL6! or! VEGF! may! in! varying! degrees! impact! on! the!










A! total! number! of! 69! ATs! were! analysed! for! the! levels! of! IL6! and!
VEGF,!out!of!which!29!(42%)!were!from!CD:!11!(16%)!were!wrapping!
mesentery! and! 18! (26%)!were! ileocaecal!mesentery.! The! following!
tissues! from! control! patients! were! considered! control:! 12! (17%)!
ileocaecal!mesenteryH!6!(9%)!omentalH!and!6!(9%)!subcutaneous!AT.!
Furthermore,! AT! from! CD! patients! other! than! the! mesentery! were!
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Paired! values! from! CD! patients! IL6! expression! demonstrated!
statistically! significantly! (p<0.05)! lower! expression! of! IL6! in! CD!

































ANOVA! test! and! showed! statistically! significant! (p<0.05)! difference!
between!tissue.!!The!means!for!VEGF!expression!were!37!(SD=24),!
33! (SD=15),!41! (SD=30),!51! (SD=36),!68! (SD=73),!68! (SD=51),!64!
(SD=15)! for! wrapping! mesentery,! ileocaecal! mesentery! from! CD,!
ileocaecal!mesentery! from! control,! omental! from!CD,! omental! from!













Statistically! significant! (p<0.05)! difference!was! also! found! in! paired!
values! of! VEGF! expression! level! in! CD! patients.! The! VEGF!
expression!level!in!the!mesenteric!AT!(mean=36!pg/mg,!SD=27)!was!









Figure%6.6.%Vascular%endothelial%growth% factor% (VEGF)%expression% level% in%
























the! mesentery! and! therefore! can! be! considered! a! control,! for! the!
measurement!of!serum!levels!of!IL6!and!VEGF!patients!with!UC!were!
placed!on!a!third!category!other!than!the!controls.!Serum!samples!of!
a! total!number!of!36!patients!were!analysed!for! the! levels!of!VEGF!
and!IL6,!22!(61%)!of!which!have!undergone!surgery!for!CD,!5!(14%)!
for! UC! and! 9! (25%)! controls.! The! serum! of! CD! (mean=58! pg/ml,!
SD=138)!patients!and!UC!(mean=50!pg/ml,!SD=104)!had!higher!IL6!
levels! than! the! control! (mean=19! pg/ml,! SD=39)! (Figure! 6.8,! A).!
However,!this!difference!in!mean!was!not!statistically!significant.!The!
mean!of!VEGF!was!statistically!significantly!(p<0.05)!higher!in!the!CD!
















95%! CI:! ?0.8,! ?0.1H! p<0.05).! In! a! correlation! matrix,! there! was! no!
significant!correlation!between!the!serum!levels!of!IL6,!VEGF,!CRP,!
WCC,! neutrophils! count,! haemoglobin! count,! CDAI,! pathological!
















al.,! 2005,! Tzeng! et! al.,! 2013).! They! are! both! recognised! as! potent!
proinflammatory!and!proangiogenic!cytokines!and!play!an! important!
role! in! the! pathogenesis! of!CD! (de!Souza! and!Fiocchi,! 2016).! The!
overall! aim! of! this! thesis! was! to! characterise! angiogenesis! in! CD!
mesenteric!adipose!tissue.!In!the!gene!expression!experiments,!both!
IL6!and!VEGF!were!down!regulated!at!the!level!of!mRNA.!To!validate!
this! finding! at! the! protein! level! this! experiment! was! designed! to!
evaluate! the! tissue! levels! of! IL6! and! VEGF! cytokines! expression!
(Maier! et! al.,! 2009,! Vogel! and! Marcotte,! 2012).! Furthermore,! the!
















CD! patients,! demonstrated! similar! means! with! the! control! tissue!
(Yamamoto! et! al.,! 2005).! Another! study!measured! the! level! of! IL6!
secreted! from!mesenteric!AT!of!CD,!colonic!cancer!and!diverticular!





and!other! type!of!cancers! (Heikkila!et!al.,!2008).! In! this!experiment!
however,! the! control! patients! are! of! benign! conditions.! The!
explanation!of!the!lower!level!of!IL6!in!the!mesenteric!AT!in!this!cohort!
of! CD! patients! may! be! due! to! the! immunosuppressive! therapy!!
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conclude!that! the!mesenteric!AT!in!this!cohort!of!CD!patients! is! IL6!










serum! of! patients! with! CD! (Kapsoritakis! et! al.,! 2003,! Pousa! et! al.,!
2008a,!Scaldaferri! et! al.,! 2009).!However,! the! expression! of!VEGF!
from!the!mesenteric!AT!of!CD!has!not!been!investigated!before.!One!
study!compared!the!secretion!of!VEGF!from!mesenteric!AT!of!patients!
undergoing! bowel! resection! for! CD,! bowel! cancer! and! diverticular!
disease! patients.! The! capacity! of! CD!mesenteric! adipose! tissue! to!
secrete! VEGF! in! CD! patient! was! significantly! higher! than! controls!
(Schäffler! et! al.,! 2006).! Among! CD! patients,! the! same! study!
demonstrated!a!significantly!lower!level!of!VEGF!secretion!in!patients!






AT! may! be! a! validated! finding! explaining! the! increase! in! vessel!
tortuosity! found! in! the! histological! analysis! (Chapter! 4).! This! is!
supported! by! the! significant! lower! level! of! VEGF! mesenteric!




Similar! results!were!reported!by!Kapsoritakis!et%al.! investigating! the!
expression! of! VEGF! in! the! bowel! specimens.! ! Although! the! serum!
level!of!VEGF!was!significantly!higher! in!CD!patients! than!controls.!
The!bowel!specimens!of!CD!patients!failed!to!!stain!for!VEGF!in!all!












tissues.! This! positive! correlation! has! been! reported! before! in!
malignant! conditions,! such! as! pituitary! (Borg! et! al.,! 2005),! breast!
(Benoy! et! al.,! 2002),! gastric! cancers! (Huang! et! al.,! 2002),! and!
melanoma!(Yang!et!al.,!2009).!IL6!and!VEGF!signaling!pathways!are!
highly! intertwined.! For! example,! IL6! induces! signal! transduction! of!
VEGF!and! regulates!VEGF!promoter! activity! (Loeffler! et! al.,! 2005).!
They!both!activate!common!pathways,!such!as!STAT3!and!ERK1/2!
(Bartoli!et!al.,!2003,!Yang!et!al.,!2003).!In!terms!of!angiogenesis,!they!
both! promote! endothelial! cell! proliferation,! migration! and! apoptosis!
(Zhang!et!al.,!2006).!In!this!cohort!of!CD!patients!and!control!however,!
the!correlation!was!stronger!and!more!significant!in!the!control!group!
than! in!CD.!Although,! the!angiogenic!mechanisms!mediated!by! IL6!
and! VEGF! appear! to! correlate! positively,! in! CD! mesentery,! the!
deficiency! in! IL6! and! VEGF! at! this! local! level! may! support! the!





This!study! is!distinctive! in! two!main!aspects:! firstly,! for! investigating!
the!expression!level!of!two!important!angiogenic!proteins!at!the!level!
of!the!mesentery!in!CD!patientsH!and!secondly,!for!the!method!used!to!
measure! these! levels.!The!majority!of! the!studies!conducted! in! this!
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regard! either! used! immunohistochemistry! of! formalin?fixed! and!
paraffin?embedded! tissue,! or! tissue! culture! to! assess! the! level! of!
protein!secreted!in!the!supernatant.!However,!in!this!experiment!the!
total! protein! was! extracted! from! the! AT! freshly! collected! and! snap!
frozen!to!preserve!the!proteins!from!degradation.!Subsequently,!well!
established! ELISA! quantification! methods! were! used! to! precisely!
quantify! the! level! of! protein! expression! by! the! tissue.! The! use! of!
immunohistochemistry! to! quantify! the! level! of! VEGF! and! IL6!




failed! after! several! attempts.! This! may! be! due! to! the! very! low!
expression! that!was!subsequently!observed! in! this!experiment.!The!
total!protein!levels!were!assessed!and!the!observed!level!of!IL6!and!




subcutaneous! AT! from! CD! patients! was! performed! to! ensure! that!
variables! between! subjects,! such! as! medication,! age,! BMI! are! all!
adjusted! for.! Finally,! the! use! of! ethylenediaminetetraacetic! acid!
(EDTA)!!plasma!to!collect!blood!samples!was!avoided!to!prevent!the!





Despite! the! strengths! of! this! experiment,! there! were! unavoidable!
limitations,! including:! low! sample! size! and! control! group!who!were!
suffering! from!pathological! conditions,! such! as! diverticular! disease,!
benign!polyps!and!UC.!This!project!had!limited!funds!and!time?frame!
therefore! more! samples! could! not! be! obtained.! Also,! access! to!
mesenteric! tissue!biopsy! is!not! feasible! from!healthy! individuals,!as!
patients!must!have!been!undergoing!bowel!resection.!
!
A! way! to! improve! this! study! would! be! to! recruit! healthy! matched!
individuals! to! analyse! the! serum! level! of! these! cytokines.!Also,! the!
deficiency!of!protein!expression!of! IL6!and!VEGF! in! the!mesentery!
could! be! validated! in! a! larger! sample! size! and! potential! pathway!
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vasculature! is! observed! (Rupnick! et! al.,! 2002).! Similarly,! in! CD!
patients!the!phenomena!of!fat!wrapping!is!characterised!by!expansion!
of!the!mesenteric!AT!to!cover!the!inflamed!bowel.!In!the!current!project!
the! histological! specimens! of! CD! mesentery! demonstrated! a!
significant! increase! in! MVD.! In! other! studies! related! to! obesity,!
differentiation! of! preadipocytes! into! adipocytes! seemed! to! be!
dependent! on!new!blood! vessel! formation! (Fukumura!et! al.,! 2003),!






(Zhang! et! al.,! 1997).! It! is! expressed! and! secreted! by! AT,!
preadipocytes! and! adipocytes! (Miyazawa?Hoshimoto! et! al.,! 2005).!
Moreover,!up!regulated!expression!of!VEGF!mRNA!is!associated!with!
increased! AT! mass! during! weight! gain! (Hattori! et! al.,! 2004).! In!
previous!chapters!(5!and!6)!studying!VEGF!mRNA!expression!in!CD!






















g! of! freshly! harvested! AT! was! minced! into! smaller! pieces! and!







from! control! patients! were! considered! control:! 6! (9%)! ileocaecal!
mesenteryH! 5! (7%)! omentalH! and! 5! (7%)! subcutaneous! AT.!



























Figure%7.2.% Interleukin%6% (IL6)%concentration% in% the%supernatant%of%adipose%




Investigations! were! also! applied! to! paired! samples! from! the! same!
patients! of! CD! and! control.! Paired! IL6! concentrations! in! the!




the! ileocaecal! mesentery! (mean=258! pg/ml,! SD=79),! omentum!













VEGF!concentration! in! the! supernatant! of! the! test! group! (wrapping!
and! ileocaecal! mesenteric! AT! from! CD! patients)! (mean=90! pg/ml,!
SD=159)!and!controls!(mean=81!pg/ml,!SD=181)!were!similar!(Figure!
7.4,!A).!To!examine!the!difference!between!CD!and!non?CD!AT,!the!
subcutaneous! and! omental! AT! harvested! from! CD! patietns! was!
excluded.!Thus,! the!following!comparison! is!between!the!test!group!








supernatant% of% adipose% tissue% for% Crohn’s% disease% and% controls% (A)% and%






in! the! mesenteric! (mean=22.3! pg/ml,! SD=33),! omental! (mean=19!
pg/ml,! SD=17)! and! subcutaneous! (mean=17! pg/ml,! SD=16)! AT! of!
control! patients! in! comparison! to! wrapping! mesentery! (mean=88!












The! levels! of! VEGF! concentration! were! also! investigated! within!
patients! and! were! similar! in! 5! paired! samples! of! control! patients’!
ileocaecal! mesentery! (mean=25! pg/ml,! SD=36),! subcutaneous!
(mean=17!pg/ml,!SD=16),!and!omental!(mean=19!pg/ml,!SD=17)!AT!
(Figure! 7.6,! A).! However,! the! concentration! of! VEGF! in! 12! paired!
samples! of! CD! patients! were! significantly! (p<0.01)! lower! in! the!
subcutaneous! (mean=61! pg/ml,! SD=152)! than! in! the! omental!
(mean=188!pg/ml,!SD=276)!AT!(Figure!7.6,!B).!The!concentration!of!
VEGF!in!the!supernatant!of!the!two!groups!comprising!the!“test!group”,!
the! wrapping! mesentery! (mean=101,! SD=128)! and! ileocaecal!
mesentery! (mean=104,! SD=207),! were! higher! than! that! in! the!












functional! and! structural! abnormality! (Wakefield! et! al.,! 1989).!
Histological!features!of!vascular!injury,!focal!arteritis,!fibrin!deposition,!
arterial! occlusion,! granulomatous! vasculitis,! and! altered! vascular!
endothelium! are! observed! in! the! segments! of! resected! specimens!
from!CD!patients!and!support! the!role!of!vasculature! in! the!disease!
pathogenesis!(Wakefield!et!al.,!1991b,!Danese,!2011).!Furthermore,!
correlation! between!microvascular! dysfunction! and! the! pathological!
features!of!CD!have!been!described!(McLaren!et!al.,!2002).!However,!
the!underlying!molecular!mechanisms!of!dysregulated!angiogenesis!
are! still! unclear.! ! In! this! thesis,! increased! MVD! (chapter! 4)! and!
dysregulated! angiogenic! gene! expression! (chapter! 5)! have! been!
demonstrated,! supporting! the! hypothesis! that! angiogenesis! in! CD!
mesenteric! AT! is! dysregulated.! IL6! and! VEGF,! two! of! the! most!
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important!angiogenic!factors!were!deficient!at!the!mRNA!and!protein!
expression! at! tissue! level.! This! experiment! had! the! objective! of!
assessing! the! level! of! secretion! of! these! two! cytokines! by! the!
mesenteric!AT!of!CD!patients.!
!
The!main! findings! in! this!experiment!demonstrated! that! the! level!of!
VEGF!secreted!by!CD!mesenteric!AT!is!significantly!higher!than!the!
level! secreted! by! AT! from! control! patients.! However,! in! paired!
comparison!of!different!AT!types!from!CD!patients!the!level!of!VEGF!




2001,! Kapsoritakis! et! al.,! 2003).! The! serum! level! of! VEGF! of! this!
cohort! is! described! in! chapter! 6.! Briefly,! the! level! was! significantly!
higher! than! controls.! However,! at! the! intestinal! mucosal! level! the!
expression!of!VEGF!was!enhanced!in!patients!with!active!disease!and!
in!patients!at!remission!(Danese!et!al.,!2006).!Similarly,!the!expression!
of! VEGF! in! the! AT! is! up! regulated! only! during! adipose! tissue!




















to! be! a! patients! systemic! effect! and! not! attributed! to! the! AT!
endogenously,! but! influenced! by! the! patients! immunosuppressive!
therapy.!!
!
There!are!several!strengths!attributed!to!this!experiment:! firstly,! it! is!
done! under! ex! vivo! controlled! conditions! whereby! patient! related!
effects,! such! as! immunosuppressive! therapy! are! circumventedH!!
secondly,!the!tissue!is!minced!into!small!pieces!during!incubation!to!




There! are! some!unavoidable! limitations,! such!as! variabilities! in! the!
processing,! for! example! although! mincing! the! tissue! into! smaller!
pieces!was!done!very!carefully,!there!can!still!be!small!sub!variations.!
Furthermore,!although!the!IL6!levels!were!similar! in!the!CD!disease!
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The! plasticity! of! AT! is! considered! to! be! the! highest! among! all!
multicellular! organs! (Cinti,! 2005).! The! remarkable! ability! of! AT! to!
rapidly! expand! and! regress! is! well! demonstrated! when! individuals!
repetitively!diet,!as!they!can!lose!and!gain!dozens!of!kilograms!over!
















The! dynamic! nature! of! AT! growth! and! regression! is! essential! for!
survival! and! requires! tightly! balanced! angiogenic! and! inflammatory!






dynamic! organ! with! endocrine,! paracrine! and! autocrine! functions!
(Ahima!and!Flier,!2000a).!To!maintain!angiogenic!and! inflammatory!
balanced! responses,! AT! produces! high! levels! of! proangiogenic,!
antiangiogenic,! proinflammatory! and! anti?inflammatory! cytokines!
(Fasshauer!et!al.,!2002,!Kralisch!et!al.,!2005).!Specifically,!VEGF!is!
expressed!and!secreted!by!adipocytes!(Zhang!et!al.,!1997)!and!this!
thesis! demonstrates! that! several! pro?and! antiangiogenic! genes! are!
expressed!in!different!types!of!AT!including!the!mesentery.!Regarding!
CD! mesentery,! these! characteristics! may! provide! the! conceptual!
background! behind! the! expansion! of! the! mesentery! conferring! the!
phenomena!of!fat!wrapping.!The!milieu!of!inflammatory!cytokines!at!
the!site!of!the!inflamed!bowel,!and!the!plastic!endogenous!nature!of!
AT! are! substantive! reasons! that! support! the! observation! of! fat!














purposed! of! demonstration,! this! chapter! has! been! divided! into! four!
sections:!1)!descriptive!statistics!of!the!AT!used!in!this!experimentH!2)!
ratio! comparison! of! AT! vascular! sprouting! versus! no! vascular!








2! controls,! one! of!which! underwent! subtotal! colectomy! for!UC! and!
another!underwent!colectomy!for!constipation.!A!total!number!of!234!
duplicates!of! tissue!culture!were!performed! including:! ! 1)! 44! (19%)!
wrapping! mesenteric,! 50! (21%)! ileocaecal! mesenteric,! 30! (13%)!
omental! and!30! (13%)! subcutaneous!AT! from!CD!patientsH! and!40!
(17%)! ileocaecal! mesenteric,! 20! (9%)! omental,! and! 20! (9%)!
subcutaneous!AT!from!control!patients!(Figure!8.1).!To!explain!further,!
for!CD!patient!number!1!for!example,!a!total!number!of!10!wrapping!
mesentery,! 10! ileocaecal! mesentery,! 10! omental! and! 10!
! 215!















circumferential! vascular! sprouting,! the! AT! was! not! included! in! the!
analysis!of!vascular!sprouting!quantification!by!ImageJ.!But!initially!the!
test!group!(wrapping!and!mesenteric!AT)!and!the!control!group!were!
compared! in! the! present! or! absent! of! circumferential! vascular!
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sprouting.!Out!of!154,! total!samples!cultured! from!CD!tissue:!32/44!
(73%),! 30/50! (60%),! 21/30! (70%),! and! 13/30! (43%)! of! wrapping!
mesenteric,! ileocaecal! mesenteric,! omental! and! subcutaneous! AT!
demonstrated!vascular!sprouting!respectively.!The!difference!in!ratios!
were! not! statistically! significant! (X2(3)=7.5,! p=0.06)! (Figure! 8.2,! B).!
Furthermore,!out!of!80!total!samples!cultured!from!the!control!patients:!
38/40!(95%),!18/20!(90%),!and!15/20!(75%)!of!ileocaecal!mesenteric,!




To! investigate! differences! in! the! ability! of! AT! to! produce! vascular!
sprouting,! the! ratios! of! vascular! sprouting! of! each! tissue! type! was!
compared! between! the! CD! and! control! tissues.! The! ability! of!





















































































































































































The! extent! of! vascular! sprouting! was! quantified! using! the! imageJ!
software.! Briefly,! the! growth! surface! area! was! divided! on! the! AT!





The! extent! of! vascular! sprouting! was! significantly! lower! in! CD!
wrapping!mesenteric!(mean=4.1,!SD=3.8)! in!comparison!to!omental!!!
AT!harvested! from!CD!patients! (mean=8.1,!SD=5.4,!p<0.0001)!and!
AT!harvested! from!control!patients! including:! ! ileocaecal!mesentery!
(mean=4.9,! SD=3.2,! p<0.05),! and! subcutaneous! AT! (mean=5.6,!
SD=3.4,!p<0.05)!(Figure!8.3).!There!was!no!statistical!difference!in!the!
extent! of! vascular! sprouting! between! the! two! tissue! types! in! the!
“disease”!group!wrapping!mesenteric!AT!and! ileocaecal!mesenteric!
AT! (mean=!2.2,!SD=1.7)!and!subcutaneous!AT!harvested! from!CD!
patients! (mean=2.8,!SD=2.4).!The! latter!of!which! is!also!part!of! the!
control!group!(Figure!8.3).!Comparison!of!the!means!of!all!types!of!AT!
to! the! combined! extent! of! vascular! sprouting! in! both!wrapping! and!
ileocaecal!mesentery!of!CD!patients!(mean=3.2,!SD=3)!demonstrated!






















































































































































Figure% 8.4.% Combined% Crohn’s% disease% (CD)% wrapping% and% ileocaecal%
mesenteric%adipose%tissue%(AT)%(test%group)%comparison%to:%all%other%tissue%
types%individually%(AT%from%nonFCD%patients%and%subcutaneous%and%omental%







The! speed! of! vascular! sprouting! was! assessed! by! measuring! the!
extent! every! 6! hours,! starting! at! day! 2! until! day! 10,! on! the! same!






at! each! time! point! of! combined! wrapping! and!mesenteric! AT! (test!
group)! from! CD! patients! were! statistically! significantly! lower! in!
comparison!to!ileocaecal!mesenteric!(mean!diff.=?0.54,!95%!CI![?0.7H?
.04],! p<0.0001)! and! subcutaneous! AT! from! control! patients! (mean!
diff.=?1.2,! 95%!CI! [?1.4H?0.9],!p<0.0001).!Similarly,! the!main! column!
effect!of!difference!in!mean!was!also!statistically!significantly!lower!in!
comparison! to! omental! AT! (mean! diff.=?2,! 95%! CI! [?2.3H?1.9],!
p<0.0001)!from!CD!patients!(Figure!8.5).!However,!the!main!column!
effect! of! difference! in! mean! was! similar! in! comparison! to!
subcutaneous! AT! (mean! diff.=0.1,! 95%! CI! [?0.13H0.3])! from! CD!





































In! addition,! combined! CD! wrapping! and! mesenteric! ATs’! vascular!
sprouting! at! 6! hourly! different! time! points! compared! to! combined!
control! tissue!demonstrated!statistically!significantly! lower!means! in!
















Table% 8.1.% Means% of% the% extent% of% vascular% sprouting% at% 6% hourly% time% point,%
comparing%the%test%group%(Crohn’s%disease%wrapping%and%ileocaecal%mesenteric%
adipose% tissue(AT))% with% the% controls% group% (ileocaecal% mesentery,%
subcutaneous% and% omental% AT% from% nonFCD% patients% and% subcutaneous% and%
omental%AT%from%CD%patients).%
Time%point! Control! Disease! Difference! p%value!
6! 0.06! 0.03! 0.03! 0.92!
7! 0.09! 0.04! 0.04! 0.90!
8! 0.12! 0.06! 0.06! 0.86!
9! 0.17! 0.08! 0.08! 0.80!
10! 0.22! 0.11! 0.11! 0.75!
11! 0.27! 0.14! 0.13! 0.70!
12! 0.35! 0.18! 0.17! 0.60!
13! 0.44! 0.21! 0.23! 0.49!
14! 0.54! 0.26! 0.29! 0.39!
15! 0.66! 0.32! 0.35! 0.30!
16! 0.78! 0.36! 0.42! 0.20!
17! 0.90! 0.43! 0.47! 0.15!
18! 1.05! 0.48! 0.58! 0.08!
19! 1.18! 0.54! 0.64! 0.05!
20! 1.33! 0.60! 0.74! <0.05!
21! 1.49! 0.69! 0.80! <0.05!
22! 1.63! 0.79! 0.84! <0.05!
23! 1.80! 0.90! 0.90! <0.01!
24! 1.99! 0.99! 1.00! <0.01!
25! 2.23! 1.15! 1.08! <0.01!
26! 2.41! 1.25! 1.16! <0.001!
27! 2.62! 1.39! 1.23! <0.001!
28! 2.84! 1.52! 1.33! <0.001!
29! 3.04! 1.64! 1.40! <0.0001!
30! 3.24! 1.85! 1.40! <0.0001!
31! 3.45! 1.96! 1.49! <0.0001!
32! 3.62! 2.09! 1.53! <0.0001!
33! 3.89! 2.25! 1.64! <0.0001!
34! 4.11! 2.39! 1.72! <0.0001!
35! 4.32! 2.50! 1.82! <0.0001!
36! 4.56! 2.66! 1.90! <0.0001!
37! 4.77! 2.79! 1.98! <0.0001!
38! 4.97! 2.95! 2.02! <0.0001!






As! in! the!case!of!any! tissue! that! is! changing!mass,! it! is! tenable! to!
speculate! that! the!expanding!AT! in!CD,!described!as! fat!wrapping,!
would! be! accompanied! by! parallel! changes! in! microcirculation!
(Crandall!et!al.,!1997).!However,! if! that!expansion! is!pathological,! it!
might! be! detrimental! to! the! course! of! the! disease! and! may! be!
perpetuated!by!inadequate!angiogenic!mechanisms.!Hence,!balanced!
angiogenesis! is! required! for! the! synthesis! of! an! adequate! capillary!





mesentery,! a! multifaceted! study! was! carried! out! including:! tissue!
histology!and!immunohistochemistry,!angiogenic!genes!and!proteins!
expression! and! finally! a! functional! assay.! This! experiment! was!
designed! to! examine! the! angiogenic! capacity! of! CD! mesentery! in!
comparison! to! other! AT! types! from! CD! patients! and! controls.! The!
multiple!tissue!type!comparison!was!conducted!keeping!in!mind!that!
AT!may!differ!in!their!angiogenic!capacity.!For!example,!the!omentum!
was! reported! to! exhibit!more!marked! angiogenic! capacity! than! the!
subcutaneous!AT!(Villaret!et!al.,!2010).!Based!on!the!findings!in!the!
previous! experiments,! it! appears! that! the! angiogenic! genes! and!
proteins!are!down!regulated!in!the!mesenteric!AT!of!the!cohort!of!CD!
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and! demonstrates! that! the! mesenteric! AT! in! CD! patients! has!




CD!patients!was!significantly!slower! than! the!controls.! In!particular,!















with! increase! inflammation! (chapter! 3)! and! impaired! angiogenic!
capacity.!These! features! in!addition! to! the!dysregulated!angiogenic!
gene! expression! may! partly! explain! the! chronic! perpetuated!
imbalanced! inflammatory! (Borley! et! al.,! 2000)! and! angiogenic!
response!in!CD!mesenteric!adipose!tissue.!
!
Furthermore,! the! current! evidence! suggests! that! there! is! a! strong!
association!between!obesity!and!metabolic!syndrome!(Carey,!1998).!





by!mesenteric!hypertrophy! (Sheehan!et! al.,! 1992),! it! is! plausible! to!
speculate!that!the!lack!of!angiogenic!capacity!of!the!mesentery!AT!in!
CD!patients!in!this!experiment!with!the!presence!of!a!macroscopically!
expanding! mesentery! reflects! a! mass! that! is! not! sufficiently!






Another! important! finding! is! the! angiogenic! impairment! seen! in! the!
subcutaneous!AT!of!CD!patients.!Although,!CD!patients!are!generally!
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underweight! (O'Keefe,! 1996,! Beattie! et! al.,! 2006),! fat! distribution!




However,! in! CD! the! increased! intra?abdominal! AT! mass! is!
independent!of!body!mass!index!or!metabolic!abnormalities!(Schäffler!





in! this! study,! it! has! been! confirmed! on!many! levels! ! including! the!
matrigel! functional! assay,! that! angiogenesis! is! dysregulated! or!
impaired! in! the! mesenteric! AT! of! CD! patients.! Although! previous!
reports! indicated! an! enhanced! synthesis! of! inflammatory! and!
angiogenic! cytokines! in! CD! mesentery,! the! contrary! has! been!
demonstrated! in! this!cohort!of!CD!patients.!For!example,! leptin! is!a!
strong! proangiogenic! adipokine! (Carino! et! al.,! 2008)! that! promotes!
angiogenesis!in!benign!and!malignant!conditions!(Barbier!et!al.,!2003).!
The!gene!expression!of!leptin!was!down!regulated!by!four!fold!in!the!

















well?established! assay! for! angiogenesis! (Rojas?Rodriguez! et! al.,!








bias.! Furthermore,! the! study! of! functional! response! confirms! the!
findings! of! dysregulated! and! impaired! angiogenic! gene! and! protein!
expression! seen! in! the! previous! experiments! and! histological!
specimens!of!CD!mesentery,!described!in!previous!chapters,!4,!5!and!
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6.!This!was! the! first! time!to!examine!the!angiogenic!capacity!of! the!




Despite! the! strengths! described! above! there! are! unavoidable!
weaknesses!including!varieties!of!the!cell!types!found!in!the!cultured!
tissue.!Although!the!ATs’!angiogenic!capacity!may!be!dependant!on!
the! proangiogenic! and! antiangiogenic! adipokines! secreted! by! AT,!




Further! assessment! of! the! angiogenic! pathways,! and! mechanistic!
studies! are! required! to! understand! the! angiogenic! response! in! the!
mesentery! of! CD! and! how! this! contributes! to! the! pathogenesis.!
Assessments!of!the!gene!expression!and!functional!assay!at!a!cellular!
level!would!provide!a!more!complete!picture!and!would!set!the!scene!







ABBAS,! M.,! SALEM,! J.,! STUCKI?KOCH,! A.,! RICKMANN,! M.,!
GRUNWALD,!V.,!HERRMANN,!T.,!JONIGK,!D.,!KREIPE,!H.!&!
HUSSEIN,! K.! 2014.! Expression! of! angiogenic! factors! is!
increased! in! metastasised! renal! cell! carcinomas.! Virchows%
Arch,!464,!197?202.!
ABRAHAM,!C.,!DULAI,!P.!S.,!VERMEIRE,!S.!&!SANDBORN,!W.!J.!
2017.! Lessons! Learned! From! Trials! Targeting! Cytokine!












ACHEN,!M.!G.! &! STACKER,! S.! A.! 1998.! The! vascular! endothelial!
growth!factor!familyH!proteins!which!guide!the!development!of!
the!vasculature.!Int%J%Exp%Pathol,!79,!255?65.!
ADDISON,!C.! L.,! ARENBERG,!D.!A.,!MORRIS,!S.!B.,! XUE,!Y.!Y.,!
BURDICK,!M.!D.,!MULLIGAN,!M.!S.,! IANNETTONI,!M.!D.!&!
STRIETER,! R.! M.! 2000a.! The! CXC! chemokine,! monokine!






STRIETER,! R.! M.! 2000b.! The! CXC! chemokine! receptor! 2,!
CXCR2,! is! the! putative! receptor! for! ELR+! CXC! chemokine?
induced!angiogenic!activity.!J%Immunol,!165,!5269?77.!
ADDISON,! N.! V.! 1983.! Abdominal! tuberculosis??a! disease! revived.!
Ann%R%Coll%Surg%Engl,!65,!105?11.!
ADENIS,!A.,!VANSEYMORTIER,!L.,!FOISSEY,!D.!&!COLOMBEL,!J.!












ALBINI,! A.,! MARCHISONE,! C.,! DEL! GROSSO,! F.,! BENELLI,! R.,!
MASIELLO,!L.,!TACCHETTI,!C.,!BONO,!M.,!FERRANTINI,!M.,!
ROZERA,! C.,! TRUINI,! M.,! BELARDELLI,! F.,! SANTI,! L.! &!
NOONAN,!D.!M.!2000.!Inhibition!of!angiogenesis!and!vascular!
tumor! growth! by! interferon?producing! cells:! A! gene! therapy!
approach.!Am%J%Pathol,!156,!1381?93.!








PARK,! H.! D.,! SHELTON,! E.! &! SCHILLING,! E.! L.! 1950.!
Vascular!reactions!of!normal!and!malignant!tissues!in!vivo.!III.!
! 233!
Vascular! reactions'!of!mice! to! fibroblasts! treated! in!vitro!with!
methylcholanthrene.!J%Natl%Cancer%Inst,!11,!555?580.!
ALKIM,! C.,! SAKIZ,! D.,! ALKIM,! H.,! LIVAOGLU,! A.,! KENDIR,! T.,!
DEMIRSOY,! H.,! ERDEM,! L.,! AKBAYIR,! N.! &! SOKMEN,! M.!









AMANO,! Y.,! LEE,! S.! W.! &! ALLISON,! A.! C.! 1993.! Inhibition! by!
glucocorticoids! of! the! formation! of! interleukin?1! alpha,!
interleukin?1! beta,! and! interleukin?6:!mediation! by! decreased!
mRNA!stability.!Mol%Pharmacol,!43,!176?82.!
AMAR,! J.,! CHABO,! C.,! WAGET,! A.,! KLOPP,! P.,! VACHOUX,! C.,!
BERMÚDEZ?HUMARÁN,!L.!G.,!SMIRNOVA,!N.,!BERGÉ,!M.,!
SULPICE,! T.,! LAHTINEN,! S.,!OUWEHAND,! A.,! LANGELLA,!
P.,! RAUTONEN,! N.,! SANSONETTI,! P.! J.! &! BURCELIN,! R.!
2011.! Intestinal! mucosal! adherence! and! translocation! of!
commensal! bacteria! at! the! early! onset! of! type! 2! diabetes:!
molecular! mechanisms! and! probiotic! treatment.! EMBO% Mol%
Med,!3,!559?72.!
AMEMIYA,!T.!&!BHUTTO,!I.!A.!2001.!Retinal!vascular!changes!and!
































in! obese! black! versus! white! adolescents:! race! differential! in!
diabetogenic! and! atherogenic! risk! factors.! J% Clin% Endocrinol%
Metab,!88,!2534?40.!
BAR?GIL!SHITRIT,!A.,!KOSLOWSKY,!B.,!KORI,!M.,!PAZ,!K.,!ADAR,!
T.,! ISRAELI,! E.,! BEN?HORIN,! S.,! BERDICHEVSKI,! T.,!
COSCAS,!D.,!GAL,!E.,!ODES,!S.,!SHAUL,!R.,!BEN?YA'ACOV,!




BARBIER,! M.,! VIDAL,! H.,! DESREUMAUX,! P.,! DUBUQUOY,! L.,!
BOURREILLE,! A.,! COLOMBEL,! J.! F.,! CHERBUT,! C.! &!
GALMICHE,! J.! P.! 2003.! Overexpression! of! leptin! mRNA! in!
mesenteric! adipose! tissue! in! inflammatory! bowel! diseases.!
Gastroenterol%Clin%Biol,!27,!987?91.!
BARTOLI,!M.,!GU,!X.,!TSAI,!N.!T.,!VENEMA,!R.!C.,!BROOKS,!S.!E.,!
MARRERO,! M.! B.! &! CALDWELL,! R.! B.! 2000.! Vascular!
endothelial! growth! factor! activates! STAT! proteins! in! aortic!
endothelial!cells.!J%Biol%Chem,!275,!33189?92.!
BARTOLI,!M.,!PLATT,!D.,!LEMTALSI,!T.,!GU,!X.,!BROOKS,!S.!E.,!
MARRERO,! M.! B.! &! CALDWELL,! R.! B.! 2003.! VEGF!
differentially! activates! STAT3! in! microvascular! endothelial!
cells.!FASEB%J,!17,!1562?4.!
BATRA,! S.! &! RAKUSAN,! K.! 1992.! Capillary! length,! tortuosity,! and!
spacing!in!rat!myocardium!during!cardiac!cycle.!Am%J%Physiol,!
263,!H1369?76.!
BEATTIE,! R.! M.,! CROFT,! N.! M.,! FELL,! J.! M.,! AFZAL,! N.! A.! &!
HEUSCHKEL,!R.!B.!2006.! Inflammatory!bowel!disease.!Arch%
Dis%Child,!91,!426?32.!
BEATTIE,! R.! M.,! WALKER?SMITH,! J.! A.! &! MURCH,! S.! H.! 1995.!
Indications! for! investigation! of! chronic! gastrointestinal!
symptoms.!Arch%Dis%Child,!73,!354?5.!
BECERRA,! S.! P.! &! NOTARIO,! V.! 2013.! The! effects! of! PEDF! on!





BELTING,! M.,! DORRELL,! M.! I.,! SANDGREN,! S.,! AGUILAR,! E.,!
AHAMED,! J.,! DORFLEUTNER,! A.,! CARMELIET,! P.,!




















pathogenesis! of! anemia! in! inflammatory! bowel! disease.!




BLANCHARD,! J.!F.! 2006.!The!epidemiology!of! inflammatory!
bowel! disease! in! Canada:! a! population?based! study.! Am% J%
Gastroenterol,!101,!1559?68.!
BERTIN,! B.,! DESREUMAUX,! P.! &!DUBUQUOY,! L.! 2010.!Obesity,!




BIKFALVI,! A.! 2004.! Platelet! factor! 4:! an! inhibitor! of! angiogenesis.!
Semin%Thromb%Hemost,!30,!379?85.!
BOERS?SONDEREN,! M.! J.,! MULDER,! S.! F.,! NAGTEGAAL,! I.! D.,!
JACOBS,! J.! F.,! WANTEN,! G.! J.,! HOENTJEN,! F.! &! VAN!
HERPEN,!C.!M.!2014.!Severe!exacerbation!of!Crohn's!disease!
! 237!
during! sunitinib! treatment.! Eur% J% Gastroenterol% Hepatol,! 26,!
234?6.!
BOLONDI,! L.,! GAIANI,! S.,! BRIGNOLA,! C.,! CAMPIERI,! M.,!
RIGAMONTI,!A.,!ZIRONI,!G.,!GIONCHETTI,!P.,!BELLOLI,!C.,!
MIGLIOLI,!M.!&!BARBARA,! L.! 1992.!Changes! in! splanchnic!
hemodynamics! in! inflammatory! bowel! disease.! Non?invasive!
assessment! by! Doppler! ultrasound! flowmetry.! Scand% J%
Gastroenterol,!27,!501?7.!
BONO,! F.,! DE! SMET,! F.,! HERBERT,! C.,! DE! BOCK,! K.,!
GEORGIADOU,!M.,!FONS,!P.,!TJWA,!M.,!ALCOUFFE,!C.,!NY,!
A.,! BIANCIOTTO,! M.,! JONCKX,! B.,! MURAKAMI,! M.,!
LANAHAN,! A.! A.,! MICHIELSEN,! C.,! SIBRAC,! D.,! DOL?
GLEIZES,!F.,!MAZZONE,!M.,!ZACCHIGNA,!S.,!HERAULT,!J.!
P.,! FISCHER,! C.,! RIGON,! P.,! RUIZ! DE! ALMODOVAR,! C.,!
CLAES,!F.,!BLANC,!I.,!POESEN,!K.,!ZHANG,!J.,!SEGURA,!I.,!
GUEGUEN,! G.,! BORDES,! M.! F.,! LAMBRECHTS,! D.,!
BROUSSY,! R.,! VAN! DE! WOUWER,! M.,! MICHAUX,! C.,!
SHIMADA,!T.,!JEAN,!I.,!BLACHER,!S.,!NOEL,!A.,!MOTTE,!P.,!
ROM,! E.,! RAKIC,! J.! M.,! KATSUMA,! S.,! SCHAEFFER,! P.,!
YAYON,! A.,! VAN! SCHEPDAEL,! A.,! SCHWALBE,! H.,!
GERVASIO,! F.! L.,! CARMELIET,! G.,! ROZENSKY,! J.,!
DEWERCHIN,! M.,! SIMONS,! M.,! CHRISTOPOULOS,! A.,!
HERBERT,!J.!M.!&!CARMELIET,!P.!2013.!Inhibition!of!tumor!








F.! 2000.! The! relationship! between! inflammatory! and! serosal!
connective! tissue!changes! in! ileal!Crohn's!disease:!evidence!
for!a!possible!causative!link.!J%Pathol,!190,!196?202.!
! 238!
BOSY?WESTPHAL,! A.,! SCHAUTZ,! B.,! LAGERPUSCH,! M.,!





BOURLIOUX,! P.,! KOLETZKO,! B.,!GUARNER,! F.! &! BRAESCO,! V.!

























WILLIAMS,! C.! B.,! DOMIZIO,! P.,! WALKER?SMITH,! J.! A.! &!
MACDONALD,! T.! T.! 1994.! Tumor! necrosis! factor! alpha?
! 239!
producing! cells! in! the! intestinal! mucosa! of! children! with!
inflammatory!bowel!disease.!Gastroenterology,!106,!1455?66.!
BRIGSTOCK,!D.!R.!2002.!Regulation!of!angiogenesis!and!endothelial!
cell! function! by! connective! tissue! growth! factor! (CTGF)! and!
cysteine?rich!61!(CYR61).!Angiogenesis,!5,!153?65.!
BROHEE,! P.,! VIOLON,! P.,! MAVROUDAKIS,! N.,! PIROTTE,! B.,!
BROTCHI,! J.,! ZEGERS! DE! BEYL,! D.! &! HILDEBRAND,! J.!
1997.!Central!nervous!system!lesions!associated!with!Crohn's!
disease.!J%Neuroimaging,!7,!195?8.!





AVNSTROM,! S.,! THORSGAARD,! N.,! ANDERSEN,! V.,!
KRABBE,!S.,!DAHLERUP,!J.!F.,!SALUPERE,!R.,!NIELSEN,!K.!
R.,!OLSEN,!J.,!MANNINEN,!P.,!COLLIN,!P.,!TSIANOS,!E.!V.,!
KATSANOS,! K.! H.,! LADEFOGED,! K.,! LAKATOS,! L.,!
BJORNSSON,!E.,!RAGNARSSON,!G.,!BAILEY,!Y.,!ODES,!S.,!
SCHWARTZ,! D.,! MARTINATO,! M.,! LUPINACCI,! G.,! MILLA,!
M.,! DE! PADOVA,! A.,! D'INCA,! R.,! BELTRAMI,! M.,!
KUPCINSKAS,!L.,!KIUDELIS,!G.,!TURCAN,!S.,!TIGHINEANU,!
O.,!MIHU,!I.,!MAGRO,!F.,!BARROS,!L.!F.,!GOLDIS,!A.,!LAZAR,!
D.,! BELOUSOVA,! E.,! NIKULINA,! I.,! HERNANDEZ,! V.,!
MARTINEZ?ARES,! D.,! ALMER,! S.,! ZHULINA,! Y.,!
HALFVARSON,!J.,!AREBI,!N.,!SEBASTIAN,!S.,!LAKATOS,!P.!
L.,! LANGHOLZ,! E.,! MUNKHOLM,! P.! &! EPICOM,!G.! 2014a.!
East?West! gradient! in! the! incidence! of! inflammatory! bowel!









V.,! LADEFOGED,! K.,! LAKATOS,! L.,! RAGNARSSON,! G.,!
BJORNSSON,!E.,!BAILEY,!Y.,!O'MORAIN,!C.,!SCHWARTZ,!
D.,! ODES,! S.,! VALPIANI,! D.,! BONI,! M.! C.,! JONAITIS,! L.,!
KUPCINSKAS,! L.,! TURCAN,! S.,! BARROS,! L.,! MAGRO,! F.,!
LAZAR,! D.,! GOLDIS,! A.,! NIKULINA,! I.,! BELOUSOVA,! E.,!
FERNANDEZ,!A.,!SANROMAN,!L.,!ALMER,!S.,!ZHULINA,!Y.,!
HALFVARSON,!J.,!AREBI,!N.,!DIGGORY,!T.,!SEBASTIAN,!S.,!
LAKATOS,! P.! L.,! LANGHOLZ,! E.,! MUNKHOLM,! P.! &! FOR!
THE,!E.?G.!2014b.!Health?related!quality!of!life!improves!during!





The!gene!encoding! collagen!alpha1(V)(COL5A1)! is! linked! to!
mixed! Ehlers?Danlos! syndrome! type! I/II.! J% Invest% Dermatol,!
106,!1273?6.!
CALKINS,! B.! M.! &! MENDELOFF,! A.! I.! 1986.! Epidemiology! of!
inflammatory!bowel!disease.!Epidemiol%Rev,!8,!60?91.!
CALLEWAERT,! B.! L.,!WILLAERT,! A.,! KERSTJENS?FREDERIKSE,!
W.! S.,! DE! BACKER,! J.,! DEVRIENDT,! K.,! ALBRECHT,! B.,!
RAMOS?ARROYO,!M.!A.,!DOCO?FENZY,!M.,!HENNEKAM,!R.!
C.,! PYERITZ,! R.! E.,! KROGMANN,! O.! N.,! GILLESSEN?
KAESBACH,! G.,! WAKELING,! E.! L.,! NIK?ZAINAL,! S.,!
FRANCANNET,!C.,!MAURAN,!P.,!BOOTH,!C.,!BARROW,!M.,!
DEKENS,!R.,!LOEYS,!B.!L.,!COUCKE,!P.!J.!&!DE!PAEPE,!A.!




&! ROBERTS,! D.! D.! 2004.! Alpha4beta1! integrin! mediates!
selective!endothelial!cell!responses!to!thrombospondins!1!and!
! 241!
2! in! vitro! and!modulates! angiogenesis! in! vivo.!Circ%Res,! 94,!
462?70.!
CANAVAN,!C.,!ABRAMS,!K.!R.,!HAWTHORNE,!B.!&!MAYBERRY,!J.!




Laparoscopically! assisted! intestinal! resection! in! 88! patients!
with!Crohn's!disease.!Surg%Endosc,!13,!595?9.!
CAREY,!D.!G.!1998.!Abdominal!obesity.!Curr%Opin%Lipidol,!9,!35?40.!











CELLIER,! C.,! SAHMOUD,! T.,! FROGUEL,! E.,! ADENIS,! A.,!
BELAICHE,! J.,! BRETAGNE,! J.! F.,! FLORENT,!C.,!BOUVRY,!
M.,!MARY,!J.!Y.!&!MODIGLIANI,!R.!1994.!Correlations!between!
clinical!activity,!endoscopic!severity,!and!biological!parameters!
in! colonic! or! ileocolonic! Crohn's! disease.! A! prospective!
multicentre! study! of! 121! cases.! The! Groupe! d'Etudes!
Therapeutiques!des!Affections!Inflammatoires!Digestives.!Gut,!
35,!231?5.!
CENSUS! 2011.! "2011! Census:! Ethnic! group,! local! authorities! in!
England!and!Wales".!Office!for!National!Statistics.!















metalloproteinase! 14! modulates! signal! transduction! and!
angiogenesis!in!the!cornea.!Surv%Ophthalmol,!61,!478?97.!
CHARRIERE,!G.,!COUSIN,!B.,!ARNAUD,!E.,!ANDRE,!M.,!BACOU,!











CHIOREAN,! M.! V.,! SANDRASEGARAN,! K.,! SAXENA,! R.,!
MAGLINTE,! D.! D.,! NAKEEB,! A.! &! JOHNSON,! C.! S.! 2007.!
Correlation! of! CT! enteroclysis! with! surgical! pathology! in!
Crohn's!disease.!Am%J%Gastroenterol,!102,!2541?50.!
CHO,! C.! H.,! KOH,! Y.! J.,! HAN,! J.,! SUNG,! H.! K.,! JONG! LEE,! H.,!





CHO,! J.! H.! &! FELDMAN,! M.! 2015.! Heterogeneity! of! autoimmune!
diseases:! pathophysiologic! insights! from! genetics! and!
implications!for!new!therapies.!Nat%Med,!21,!730?8.!
CHOMCZYNSKI,!P.!&!SACCHI,!N.!1987.!Single?step!method!of!RNA!
isolation! by! acid! guanidinium! thiocyanate?phenol?chloroform!
extraction.!Anal%Biochem,!162,!156?9.!
CHOMCZYNSKI,!P.!&!SACCHI,!N.!2006.!The!single?step!method!of!
RNA! isolation! by! acid! guanidinium! thiocyanate?phenol?
chloroform!extraction:!twenty?something!years!on.!Nat%Protoc,!
1,!581?5.!
CHRISTIAENS,! V.! &! LIJNEN,! H.! R.! 2010.! Angiogenesis! and!
development!of!adipose!tissue.!Mol%Cell%Endocrinol,!318,!2?9.!
CINTI,! S.! 2005.! The! adipose! organ.!Prostaglandins% Leukot% Essent%
Fatty%Acids,!73,!9?15.!
CLAFFEY,!K.! P.,!WILKISON,!W.!O.!&!SPIEGELMAN,!B.!M.! 1992.!
Vascular! endothelial! growth! factor.! Regulation! by! cell!
















COSTA,! M.! D.,! PEREIRA,! J.! B.,! PALA,! M.,! FERNANDES,! V.,!
OLIVIERI,! A.,! ACHILLI,! A.,! PEREGO,!U.! A.,!RYCHKOV,!S.,!
! 244!
NAUMOVA,!O.,!HATINA,!J.,!WOODWARD,!S.!R.,!ENG,!K.!K.,!
MACAULAY,! V.,! CARR,! M.,! SOARES,! P.,! PEREIRA,! L.! &!
RICHARDS,! M.! B.! 2013.! A! substantial! prehistoric! European!
ancestry!amongst!Ashkenazi!maternal!lineages.!Nat%Commun,!
4,!2543.!
COTTONE,! M.,! MAGLIOCCO,! A.,! ROSSELLI,! M.,! PINZONE,! F.,!












CROHN,! B.! B.,! GINZBURG,! L.! &! OPPENHEIMER,! G.! D.! 1984.!
Landmark!article!Oct!15,!1932.!Regional!ileitis.!A!pathological!
and! clinical! entity.! By! Burril! B.! Crohn,! Leon! Ginzburg,! and!
Gordon!D.!Oppenheimer.!JAMA,!251,!73?9.!
CULLIGAN,!K.,!COFFEY,!J.!C.,!KIRAN,!R.!P.,!KALADY,!M.,!LAVERY,!
I.! C.! &! REMZI,! F.! H.! 2012.! The! mesocolon:! a! prospective!
observational!study.!Colorectal%Dis,!14,!421?8H!discussion!428?
30.!
CULLIGAN,! K.,! WALSH,! S.,! DUNNE,! C.,! WALSH,! M.,! RYAN,! S.,!
QUONDAMATTEO,!F.,!DOCKERY,!P.!&!COFFEY,!J.!C.!2014.!
The! mesocolon:! a! histological! and! electron! microscopic!
characterization!of!the!mesenteric!attachment!of!the!colon!prior!
to!and!after!surgical!mobilization.!Ann%Surg,!260,!1048?56.!




FOLKMAN,! J.,! MOULTON,! K.! S.! &! RUPNICK,! M.! A.! 2003.!
Adipose! tissue! growth! and! regression! are! regulated! by!
angiopoietin?1.!Biochem%Biophys%Res%Commun,!311,!563?71.!
DANESE,!S.!2011.!Role!of!the!vascular!and!lymphatic!endothelium!in!
the!pathogenesis!of! inflammatory!bowel!disease:! 'brothers! in!
arms'.!Gut,!60,!998?1008.!
DANESE,!S.,!SANS,!M.,!DE!LA!MOTTE,!C.,!GRAZIANI,!C.,!WEST,!
G.,! PHILLIPS,! M.! H.,! POLA,! R.,! RUTELLA,! S.,! WILLIS,! J.,!













XU,! H.,! BENEDICT,! W.! &! BOUCK,! N.! P.! 1999.! Pigment!














DEBAN,! L.,! CORREALE,! C.,! VETRANO,! S.,! MALESCI,! A.! &!
DANESE,! S.! 2008.! Multiple! pathogenic! roles! of!
microvasculature!in!inflammatory!bowel!disease:!a!Jack!of!all!
trades.!Am%J%Pathol,!172,!1457?66.!
DEL! CORSO,! L.,! MORUZZO,! D.,! CONTE,! B.,! AGELLI,! M.,!
ROMANELLI,!A.!M.,!PASTINE,!F.,!PROTTI,!M.,!PENTIMONE,!
F.!&!BAGGIANI,!G.!1998.!Tortuosity,!kinking,!and!coiling!of!the!
carotid! artery:! expression! of! atherosclerosis! or! aging?!
Angiology,!49,!361?71.!
DENG,! X.,! TOLSTANOVA,! G.,! KHOMENKO,! T.,! CHEN,! L.,!
TARNAWSKI,! A.,! SZABO,! S.! &! SANDOR,! Z.! 2009.!
Mesalamine! restores! angiogenic! balance! in! experimental!









DESREUMAUX,! P.,! BRANDT,! E.,! GAMBIEZ,! L.,! EMILIE,! D.,!
GEBOES,! K.,! KLEIN,! O.,! ECTORS,! N.,! CORTOT,! A.,!
CAPRON,! M.! &! COLOMBEL,! J.! F.! 1997.! Distinct! cytokine!
patterns! in!early!and!chronic! ileal! lesions!of!Crohn's!disease.!
Gastroenterology,!113,!118?26.!
DESREUMAUX,! P.,! ERNST,! O.,! GEBOES,! K.,! GAMBIEZ,! L.,!
BERREBI,!D.,!MULLER?ALOUF,!H.,!HAFRAOUI,!S.,!EMILIE,!
D.,!ECTORS,!N.,!PEUCHMAUR,!M.,!CORTOT,!A.,!CAPRON,!
M.,! AUWERX,! J.! &! COLOMBEL,! J.! F.! 1999.! Inflammatory!




KNEBELMANN,! B.,! SEGAL,! M.! &! SUKHATME,! V.! P.! 1999.!
Endostatin! induces! endothelial! cell! apoptosis.! J% Biol% Chem,!
274,!11721?6.!
DHILLON,! A.! P.,! ANTHONY,! A.,! SIM,! R.,! WAKEFIELD,! A.! J.,!
SANKEY,!E.!A.,!HUDSON,!M.,!ALLISON,!M.!C.!&!POUNDER,!
R.! E.! 1992.! Mucosal! capillary! thrombi! in! rectal! biopsies.!
Histopathology,!21,!127?33.!
DI!SABATINO,!A.,!CICCOCIOPPO,!R.,!ARMELLINI,!E.,!MORERA,!R.,!
RICEVUTI,! L.,!CAZZOLA,!P.,! FULLE,! I.! &!CORAZZA,!G.!R.!
2004.!Serum!bFGF!and!VEGF!correlate!respectively!with!bowel!
wall! thickness! and! intramural! blood! flow! in! Crohn's! disease.!
Inflamm%Bowel%Dis,!10,!573?7.!
DIAMANTI,! A.,! CAPRIATI,! T.,! PAPADATOU,! B.,! KNAFELZ,! D.,!
BRACCI,!F.,!CORSETTI,!T.,!ELIA,!D.!&!TORRE,!G.!2015.!The!
clinical! implications! of! thalidomide! in! inflammatory! bowel!
diseases.!Expert%Rev%Clin%Immunol,!11,!699?708.!
DIGNASS,! A.,! LINDSAY,! J.! O.,! STURM,! A.,! WINDSOR,! A.,!
COLOMBEL,!J.!F.,!ALLEZ,!M.,!D'HAENS,!G.,!D'HOORE,!A.,!
MANTZARIS,!G.,!NOVACEK,!G.,!ORESLAND,!T.,!REINISCH,!
W.,! SANS,!M.,! STANGE,! E.,! VERMEIRE,! S.,! TRAVIS,! S.! &!
VAN! ASSCHE,! G.! 2012.! Second! European! evidence?based!
consensus! on! the! diagnosis! and! management! of! ulcerative!
colitis! part! 2:! current!management.! J%Crohns%Colitis,! 6,! 991?
1030.!
DIGNASS,! A.,! VAN! ASSCHE,! G.,! LINDSAY,! J.! O.,! LEMANN,! M.,!
SODERHOLM,!J.,!COLOMBEL,!J.!F.,!DANESE,!S.,!D'HOORE,!




the! diagnosis! and! management! of! Crohn's! disease:! Current!
management.!J%Crohns%Colitis,!4,!28?62.!
! 248!
DONNELLAN,!W.! L.! 1966.! Early! histological! changes! in! ulcerative!










VEGF! and! histamine?induced! MMP?2! production! in!
microvascular!endothelial!cells.!J%Cell%Biochem,!107,!272?83.!
DROUET,! M.,! DUBUQUOY,! L.,! DESREUMAUX,! P.! &! BERTIN,! B.!
2012.!Visceral!fat!and!gut!inflammation.!Nutrition,!28,!113?7.!
DUERR,! R.! H.,! TAYLOR,! K.! D.,! BRANT,! S.! R.,! RIOUX,! J.! D.,!
SILVERBERG,! M.! S.,! DALY,! M.! J.,! STEINHART,! A.! H.,!
ABRAHAM,! C.,! REGUEIRO,! M.,! GRIFFITHS,! A.,!
DASSOPOULOS,! T.,! BITTON,! A.,! YANG,! H.,! TARGAN,! S.,!
DATTA,!L.!W.,!KISTNER,!E.!O.,!SCHUMM,!L.!P.,!LEE,!A.!T.,!
GREGERSEN,! P.! K.,! BARMADA,! M.! M.,! ROTTER,! J.! I.,!
NICOLAE,! D.! L.! &! CHO,! J.! H.! 2006.! A! genome?wide!
association! study! identifies! IL23R! as! an! inflammatory! bowel!
disease!gene.!Science,!314,!1461?3.!





and! angiogenesis.! Iron! deficiency! and! angiogenesis.!Cancer%
Cell%Int,!10,!28.!
EL! HOMSI,! M.,! DUCROC,! R.,! CLAUSTRE,! J.,! JOURDAN,! G.,!
GERTLER,!A.,!ESTIENNE,!M.,!BADO,!A.,!SCOAZEC,!J.!Y.!&!
PLAISANCIÉ,! P.! 2007.! Leptin! modulates! the! expression! of!
! 249!
secreted!and!membrane?associated!mucins!in!colonic!epithelial!
cells! by! targeting! PKC,! PI3K,! and! MAPK! pathways.! Am% J%
Physiol%Gastrointest%Liver%Physiol,!293,!G365?73.!
ELKIN,!M.,!ILAN,!N.,!ISHAI?MICHAELI,!R.,!FRIEDMANN,!Y.,!PAPO,!
O.,! PECKER,! I.! &! VLODAVSKY,! I.! 2001.! Heparanase! as!
mediator!of!angiogenesis:!mode!of!action.!FASEB%J,!15,!1661?
3.!









FAIN,! J.! N.! &! MADAN,! A.! K.! 2005.! Insulin! enhances! vascular!
endothelial! growth! factor,! interleukin?8,! and! plasminogen!
activator! inhibitor! 1! but! not! interleukin?6! release! by! human!
adipocytes.!Metabolism,!54,!220?6.!
FAIN,!J.!N.,!MADAN,!A.!K.,!HILER,!M.!L.,!CHEEMA,!P.!&!BAHOUTH,!
S.! W.! 2004.! Comparison! of! the! release! of! adipokines! by!




D.,! GENT,! A.! E.! &! IRVINE,! E.! J.! 2001.! Low! mortality! in!
ulcerative!colitis!and!Crohn's!disease!in!three!regional!centers!
in!England.!Am%J%Gastroenterol,!96,!501?7.!
FASSHAUER,! M.,! KLEIN,! J.,! NEUMANN,! S.,! ESZLINGER,! M.! &!
PASCHKE,!R.!2002.!Hormonal!regulation!of!adiponectin!gene!





K.,! KUTSCHERA,! S.,! BARTELS,! S.,! APPAK,! S.,!
BESEMFELDER,! E.,! TERHARDT,! D.,! CHAVAKIS,! E.,!
WIELAND,! T.,! KLEIN,! C.,! THOMAS,! M.,! UEMURA,! A.,!





FERRARA,!N.,!HOUCK,!K.,! JAKEMAN,! L.! &! LEUNG,!D.!W.! 1992.!
Molecular!and!biological!properties!of!the!vascular!endothelial!
growth!factor!family!of!proteins.!Endocr%Rev,!13,!18?32.!
FIOCCHI,! C.! 2002.! Inflammatory! bowel! disease:! dogmas! and!
heresies.!Dig%Liver%Dis,!34,!306?11.!
FLORIE,!J.,!WASSER,!M.!N.,!ARTS?CIESLIK,!K.,!AKKERMAN,!E.!M.,!
SIERSEMA,! P.! D.! &! STOKER,! J.! 2006.! Dynamic! contrast?











FOLKMAN,! J.,! KLAGSBRUN,! M.,! SASSE,! J.,! WADZINSKI,! M.,!
INGBER,! D.! &! VLODAVSKY,! I.! 1988.! A! heparin?binding!








with! systemic! inflammation! in! obese! humans.!Diabetes,! 56,!
1010?3.!
FORSYTHE,!J.!A.,!JIANG,!B.!H.,!IYER,!N.!V.,!AGANI,!F.,!LEUNG,!S.!
W.,! KOOS,! R.! D.! &! SEMENZA,! G.! L.! 1996.! Activation! of!
vascular! endothelial! growth! factor! gene! transcription! by!
hypoxia?inducible!factor!1.!Mol%Cell%Biol,!16,!4604?13.!
FRAYN,!K.!N.,!KARPE,!F.,!FIELDING,!B.!A.,!MACDONALD,!I.!A.!&!






ulcers! in! Crohn's! disease:! correlative! findings! by!magnifying!
colonoscopy,!electron!microscopy,!and!immunohistochemistry.!
Gut,!38,!724?32.!
FUKUMURA,! D.,! USHIYAMA,! A.,! DUDA,! D.! G.,! XU,! L.,! TAM,! J.,!
KRISHNA,!V.,!CHATTERJEE,!K.,!GARKAVTSEV,!I.!&!JAIN,!R.!








HOFMANN,! J.! J.,! EBARASI,! L.,! NYSTROM,! S.,! RYMO,! S.,!
CHEN,! L.! L.,! PANG,! M.! F.,! JIN,! Y.,! RASCHPERGER,! E.,!
ROSWALL,!P.,!SCHULTE,!D.,!BENEDITO,!R.,!LARSSON,!J.,!
! 252!
HELLSTROM,! M.,! FUXE,! J.,! UHLEN,! P.,! ADAMS,! R.,!
JAKOBSSON,!L.,!MAJUMDAR,!A.,!VESTWEBER,!D.,!UV,!A.!&!
BETSHOLTZ,!C.!2012.!The!sphingosine?1?phosphate!receptor!
S1PR1! restricts! sprouting! angiogenesis! by! regulating! the!
interplay! between! VE?cadherin! and! VEGFR2.! Dev% Cell,! 23,!
587?99.!
GASCHE,! C.,! DEJACO,! C.,! WALDHOER,! T.,! TILLINGER,! W.,!
REINISCH,! W.,! FUEGER,! G.! F.,! GANGL,! A.! &! LOCHS,! H.!
1997.! Intravenous! iron! and! erythropoietin! for! anemia!
associated!with!Crohn!disease.!A!randomized,!controlled!trial.!
Ann%Intern%Med,!126,!782?7.!
GAUTIER,! G.,! HUMBERT,! M.,! DEAUVIEAU,! F.,! SCUILLER,! M.,!
HISCOTT,! J.,! BATES,! E.! E.,! TRINCHIERI,! G.,! CAUX,! C.! &!




GORGOGLIONE,! M.,! GURAV,! K.,! TRAN,! K.! V.,!
STRAUBHAAR,! J.,! NICOLORO,! S.,! CZECH,! M.! P.,!
THOMPSON,! M.,! PERUGINI,! R.! A.! &! CORVERA,! S.! 2011.!
Depot?specific! differences! and! insufficient! subcutaneous!
adipose! tissue! angiogenesis! in! human! obesity.! Circulation,!
123,!186?94.!
GEBOES,! K.,! RUTGEERTS,! P.,! OPDENAKKER,! G.,! OLSON,! A.,!
PATEL,! K.,! WAGNER,! C.! L.! &! MARANO,! C.! W.! 2005.!
Endoscopic! and! histologic! evidence! of! persistent! mucosal!
healing! and! correlation! with! clinical! improvement! following!
sustained! infliximab! treatment! for!Crohn's!disease.!Curr%Med%
Res%Opin,!21,!1741?54.!
GELLER,! S.! A.! &! COHEN,! A.! 1983.! Arterial! inflammatory?cell!
infiltration!in!Crohn's!disease.!Arch%Pathol%Lab%Med,!107,!473?
5.!
GERETY,!S.! S.,!WANG,!H.!U.,!CHEN,! Z.! F.! &!ANDERSON,!D.! J.!
1999.!Symmetrical!mutant!phenotypes!of!the!receptor!EphB4!
! 253!
and! its! specific! transmembrane! ligand! ephrin?B2! in!
cardiovascular!development.!Mol%Cell,!4,!403?14.!
GHEORGHE,! C.,! PASCU,! O.,! GHEORGHE,! L.,! IACOB,! R.,!
DUMITRU,!E.,!TANTAU,!M.,!VADAN,!R.,!GOLDIS,!A.,!BALAN,!
G.,!IACOB,!S.,!DOBRU,!D.!&!SAFTOIU,!A.!2004.!Epidemiology!
of! inflammatory! bowel! disease! in! adults! who! refer! to!
gastroenterology!care! in!Romania:!a!multicentre!study.!Eur%J%
Gastroenterol%Hepatol,!16,!1153?9.!
GIATROMANOLAKI,! A.,! SIVRIDIS,! E.,! MALTEZOS,! E.,!
PAPAZOGLOU,! D.,! SIMOPOULOS,! C.,! GATTER,! K.! C.,!
HARRIS,! A.! L.! &! KOUKOURAKIS,! M.! I.! 2003.! Hypoxia!




K.! &! VAN!DAMME,! J.! 2005.! GCP?2/CXCL6! synergizes! with!
other! endothelial! cell?derived! chemokines! in! neutrophil!







GRIGA,! T.,! GUTZEIT,! A.,! SOMMERKAMP,! C.! &! MAY,! B.! 1999a.!
Increased!production!of!vascular!endothelial!growth! factor!by!































a! growth! factor! for! colonic! epithelial! cells.!Gastroenterology,!
121,!79?90.!
HASHIZUME,!M.,!HAYAKAWA,!N.,!SUZUKI,!M.!&!MIHARA,!M.!2009.!





Outcome! of! Gastrointestinal! Involvement! in! Behcet's!
Syndrome:! A! Strobe?Compliant! Observational! Study! From! a!
! 255!
Dedicated!Multidisciplinary! Center.!Medicine% (Baltimore),! 95,!
e3348.!
HATEMI,!I.,!HATEMI,!G.,!PAMUK,!O.!N.,!ERZIN,!Y.!&!CELIK,!A.!F.!
2015.! TNF?alpha! antagonists! and! thalidomide! for! the!
management!of!gastrointestinal!Behçet's!syndrome!refractory!








OKAMOTO,! E.,! NORIYUKI,! M.,! HONDA,! K.,! KIYAMA,! H.! &!
ISHIKO,! O.! 2004.! VEGF!mRNA! in! adipocytes! increase! with!
rebound!weight?gain! after! diet?restriction.! Int% J%Mol%Med,! 13,!
395?9.!
HAUSMAN,! G.! J.! &! RICHARDSON,! R.! L.! 2004.! Adipose! tissue!
angiogenesis.!J%Anim%Sci,!82,!925?34.!
HEIKKILA,! K.,! EBRAHIM,! S.! &! LAWLOR,! D.! A.! 2008.! Systematic!
review!of!the!association!between!circulating!interleukin?6!(IL?
6)!and!cancer.!Eur%J%Cancer,!44,!937?45.!





&! SMITH,! L.! E.! 2001.! Low! IGF?I! suppresses! VEGF?survival!




Y.! &! SHIBUYA,! M.! 2005.! Membrane! fixation! of! vascular!
endothelial! growth! factor! receptor! 1! ligand?binding!domain! is!
! 256!
important! for! vasculogenesis! and! angiogenesis! in!mice.!Mol%
Cell%Biol,!25,!346?54.!
HOBBS,!J.!E.,!ZAKARIJA,!A.,!CUNDIFF,!D.!L.,!DOLL,!J.!A.,!HYMEN,!











R.,! MATSUDA,! M.! &! SHIMOMURA,! I.! 2007.! Adipose! tissue!





6! receptor! in! the! colonic! mucosa! of! inflammatory! bowel!
disease.!J%Gastroenterol%Hepatol,!14,!987?96.!
HOTAMISLIGIL,! G.! S.,! SHARGILL,! N.! S.! &! SPIEGELMAN,! B.! M.!
1993.!Adipose!expression!of!tumor!necrosis!factor?alpha:!direct!
role!in!obesity?linked!insulin!resistance.!Science,!259,!87?91.!








J.,! MCKENZIE,! B.! S.,! POWRIE,! F.! &! MALOY,! K.! J.! 2006.!
! 257!




F.,! LE! QUELLEC,! A.,! ALTWEGG,! R.,! GUILLEVIN,! L.! &!
GROUP,!F.!V.!S.!2015.! Inflammatory!bowel!diseases! in!anti?
neutrophil! cytoplasmic! antibody?associated! vasculitides:! 11!
retrospective! cases! from! the! French!Vasculitis! Study!Group.!
Rheumatology%(Oxford),!54,!1970?5.!
HUMPHRIES,!M.!M.,!KRAMER,!D.!L.!&!THOMAS,!D.!W.!2003.!The!
role! of! energy! availability! in! Mammalian! hibernation:! an!
experimental! test! in! free?ranging! eastern! chipmunks.!Physiol%
Biochem%Zool,!76,!180?6.!
HUNT,! D.! &! GIOVANNONI,! G.! 2012.! Natalizumab?associated!




2001.! Tumor! rejection! by! disturbing! tumor! stroma! cell!
interactions.!J%Exp%Med,!194,!1549?59.!
IRUELA?ARISPE,! M.! L.,! LOMBARDO,! M.,! KRUTZSCH,! H.! C.,!
LAWLER,! J.! &! ROBERTS,! D.! D.! 1999.! Inhibition! of!







R.! &! HESS,! O.! M.! 1996.! Tortuosity! of! coronary! arteries! in!
chronic! pressure! and! volume! overload.! Cathet% Cardiovasc%
Diagn,!38,!25?31.!
JAKOBSSON,! L.! &! VAN! MEETEREN,! L.! A.! 2013.! Transforming!





A.! &! LETARTE,! M.! 2010.! Dextran! sulfate! sodium! leads! to!






iron! transport! and! transporter! expression! in! human! intestinal!
epithelial!cells.!FEBS%Lett,!573,!195?201.!
JOUKOV,!V.,!SORSA,!T.,!KUMAR,!V.,!JELTSCH,!M.,!CLAESSON?
WELSH,! L.,! CAO,! Y.,! SAKSELA,! O.,! KALKKINEN,! N.! &!
ALITALO,!K.! 1997.!Proteolytic! processing! regulates! receptor!
specificity!and!activity!of!VEGF?C.!EMBO%J,!16,!3898?911.!
JUNG,!S.!H.,!SAXENA,!A.,!KAUR,!K.,!FLETCHER,!E.,!PONEMONE,!
V.,! NOTTINGHAM,! J.! M.,! SHEPPE,! J.! A.,! PETRONI,! M.,!
GREENE,!J.,!GRAVES,!K.,!BALIGA,!M.!S.!&!FAYAD,!R.!2013.!
The! role! of! adipose! tissue?associated! macrophages! and! T!
lymphocytes! in! the! pathogenesis! of! inflammatory! bowel!
disease.!Cytokine,!61,!459?68.!
KANAAN,! Z.,! AHMAD,! S.,! ROBERTS,! H.,! THE,! T.,! GIRDLER,! S.,!
PAN,!J.,!RAI,!S.!N.,!WELLER,!E.!B.,! JR.!&!GALANDIUK,!S.!
2012.!Crohn's!disease!in!Caucasians!and!African!Americans,!
as! defined! by! clinical! predictors! and! single! nucleotide!
polymorphisms.!J%Natl%Med%Assoc,!104,!420?7.!
KANAZAWA,! S.,! TSUNODA,! T.,! ONUMA,! E.,! MAJIMA,! T.,!
KAGIYAMA,!M.!&!KIKUCHI,!K.!2001.!VEGF,!basic?FGF,!and!
TGF?beta! in! Crohn's! disease! and! ulcerative! colitis:! a! novel!








Z.! 2000.! The! epidemiology! and! the! pathogenesis! of!
inflammatory!bowel!disease.!Eur%J%Radiol,!35,!154?67.!











of! midkine! expression! in! thyroid! papillary! carcinoma.! Mod%
Pathol,!13,!1060?5.!
KAUR,! B.,! BRAT,! D.! J.,! DEVI,! N.! S.! &! VAN! MEIR,! E.! G.! 2005.!
Vasculostatin,! a! proteolytic! fragment! of! brain! angiogenesis!
inhibitor! 1,! is! an! antiangiogenic! and! antitumorigenic! factor.!
Oncogene,!24,!3632?42.!
KEANE,!M.!P.,!BELPERIO,!J.!A.,!ARENBERG,!D.!A.,!BURDICK,!M.!
D.,! XU,! Z.! J.,! XUE,! Y.! Y.! &! STRIETER,! R.! M.! 1999.! IFN?
gamma?inducible! protein?10! attenuates! bleomycin?induced!











KINDZELSKII,! A.! L.,! AMHAD,! I.,! KELLER,! D.,! ZHOU,! M.! J.,!
HAUGLAND,!R.!P.,!GARNI?WAGNER,!B.!A.,!GYETKO,!M.!R.,!




KIRCHER,! P.! R.,! SPAULDING,! K.! A.,! VADEN,! S.,! LANG,! J.,!
DOHERR,!M.!&!GASCHEN,!L.!2004.!Doppler!ultrasonographic!
evaluation! of! gastrointestinal! hemodynamics! in! food!
hypersensitivities:!a!canine!model.!J%Vet%Intern%Med,!18,!605?
11.!
KNOD,! J.! L.,! CRAWFORD,! K.,! DUSING,! M.,! COLLINS,! M.! H.,!
CHERNOGUZ,! A.! &! FRISCHER,! J.! S.! 2016a.! Angiogenesis!
and! Vascular! Endothelial! Growth! Factor?A! Expression!
Associated!with! Inflammation! in!Pediatric!Crohn's!Disease.!J%
Gastrointest%Surg,!20,!624?30.!





growth! factor! receptor?2! inhibition! in! experimental! murine!
colitis.!J%Surg%Res,!184,!101?7.!
KNUTSON,! H.,! LUNDERQUIST,! A.! &! LUNDERQUIST,! A.! 1968.!
Vascular! changes! in! Crohn's! disease.! Am% J% Roentgenol%
Radium%Ther%Nucl%Med,!103,!380?5.!
KOCH,!A.!E.,!HALLORAN,!M.!M.,!HASKELL,!C.!J.,!SHAH,!M.!R.!&!
POLVERINI,! P.! J.! 1995.! Angiogenesis! mediated! by! soluble!
forms! of! E?selectin! and! vascular! cell! adhesion! molecule?1.!
Nature,!376,!517?9.!









KOPP,! A.,! BUECHLER,! C.,! BALA,! M.,! NEUMEIER,! M.,!
SCHOLMERICH,!J.!&!SCHAFFLER,!A.!2010.!Toll?like!receptor!





R.,! STUMVOLL,! M.! &! FASSHAUER,! M.! 2005.! Hormonal!
regulation! of! the! novel! adipocytokine! visfatin! in! 3T3?L1!
adipocytes.!J%Endocrinol,!185,!R1?8.!







KREUGER,! J.! &! PHILLIPSON,! M.! 2016.! Targeting! vascular! and!
leukocyte! communication! in! angiogenesis,! inflammation! and!
fibrosis.!Nat%Rev%Drug%Discov,!15,!125?42.!
KUGATHASAN,!S.,!SAUBERMANN,!L.!J.,!SMITH,!L.,!KOU,!D.,!ITOH,!


















MESTER,! G.,! BALOGH,! M.,! SZIPOCS,! I.,! MOLNAR,! C.,!
KOMAROMI,!E.!&!LAKATOS,!P.!L.!2011.! Incidence,!disease!
phenotype! at! diagnosis,! and! early! disease! course! in!
inflammatory!bowel!diseases!in!Western!Hungary,!2002?2006.!
Inflamm%Bowel%Dis,!17,!2558?65.!
LAKATOS,! P.! L.,! SZALAY,! F.,! TULASSAY,! Z.,! MOLNAR,! T.,!
KOVACS,! A.,! GASZTONYI,! B.,! PAPP,! J.,! LAKATOS,! L.! &!
HUNGARIAN,! I.! B.! D.! S.! G.! 2005.! Clinical! presentation! of!
Crohn's! disease.! association! between! familial! disease,!
smoking,! disease! phenotype,! extraintestinal! manifestations!
and!need!for!surgery.!Hepatogastroenterology,!52,!817?22.!
LAPIDUS,! A.! 2006.! Crohn's! disease! in! Stockholm! County! during!
1990?2001:!an!epidemiological!update.!World%J%Gastroenterol,!
12,!75?81.!
LAROUX,! F.! S.! &! GRISHAM,! M.! B.! 2001.! Immunological! basis! of!




adipose! tissue! and! leptin! increase! colonic! epithelial! tight!
junction! permeability! via! a! RhoA?ROCK?dependent! pathway.!
FASEB%J,!28,!1059?70.!
! 263!
LEE,! H.,! SCHLERETH,! S.! L.,! PARK,! E.! Y.,! EMAMI?NAEINI,! P.,!
CHAUHAN,!S.!K.!&!DANA,!R.!2014.!A!novel!pro?angiogenic!













phenotype! of! Crohn's! disease! in! the! Chinese! population.!
Inflamm%Bowel%Dis,!10,!646?51.!
LEVANON,! K.,! VARDA?BLOOM,! N.,! GREENBERGER,! S.,!
BARSHACK,! I.,! GOLDBERG,! I.,! ORENSTEIN,! A.,!
BREITBART,!E.,!SHAISH,!A.!&!HARATS,!D.!2006.!Vascular!
wall!maturation!and!prolonged!angiogenic!effect!by!endothelial?







kinase?1! activity! induce! a! pro?inflammatory,! pro?angiogenic!
phenotype!in!endothelial!cells.!Cell%Mol%Biol%Lett,!14,!424?41.!
LIU,!S.!C.,!CHUANG,!S.!M.,!HSU,!C.!J.,!TSAI,!C.!H.,!WANG,!S.!W.!&!
TANG,! C.! H.! 2014.! CTGF! increases! vascular! endothelial!




LOEFFLER,! S.,! FAYARD,! B.,! WEIS,! J.! &! WEISSENBERGER,! J.!





LOEYS,! B.! L.,! CHEN,! J.,! NEPTUNE,! E.! R.,! JUDGE,! D.! P.,!
PODOWSKI,! M.,! HOLM,! T.,! MEYERS,! J.,! LEITCH,! C.! C.,!
KATSANIS,! N.,! SHARIFI,! N.,! XU,! F.! L.,! MYERS,! L.! A.,!
SPEVAK,! P.! J.,! CAMERON,! D.! E.,! DE! BACKER,! J.,!
HELLEMANS,! J.,! CHEN,! Y.,! DAVIS,! E.! C.,! WEBB,! C.! L.,!
KRESS,!W.,!COUCKE,!P.,!RIFKIN,!D.!B.,!DE!PAEPE,!A.!M.!&!
DIETZ,! H.! C.! 2005.! A! syndrome! of! altered! cardiovascular,!
craniofacial,!neurocognitive!and!skeletal!development!caused!
by!mutations!in!TGFBR1!or!TGFBR2.!Nat%Genet,!37,!275?81.!
LOFTUS,! C.! G.,! LOFTUS,! E.! V.,! JR.,! HARMSEN,! W.! S.,!
ZINSMEISTER,!A.!R.,!TREMAINE,!W.!J.,!MELTON,!L.!J.,!3RD!






LOLY,! C.,! BELAICHE,! J.! &! LOUIS,! E.! 2008.! Predictors! of! severe!
Crohn's!disease.!Scand%J%Gastroenterol,!43,!948?54.!
LORD,!G.!2002.!Role!of! leptin! in! immunology.!Nutr%Rev,!60,!S35?8H!
discussion!S68?84,!85?7.!
LORD,! G.! M.,! MATARESE,! G.,! HOWARD,! J.! K.,! BAKER,! R.! J.,!
BLOOM,!S.!R.!&!LECHLER,!R.!I.!1998.!Leptin!modulates!the!






R.,! DEVOS,!M.,! PORCHER,!R.,! PAINTAUD,!G.,! PIVER,! E.,!
COLOMBEL,! J.! F.,! LEMANN,! M.! &! GROUPE! D'ETUDES!
THERAPEUTIQUES!DES!AFFECTIONS!INFLAMMATOIRES,!
D.! 2012.! Maintenance! of! remission! among! patients! with!




crosslinking! of! collagen! distinguish! fetal! from! adult! sheep!
wound!repair.!J%Pediatr%Surg,!34,!218?23.!
LUDWIG,! D.,! WIENER,! S.,! BRÜNING,! A.,! SCHWARTING,! K.,!
JANTSCHEK,!G.!&!STANGE,!E.!F.!1999.!Mesenteric!blood!flow!
















MACONI,! G.,! IMBESI,! V.! &! BIANCHI! PORRO,! G.! 1996.! Doppler!





regulate! distinct! anti?tumor! properties.! J% Biol% Chem,! 275,!
23745?50.!
MAESHIMA,!Y.,!COLORADO,!P.!C.,!TORRE,!A.,!HOLTHAUS,!K.!A.,!
GRUNKEMEYER,! J.! A.,! ERICKSEN,! M.! B.,! HOPFER,! H.,!
XIAO,! Y.,! STILLMAN,! I.! E.! &! KALLURI,! R.! 2000b.! Distinct!
antitumor!properties!of!a!type!IV!collagen!domain!derived!from!
basement!membrane.!J%Biol%Chem,!275,!21340?8.!
MAHID,! S.! S.,! MINOR,! K.! S.,! SOTO,! R.! E.,! HORNUNG,! C.! A.! &!
GALANDIUK,! S.! 2006.! Smoking! and! inflammatory! bowel!
disease:!a!meta?analysis.!Mayo%Clin%Proc,!81,!1462?71.!




and! protein! in! complex! biological! samples.! FEBS% Lett,! 583,!
3966?73.!
MAN,!K.,!NG,!K.!T.,!XU,!A.,!CHENG,!Q.,!LO,!C.!M.,!XIAO,!J.!W.,!SUN,!
B.! S.,! LIM,! Z.! X.,! CHEUNG,! J.! S.,! WU,! E.! X.,! SUN,! C.! K.,!
POON,!R.!T.!&!FAN,!S.!T.!2010.!Suppression!of! liver! tumor!
growth! and!metastasis! by! adiponectin! in! nude!mice! through!
inhibition! of! tumor! angiogenesis! and! downregulation! of! Rho!






levels! by! fat! pads! derived! from! s.c.! implanted! 3T3?F442A!
preadipocytes.!Proc%Natl%Acad%Sci%U%S%A,!94,!4300?5.!
MARLIER,! D.,! LEROY,! C.,! STURBOIS,! M.,! DELLEUR,! V.,!
POULIPOULIS,! A.! &! VINDEVOGEL,! H.! 2006.! Increasing!
! 267!
incidence! of! megabacteriosis! in! canaries! (Serinus! canarius!
domesticus).!Vet%J,!172,!549?52.!
MARONI,!D.!&!DAVIS,! J.! S.! 2011.! TGFB1! disrupts! the! angiogenic!
potential! of! microvascular! endothelial! cells! of! the! corpus!
luteum.!J%Cell%Sci,!124,!2501?10.!
MASSEY,! D.! &! PARKES,! M.! 2007.! Common! pathways! in! Crohn's!




MATHEW,! C.! G.! &! LEWIS,! C.! M.! 2004.! Genetics! of! inflammatory!
bowel! disease:! progress!and!prospects.!Hum%Mol%Genet,! 13!
Spec!No!1,!R161?8.!
MAUNOURY,!V.,!MORDON,!S.,!GEBOES,!K.,!KLEIN,!O.,!DEBAERT,!
A.,! CORTOT,! A.,! DESREUMAUX,! P.! &! COLOMBEL,! J.! F.!
2000.! Early! vascular! changes! in! Crohn's! disease:! an!
endoscopic!fluorescence!study.!Endoscopy,!32,!700?5.!
MAYBERRY,! J.! F.,! LOBO,! A.,! FORD,! A.! C.! &! THOMAS,! A.! 2013.!
NICE!clinical!guideline! (CG152):! the!management!of!Crohn's!






is!modulated!by!a! phosphatidylinositol! 3?kinase/Akt! signaling!










MCMELLEN,! M.! E.,! WAKEMAN,! D.,! ERWIN,! C.! R.,! GUO,! J.! &!
WARNER,! B.! W.! 2010.! Epidermal! growth! factor! receptor!
signaling!modulates!chemokine!(CXC)!ligand!5!expression!and!
is! associated! with! villus! angiogenesis! after! small! bowel!
resection.!Surgery,!148,!364?70.!
MEJIAS,!M.,!GARCIA?PRAS,!E.,!TIANI,!C.,!MIQUEL,!R.,!BOSCH,!J.!
&! FERNANDEZ,! M.! 2009.! Beneficial! effects! of! sorafenib! on!





MEKHJIAN,! H.! S.,! SWITZ,! D.! M.,! WATTS,! H.! D.,! DEREN,! J.! J.,!
KATON,!R.!M.!&!BEMAN,!F.!M.!1979b.!National!Cooperative!
Crohn's! Disease! Study:! factors! determining! recurrence! of!
Crohn's!disease!after!surgery.!Gastroenterology,!77,!907?13.!
MICHEL,! P.,! ST?ONGE,! L.,! LOWE,! A.!M.,! BIGRAS?POULIN,!M.! &!
BRASSARD,! P.! 2010.! Geographical! variation! of! Crohn's!
disease!residual!incidence!in!the!Province!of!Quebec,!Canada.!
Int%J%Health%Geogr,!9,!22.!













VEGF?A?stimulated! lamellipodial! extensions! and! motility! of!
vascular! endothelial! cells! by! chondromodulin?I,! a! cartilage?
derived!angiogenesis!inhibitor.!Exp%Cell%Res,!316,!775?88.!
MIYAZAWA?HOSHIMOTO,! S.,! TAKAHASHI,! K.,! BUJO,! H.,!
HASHIMOTO,! N.,! YAGUI,! K.! &! SAITO,! Y.! 2005.! Roles! of!




2011.! Predicting! climate! change! impacts! on! polar! bear! litter!
size.!Nat%Commun,!2,!186.!
MOLNAR,!T.,!LAKATOS,!P.!L.,!FARKAS,!K.,!NAGY,!F.,!SZEPES,!Z.,!
MIHELLER,! P.,! HORVATH,! G.,! PAPP,! M.,! PALATKA,! K.,!
NYARI,!T.,!BALINT,!A.,!LORINCZY,!K.!&!WITTMANN,!T.!2013.!
Predictors! of! relapse! in! patients! with! Crohn's! disease! in!
remission!after!1!year!of!biological!therapy.!Aliment%Pharmacol%
Ther,!37,!225?33.!
MOLODECKY,! N.! A.,! SOON,! I.! S.,! RABI,! D.! M.,! GHALI,! W.! A.,!
FERRIS,! M.,! CHERNOFF,! G.,! BENCHIMOL,! E.! I.,!
PANACCIONE,!R.,!GHOSH,!S.,!BARKEMA,!H.!W.!&!KAPLAN,!
G.! G.! 2012.! Increasing! incidence! and! prevalence! of! the!
inflammatory!bowel! diseases!with! time,! based!on! systematic!
review.!Gastroenterology,!142,!46?54!e42H!quiz!e30.!
MORISAKI,!T.,!LYON,!K.,!DELUCA,!K.!F.,!DELUCA,!J.!G.,!ENGLISH,!
B.! P.,! ZHANG,! Z.,! LAVIS,! L.! D.,! GRIMM,! J.! B.,!





MOUSSAD,! E.! E.! &! BRIGSTOCK,! D.! R.! 2000.! Connective! tissue!
growth!factor:!what's!in!a!name?!Mol%Genet%Metab,!71,!276?92.!
MUNAUT,! C.,! NOEL,! A.,! HOUGRAND,! O.,! FOIDART,! J.! M.,!
BONIVER,!J.!&!DEPREZ,!M.!2003.!Vascular!endothelial!growth!
! 270!
factor! expression! correlates! with! matrix! metalloproteinases!
MT1?MMP,!MMP?2!and!MMP?9!in!human!glioblastomas.!Int%J%
Cancer,!106,!848?55.!




A.! &! MACDONALD,! T.! T.! 1991.! Serum! concentrations! of!
tumour!necrosis!factor!alpha!in!childhood!chronic!inflammatory!
bowel!disease.!Gut,!32,!913?7.!
NAIR,! R.,! TEO,! W.! S.,! MITTAL,! V.! &! SWARBRICK,! A.! 2014.! ID!
proteins! regulate! diverse! aspects! of! cancer! progression! and!
provide!novel!therapeutic!opportunities.!Mol%Ther,!22,!1407?15.!
NAKAGAWA,! T.,! LI,! J.! H.,! GARCIA,! G.,! MU,! W.,! PIEK,! E.,!
BOTTINGER,! E.! P.,! CHEN,! Y.,! ZHU,! H.! J.,! KANG,! D.! H.,!
SCHREINER,!G.!F.,!LAN,!H.!Y.!&!JOHNSON,!R.!J.!2004.!TGF?
beta! induces! proangiogenic! and! antiangiogenic! factors! via!
parallel!but!distinct!Smad!pathways.!Kidney%Int,!66,!605?13.!





is! the! principal! factor! produced! by! synovia! of! patients! with!
rheumatoid! arthritis! that! induces! B?lymphocytes! to! secrete!




LI,! M.! F.,! NG,! K.! K.,! KAMM,! M.! A.,! STUDD,! C.,! BELL,! S.,!
LEONG,!R.,!DE!SILVA,!H.!J.,!KASTURIRATNE,!A.,!MUFEENA,!
M.!N.,!LING,!K.!L.,!OOI,!C.!J.,!TAN,!P.!S.,!ONG,!D.,!GOH,!K.!





J.,! CHAN,! F.! K.,! ASIA?PACIFIC,! C.! S.! &! COLITIS!
EPIDEMIOLOGIC! STUDY! STUDY,! G.! 2013.! Incidence! and!
phenotype! of! inflammatory! bowel! disease! based! on! results!





FUKUDOME,! T.,! OGAWA,!M.,! OKETANI,! N.,! SAIHARA,! K.,!
SHINSATO,! T.,! SHIRASAWA,! T.,! MIZOGUCHI,! E.,!
KUBOZONO,!T.,!ICHIKI,!H.,!NINOMIYA,!Y.,!MATSUSHITA,!T.,!
NAKASAKI,!M.!&!TEI,!C.!2008.!Adiponectin!is!a!better!predictor!
of! endothelial! function! of! the! coronary! artery! than!HOMA?R,!
body!mass!index,!immunoreactive!insulin,!or!triglycerides.!Int%J%
Cardiol,!126,!53?61.!
OLSSON,! A.! K.,! DIMBERG,! A.,! KREUGER,! J.! &! CLAESSON?









ESCRIBANO,! M.! F.! 2015.! Association! of! haplotypes! of! the!




localization! of! tenomodulin,! a! transmembrane! type!
! 272!








WOODWARD,!E.!G.!&!ELLIS,! T.! J.! 2008.!Diabetes! and! the!
tortuosity!of!vessels!of!the!bulbar!conjunctiva.!Ophthalmology,!
115,!e27?32.!
PAGNOUX,! C.,! MAHR,! A.,! COHEN,! P.! &! GUILLEVIN,! L.! 2005.!
Presentation! and! outcome! of! gastrointestinal! involvement! in!
systemic!necrotizing!vasculitides:!analysis!of!62!patients!with!
polyarteritis! nodosa,! microscopic! polyangiitis,! Wegener!
granulomatosis,! Churg?Strauss! syndrome,! or! rheumatoid!
arthritis?associated! vasculitis.!Medicine% (Baltimore),! 84,! 115?
28.!
PALADE,! G.! 1975.! Intracellular! aspects! of! the! process! of! protein!
synthesis.!Science,!189,!867.!
PAPADAKI,!H.!A.,!KRITIKOS,!H.!D.,!VALATAS,!V.,!BOUMPAS,!D.!T.!








visceral! adiposity! with! serum! concentrations! of! CRP,! TNF?
alpha!and!IL?6.!Diabetes%Res%Clin%Pract,!69,!29?35.!
PARK,!H.! Y.,! KWON,!H.!M.,! LIM,!H.! J.,! HONG,!B.! K.,! LEE,! J.! Y.,!
PARK,!B.!E.,!JANG,!Y.,!CHO,!S.!Y.!&!KIM,!H.!S.!2001.!Potential!
role! of! leptin! in! angiogenesis:! leptin! induces! endothelial! cell!
! 273!
proliferation! and! expression! of! matrix! metalloproteinases! in!
vivo!and!in!vitro.!Exp%Mol%Med,!33,!95?102.!
PARK,!J.!S.,!CHO,!M.!H.,!NAM,!J.!S.,!AHN,!C.!W.,!CHA,!B.!S.,!LEE,!
E.! J.,! LIM,! S.! K.,! KIM,! K.! R.! &! LEE,! H.! C.! 2010.! Visceral!
adiposity! and! leptin! are! independently! associated! with! C?
reactive! protein! in! Korean! type! 2! diabetic! patients.! Acta%
Diabetol,!47,!113?8.!
















J.,! ROGLER,! G.! &! HERFARTH,! H.! 2006b.! Profiling!
adipocytokine!secretion! from!creeping!fat! in!Crohn's!disease.!
Inflamm%Bowel%Dis,!12,!471?7.!
PERSSON,! P.! G.,! BERNELL,! O.,! LEIJONMARCK,! C.! E.,!
FARAHMAND,! B.! Y.,! HELLERS,! G.! &! AHLBOM,! A.! 1996.!
Survival! and! cause?specific! mortality! in! inflammatory! bowel!
disease:! a! population?based! cohort! study.!Gastroenterology,!
110,!1339?45.!
PEYRIN?BIROULET,! L.,! CHAMAILLARD,! M.,! GONZALEZ,! F.,!
BECLIN,! E.,! DECOURCELLE,! C.,! ANTUNES,! L.,! GAY,! J.,!













POULIOT,! M.! C.,! DESPRES,! J.! P.,! NADEAU,! A.,! MOORJANI,! S.,!




POUSA,! I.! D.,! MATE,! J.,! SALCEDO?MORA,! X.,! ABREU,! M.! T.,!








2009.! Inflammatory! cells! and! chemokines! sustain! FGF2?
induced!angiogenesis.!Eur%Cytokine%Netw,!20,!39?50.!
PRICE,!A.!B.!1990.!Ischaemic!colitis.!Curr%Top%Pathol,!81,!229?46.!
PRIOR,! P.,! GYDE,! S.,! COOKE,! W.! T.,! WATERHOUSE,! J.! A.! &!
ALLAN,! R.! N.! 1981.! Mortality! in! Crohn's! disease.!
Gastroenterology,!80,!307?12.!





2008.! Heparanase! stimulation! of! protease! expression!




A! novel! function! for! tissue! inhibitor! of! metalloproteinases?3!
(TIMP3):! inhibition! of! angiogenesis! by! blockage! of! VEGF!
binding!to!VEGF!receptor?2.!Nat%Med,!9,!407?15.!
QIN,!Z.,!SCHWARTZKOPFF,!J.,!PRADERA,!F.,!KAMMERTOENS,!T.,!






D.! V.! 2008.! Obesity! in! C57BL/6J! mice! is! characterized! by!
adipose! tissue! hypoxia! and! cytotoxic! T?cell! infiltration.! Int% J%
Obes%(Lond),!32,!451?63.!
REED,! M.! J.,! KOIKE,! T.,! SADOUN,! E.,! SAGE,! E.! H.! &!
PUOLAKKAINEN,! P.! 2003.! Inhibition! of! TIMP1! enhances!
angiogenesis!in!vivo!and!cell!migration!in!vitro.!Microvasc%Res,!
65,!9?17.!
REGA,! G.,! KAUN,! C.,! DEMYANETS,! S.,! PFAFFENBERGER,! S.,!
RYCHLI,!K.,!HOHENSINNER,!P.!J.,!KASTL,!S.!P.,!SPEIDL,!W.!
S.,!WEISS,!T.!W.,!BREUSS,!J.!M.,!FURNKRANZ,!A.,!UHRIN,!
P.,! ZAUJEC,! J.,! ZILBERFARB,! V.,! FREY,!M.,! ROEHLE,! R.,!
MAURER,! G.,! HUBER,! K.! &! WOJTA,! J.! 2007.! Vascular!
endothelial! growth! factor! is! induced! by! the! inflammatory!
cytokines! interleukin?6! and! oncostatin! m! in! human! adipose!
tissue!in!vitro!and!in!murine!adipose!tissue!in!vivo.!Arterioscler%
Thromb%Vasc%Biol,!27,!1587?95.!
REINISCH,! W.,! GASCHÉ,! C.,! TILLINGER,! W.,! WYATT,! J.,!
LICHTENBERGER,! C.,! WILLHEIM,! M.,! DEJACO,! C.,!
! 276!
WALDHÖR,!T.,!BAKOS,!S.,!VOGELSANG,!H.,!GANGL,!A.!&!
LOCHS,!H.!1999.!Clinical! relevance!of!serum! interleukin?6! in!
Crohn's! disease:! single! point! measurements,! therapy!
monitoring,! and! prediction! of! clinical! relapse.! Am% J%
Gastroenterol,!94,!2156?64.!
REN,!Z.,!SHIN,!A.,!CAI,!Q.,!SHU,!X.!O.,!GAO,!Y.!T.!&!ZHENG,!W.!
2007.! IGFBP3! mRNA! expression! in! benign! and! malignant!
breast!tumors.!Breast%Cancer%Res,!9,!R2.!
RENY,! J.! L.,! PAUL,! J.! F.,! LEFÈBVRE,! C.,! CHAMPION,! K.,!
EMMERICH,!J.,!BLÉTRY,!O.,!PIETTE,!J.!C.!&!FIESSINGER,!
J.! N.! 2003.! Association! of! Takayasu's! arteritis! and! Crohn's!
disease.!Results!of!a!study!on!44!Takayasu!patients!and!review!
of!the!literature.!Ann%Med%Interne%(Paris),!154,!85?90.!
RIBATTI,! D.,! CONCONI,! M.! T.! &! NUSSDORFER,! G.! G.! 2007.!
Nonclassic! endogenous! novel! [corrected]! regulators! of!
angiogenesis.!Pharmacol%Rev,!59,!185?205.!
RIBATTI,! D.,! VACCA,! A.,! RONCALI,! L.! &! DAMMACCO,! F.! 1991.!






GOYETTE,! P.,! HUETT,! A.,! GREEN,! T.,! KUBALLA,! P.,!
BARMADA,! M.! M.,! DATTA,! L.! W.,! SHUGART,! Y.! Y.,!




wide! association! study! identifies! new! susceptibility! loci! for!
Crohn! disease! and! implicates! autophagy! in! disease!
pathogenesis.!Nat%Genet,!39,!596?604.!
RODRIGUES,!V.!S.,!MILANSKI,!M.,!FAGUNDES,!J.!J.,!TORSONI,!A.!
S.,! AYRIZONO,! M.! L.,! NUNEZ,! C.! E.,! DIAS,! C.! B.,!
! 277!
MEIRELLES,!L.!R.,!DALAL,!S.,!COY,!C.!S.,!VELLOSO,!L.!A.!&!
LEAL,! R.! F.! 2012.! Serum! levels! and! mesenteric! fat! tissue!
expression! of! adiponectin! and! leptin! in! patients!with!Crohn's!
disease.!Clin%Exp%Immunol,!170,!358?64.!
ROJAS?RODRIGUEZ,! R.,! GEALEKMAN,! O.,! KRUSE,! M.! E.,!
ROSENTHAL,!B.,!RAO,!K.,!MIN,!S.,!BELLVE,!K.!D.,!LIFSHITZ,!
L.! M.! &! CORVERA,! S.! 2014.! Adipose! tissue! angiogenesis!
assay.!Methods%Enzymol,!537,!75?91.!
ROLFE,!D.!F.!&!BROWN,!G.!C.!1997.!Cellular!energy!utilization!and!
molecular! origin! of! standard! metabolic! rate! in! mammals.!
Physiol%Rev,!77,!731?58.!
ROMAGNANI,! P.,! ANNUNZIATO,! F.,! LASAGNI,! L.,! LAZZERI,! E.,!
BELTRAME,!C.,!FRANCALANCI,!M.,!UGUCCIONI,!M.,!GALLI,!
G.,!COSMI,!L.,!MAURENZIG,!L.,!BAGGIOLINI,!M.,!MAGGI,!E.,!








M.,! LOWELL,!B.!B.,! LANGER,!R.!&!FOLKMAN,!M.! J.! 2002.!
Adipose!tissue!mass!can!be!regulated!through!the!vasculature.!
Proc%Natl%Acad%Sci%U%S%A,!99,!10730?5.!
RUTELLA,! S.,! FIORINO,! G.,! VETRANO,! S.,! CORREALE,! C.,!
SPINELLI,! A.,! PAGANO,! N.,! ARENA,! V.,! MAGGIANO,! N.,!
REPICI,! A.,! MALESCI,! A.! &! DANESE,! S.! 2011.! Infliximab!





P.,! HEINRICHS,! D.,! BERRES,! M.! L.,! DOLESCHEL,! D.,!
! 278!
SCHOLTEN,! D.,! WEISKIRCHEN,! R.,! MOELLER,! M.! J.,!
KIESSLING,!F.,!TRAUTWEIN,!C.!&!WASMUTH,!H.!E.!2012.!

























LOFBERG,! R.,! MODIGLIANI,! R.,! PRESENT,! D.! H.,!
RUTGEERTS,! P.,! SCHOLMERICH,! J.,! STANGE,! E.! F.! &!




SIM,! R.,! MORE,! L.,! HUDSON,! M.,! SAWYERR,! A.! M.! &!
! 279!




J.! 2007.! Inhibition! of! epidermal! growth! factor! receptor! and!
vascular!endothelial!growth!factor!receptor!phosphorylation!on!
tumor?associated! endothelial! cells! leads! to! treatment! of!




QU,! X.,! ADAMS,! R.! H.,! BALDWIN,! H.! S.,! RUIZ! DE!
ALMODOVAR,!C.,! RODEWALD,!H.! R.! &! AUGUSTIN,!H.!G.!
2015.!The!Orphan!Receptor!Tie1!Controls!Angiogenesis!and!
Vascular!Remodeling! by!Differentially!Regulating! Tie2! in! Tip!
and!Stalk!Cells.!Cell%Rep,!12,!1761?73.!
SCALDAFERRI,! F.,! VETRANO,! S.,! SANS,! M.,! ARENA,! V.,!
STRAFACE,! G.,! STIGLIANO,! E.,! REPICI,! A.,! STURM,! A.,!
MALESCI,!A.,!PANES,!J.,!YLA?HERTTUALA,!S.,!FIOCCHI,!C.!
&! DANESE,! S.! 2009.! VEGF?A! links! angiogenesis! and!









for! Crohn's! Disease:! Role! of! Preoperative! Therapy! in!
Postoperative!Outcome.!Dig%Surg,!32,!243?50.!
SCHAFFLER,!A.,!FURST,!A.,!BUCHLER,!C.,!PAUL,!G.,!ROGLER,!G.,!
SCHOLMERICH,! J.! &! HERFARTH,! H.! 2006.! Vascular!




SCHWARTZ,! D.! A.,! LOFTUS,! E.! V.,! JR.,! TREMAINE,! W.! J.,!
PANACCIONE,!R.,!HARMSEN,!W.!S.,!ZINSMEISTER,!A.!R.!&!
SANDBORN,! W.! J.! 2002.! The! natural! history! of! fistulizing!
Crohn's! disease! in! Olmsted! County,! Minnesota.!
Gastroenterology,!122,!875?80.!
SCHÄFFLER,! A.! &! HERFARTH,! H.! 2005.! Creeping! fat! in! Crohn's!
disease:!travelling!in!a!creeper!lane!of!research?!Gut,!54,!742?
4.!
SCHÄFFLER,! A.,! MÜLLER?LADNER,! U.,! SCHÖLMERICH,! J.! &!
BÜCHLER,!C.!2006.!Role!of!adipose!tissue!as!an!inflammatory!
organ!in!human!diseases.!Endocr%Rev,!27,!449?67.!
SCHÄFFLER,! A.,! SCHÖLMERICH,! J.! &! BÜCHLER,! C.! 2005.!
Mechanisms!of!disease:!adipocytokines!and!visceral!adipose!
tissue??emerging! role! in! nonalcoholic! fatty! liver! disease.!Nat%
Clin%Pract%Gastroenterol%Hepatol,!2,!273?80.!
SCHÜRER?MALY,! C.! C.,! FRIED,! M.,! MALY,! F.! E.,! BINEK,! J.! &!
FRENZER,! A.! 1997.! Vascular! endothelial! growth! factor! in!
serum!of! patients!with! inflammatory! bowel! disease.!Scand% J%
Gastroenterol,!32,!959?60.!
SEETHARAM,! L.,! GOTOH,! N.,! MARU,! Y.,! NEUFELD,! G.,!








hypoxia! via! de! novo! protein! synthesis! binds! to! the! human!











SHIBUYA,! M.! 2006.! Vascular! endothelial! growth! factor! receptor?1!















GOEKE,! N.! M.,! OLSON,! B.! J.! &! KLENK,! D.! C.! 1985.!
Measurement! of! protein! using! bicinchoninic! acid.! Anal%
Biochem,!150,!76?85.!
SOLEM,!C.!A.,!LOFTUS,!E.!V.,!JR.,!TREMAINE,!W.!J.,!HARMSEN,!
W.! S.,! ZINSMEISTER,! A.! R.! &! SANDBORN,! W.! J.! 2005.!
Correlation! of! C?reactive! protein! with! clinical,! endoscopic,!
histologic,! and! radiographic! activity! in! inflammatory! bowel!
disease.!Inflamm%Bowel%Dis,!11,!707?12.!
! 282!








A.! &! BOUSVAROS,! A.! 2001.! Elevated! serum! hepatocyte!
growth! factor! in! children!and! young!adults!with! inflammatory!
bowel!disease.!J%Pediatr%Gastroenterol%Nutr,!33,!548?53.!
STEPHENSON,!J.!R.,!PAAVOLA,!K.!J.,!SCHAEFER,!S.!A.,!KAUR,!B.,!




D.! A.,! BURDICK,! M.! D.,! KASPER,! J.,! DZUIBA,! J.,! VAN!
DAMME,! J.,!WALZ,!A.,!MARRIOTT,!D.!&!ET!AL.! 1995.!The!
functional! role!of! the!ELR!motif! in!CXC!chemokine?mediated!
angiogenesis.!J%Biol%Chem,!270,!27348?57.!









WEI,! L.! H.! 2005.! A! novel! peptide! specifically! binding! to!
interleukin?6! receptor! (gp80)! inhibits!angiogenesis!and! tumor!
growth.!Cancer%Res,!65,!4827?35.!
SULPICE,!E.,!BRYCKAERT,!M.,!LACOUR,!J.,!CONTRERES,!J.!O.!&!
TOBELEM,! G.! 2002.! Platelet! factor! 4! inhibits! FGF2?induced!
! 283!
endothelial! cell! proliferation! via! the! extracellular! signal?
regulated!kinase!pathway!but!not!by!the!phosphatidylinositol!3?
kinase!pathway.!Blood,!100,!3087?94.!
SY,! A.,! KHALIDI,! N.,! DEHGHAN,! N.,! BARRA,! L.,! CARETTE,! S.,!








SZEKANECZ,! Z.! &! KOCH,! A.! E.! 2004.! Vascular! endothelium! and!
immune! responses:! implications! for! inflammation! and!
angiogenesis.!Rheum%Dis%Clin%North%Am,!30,!97?114.!




TAKENAKA,! K.,! OHTSUKA,! K.,! KITAZUME,! Y.,! NAGAHORI,! M.,!





TANG,!W.,! ZEVE,!D.,! SUH,! J.!M.,! BOSNAKOVSKI,!D.,! KYBA,!M.,!
HAMMER,!R.!E.,! TALLQUIST,!M.!D.!&!GRAFF,! J.!M.! 2008.!





S.,! NAKAMURA,! S.,! ARORA,! V.,! ROBINSON,! A.! M.,!
THAKKAR,!R.!B.!&!HIBI,!T.!2015.!Adalimumab!for!the!treatment!
! 284!
of! Japanese! patients! with! intestinal! Behçet's! disease.! Clin%
Gastroenterol%Hepatol,!13,!940?8.e3.!
TAYLOR,! C.! T.! 2008.! Mitochondria,! oxygen! sensing,! and! the!
regulation!of!HIF?2alpha.!Focus!on!"Induction!of!HIF?2alpha!is!




EDDY,! R.! L.! &! SHOWS,! T.! B.! 1991.! Identification! of! a! new!
endothelial! cell! growth! factor! receptor! tyrosine! kinase.!
Oncogene,!6,!1677?83.!












2008.!An!update!on! the!epidemiology!of! inflammatory! bowel!
disease!in!Asia.!Am%J%Gastroenterol,!103,!3167?82.!
THORGEIRSSON,!U.!P.,!YOSHIJI,!H.,!SINHA,!C.!C.!&!GOMEZ,!D.!E.!
1996.!Breast! cancerH! tumor! neovasculature!and! the!effect! of!
tissue! inhibitor! of! metalloproteinases?1! (TIMP?1)! on!
angiogenesis.!In%Vivo,!10,!137?44.!
THORNTON,! M.! &! SOLOMON,! M.! J.! 2002.! Crohn's! disease:! in!
defense!of!a!microvascular!aetiology.!Int%J%Colorectal%Dis,!17,!
287?97.!





Crohn's! disease! assessment! with! histopathology! of! surgical!
specimens.!Eur%Radiol,!24,!619?29.!
TOI,!M.,!MATSUMOTO,!T.!&!BANDO,!H.!2001.!Vascular!endothelial!







in! chronic! inflammatory! diseases.! Inflamm% Allergy% Drug%
Targets,!11,!159?68.!
TRINCHIERI,!G.!&!SHER,!A.!2007.!Cooperation!of!Toll?like!receptor!
signals! in! innate! immune!defence.!Nat%Rev%Immunol,!7,!179?
90.!
TRUJILLO,!M.!E.!&!SCHERER,!P.!E.!2005.!Adiponectin??journey!from!
an!adipocyte! secretory! protein! to! biomarker! of! the!metabolic!
syndrome.!J%Intern%Med,!257,!167?75.!










JIMENEZ,! W.! &! MORALES?RUIZ,! M.! 2007.! Antiangiogenic!
treatment! with! sunitinib! ameliorates! inflammatory! infiltrate,!




HWANG,! W.! L.! &! TANG,! C.! H.! 2013.! Interleukin?6! induces!
vascular! endothelial! growth! factor! expression! and! promotes!
angiogenesis! through! apoptosis! signal?regulating! kinase! 1! in!
human!osteosarcoma.!Biochem%Pharmacol,!85,!531?40.!
TZIMA,! E.,! IRANI?TEHRANI,! M.,! KIOSSES,! W.! B.,! DEJANA,! E.,!
SCHULTZ,!D.!A.,!ENGELHARDT,!B.,!CAO,!G.,!DELISSER,!H.!
&!SCHWARTZ,!M.!A.!2005.!A!mechanosensory!complex!that!
mediates! the! endothelial! cell! response! to! fluid! shear! stress.!
Nature,!437,!426?31.!
TÓTH,!K.,!VAUGHAN,!M.!M.,!SLOCUM,!H.!K.,!ARREDONDO,!M.!A.,!
TAKITA,! H.,! BAKER,! R.! M.! &! RUSTUM,! Y.! M.! 1994.! New!
immunohistochemical!"sandwich"!staining!method!for!mdr1!P?
glycoprotein! detection! with! JSB?1! monoclonal! antibody! in!
formalin?fixed,!paraffin?embedded!human!tissues.!Am%J%Pathol,!
144,!227?36.!
UEHA,! S.,! SHAND,! F.! H.! &! MATSUSHIMA,! K.! 2012.! Cellular! and!
molecular! mechanisms! of! chronic! inflammation?associated!
organ!fibrosis.!Front%Immunol,!3,!71.!
VAISMAN,! N.,! GOSPODAROWICZ,! D.! &! NEUFELD,! G.! 1990.!
Characterization! of! the! receptors! for! vascular! endothelial!
growth!factor.!J%Biol%Chem,!265,!19461?6.!
VAN! BELLE,! E.,! WITZENBICHLER,! B.,! CHEN,! D.,! SILVER,! M.,!
CHANG,!L.,!SCHWALL,!R.!&!ISNER,!J.!M.!1998.!Potentiated!
angiogenic!effect!of!scatter!factor/hepatocyte!growth!factor!via!
induction! of! vascular! endothelial! growth! factor:! the! case! for!
paracrine! amplification! of! angiogenesis.!Circulation,! 97,! 381?
90.!
VAN! KEMSEKE,! C.,! BELAICHE,! J.! &! LOUIS,! E.! 2000.! Frequently!
relapsing! Crohn's! disease! is! characterized! by! persistent!







SUGHRUE,! K.! M.,! TRUONG,! A.! N.,! WYGANT,! J.! N.,!
MCINTYRE,! B.! W.,! ESKIN,! S.! G.,! TILTON,! R.! G.! &!
POLVERINI,! P.! J.! 1998.! Angiogenesis! induced! by! tumor!
necrosis! factor?agrH! is! mediated! by! alpha4! integrins.!
Angiogenesis,!2,!265?75.!
VAVRICKA,! S.! R.,! BRUN,! L.,! BALLABENI,! P.,! PITTET,! V.,! PRINZ!
VAVRICKA,!B.!M.,!ZEITZ,!J.,!ROGLER,!G.!&!SCHOEPFER,!A.!




DEVENTER,! S.! J.! &! DE! SMET,! M.! D.! 2001.! Prevalence! of!
subclinical! anterior! uveitis! in! adult! patients!with! inflammatory!
bowel!disease.!Br%J%Ophthalmol,!85,!219?21.!
VERMA,! A.,! DEB,! D.! K.,! SASSANO,! A.,! KAMBHAMPATI,! S.,!
WICKREMA,!A.,!UDDIN,!S.,!MOHINDRU,!M.,!VAN!BESIEN,!K.!
&!PLATANIAS,!L.!C.!2002.!Cutting!edge:!activation!of!the!p38!
mitogen?activated! protein! kinase! signaling! pathway!mediates!
cytokine?induced!hemopoietic!suppression!in!aplastic!anemia.!
J%Immunol,!168,!5984?8.!
VERMEIRE,! S.,! VAN! ASSCHE,! G.! &! RUTGEERTS,! P.! 2004.! C?
reactive!protein!as!a!marker! for! inflammatory!bowel!disease.!
Inflamm%Bowel%Dis,!10,!661?5.!
VERMEIRE,! S.,! VAN! ASSCHE,! G.! &! RUTGEERTS,! P.! 2006.!
Laboratory!markers!in!IBD:!useful,!magic,!or!unnecessary!toys?!
Gut,!55,!426?31.!
VILLARET,! A.,! GALITZKY,! J.,! DECAUNES,! P.,! ESTEVE,! D.,!
MARQUES,! M.! A.,! SENGENES,! C.,! CHIOTASSO,! P.,!
TCHKONIA,! T.,! LAFONTAN,! M.,! KIRKLAND,! J.! L.! &!
BOULOUMIE,!A.! 2010.!Adipose! tissue!endothelial! cells! from!
! 288!
obese! human! subjects:! differences! among! depots! in!
angiogenic,!metabolic,!and!inflammatory!gene!expression!and!
cellular!senescence.!Diabetes,!59,!2755?63.!
VIND,! I.,! RIIS,! L.,! JESS,! T.,! KNUDSEN,! E.,! PEDERSEN,! N.,!
ELKJAER,! M.,! BAK! ANDERSEN,! I.,! WEWER,! V.,!




study! from! the! Danish! Crohn! colitis! database.! Am% J%
Gastroenterol,!101,!1274?82.!
VLODAVSKY,! I.,! MIAO,! H.! Q.,! MEDALION,! B.,! DANAGHER,! P.! &!
RON,! D.! 1996.! Involvement! of! heparan! sulfate! and! related!
molecules! in! sequestration! and! growth! promoting! activity! of!
fibroblast!growth!factor.!Cancer%Metastasis%Rev,!15,!177?86.!
VOGEL,!C.!&!MARCOTTE,!E.!M.!2012.!Insights!into!the!regulation!of!











































WANG,! Z.! &!HUANG,!H.! 2013.! Platelet! factor?4! (CXCL4/PF?4):! an!









WEJMAN,! J.,! PYZLAK,! M.,! SZUKIEWICZ,! D.,! JAROSZ,! D.,!
TARNOWSKI,!W.!&!SZEWCZYK,!G.! 2013.! Thrombospondin!










WAELKENS,! E.,! DE! BRUIJN,! E.! A.,! PARIDAENS,! R.,!
MERLEVEDE,!W.!&!VAN!OOSTEROM,!A.!T.!1999.!Vascular!
endothelial! growth! factor! measured! in! platelet! poor! plasma!
allows! optimal! separation! between! cancer! patients! and!
volunteers:!a!key!to!study!an!angiogenic!marker!in!vivo?!Ann%
Oncol,!10,!965?71.!
YAHATA,! Y.,! SHIRAKATA,! Y.,! TOKUMARU,! S.,! YAMASAKI,! K.,!
SAYAMA,!K.,!HANAKAWA,!Y.,!DETMAR,!M.!&!HASHIMOTO,!
K.! 2003.! Nuclear! translocation! of! phosphorylated! STAT3! is!
essential!for!vascular!endothelial!growth!factor?induced!human!
dermal! microvascular! endothelial! cell! migration! and! tube!
formation.!J%Biol%Chem,!278,!40026?31.!
YAMAMOTO,! K.,! KIYOHARA,! T.,! MURAYAMA,! Y.,! KIHARA,! S.,!
OKAMOTO,!Y.,!FUNAHASHI,!T.,!ITO,!T.,!NEZU,!R.,!TSUTSUI,!
S.,! MIYAGAWA,! J.! I.,! TAMURA,! S.,! MATSUZAWA,! Y.,!
SHIMOMURA,! I.! &! SHINOMURA,! Y.! 2005.! Production! of!




2009.! Norepinephrine! upregulates! VEGF,! IL?8,! and! IL?6!
expression! in!human!melanoma! tumor!cell! lines:! implications!
! 291!
for! stress?related! enhancement! of! tumor! progression.! Brain%
Behav%Immun,!23,!267?75.!
YANG,!H.,!MCELREE,!C.,!ROTH,!M.!P.,!SHANAHAN,!F.,!TARGAN,!
S.! R.! &! ROTTER,! J.! I.! 1993.! Familial! empirical! risks! for!




differentially! regulates! androgen! receptor! transactivation! via!
PI3K?Akt,!STAT3,!and!MAPK,!three!distinct!signal!pathways!in!





of! inflammatory! bowel! disease! in! the! Songpa?Kangdong!
district,! Seoul,! Korea,! 1986?2005:! a! KASID! study.! Inflamm%
Bowel%Dis,!14,!542?9.!





growth! factor! and! vascular! endothelial! growth! factor!
phosphorylation! for! antivascular! therapy! of! human! prostate!
cancer!in!the!prostate!of!nude!mice.!Prostate,!65,!203?15.!
YIN,!D.,!WANG,!X.!Y.,!YAN,!X.!B.!&!LIAO,!W.!H.!2005.![Correlation!
between! dynamic! contrast?enhanced!MRI! and! expression! of!
microvascular!density!in!the!glioma].!Zhong%Nan%Da%Xue%Xue%
Bao%Yi%Xue%Ban,!30,!686?9.!





ZHANG,! L.,! BADGWELL,! D.! B.,! BEVERS,! J.! J.,! 3RD,!
SCHLESSINGER,! K.,! MURRAY,! P.! J.,! LEVY,! D.! E.! &!
WATOWICH,!S.!S.!2006.!IL?6!signaling!via!the!STAT3/SOCS3!




growth! factor! is! the! major! angiogenic! factor! in! omentum:!
mechanism! of! the! omentum?mediated! angiogenesis.! J% Surg%
Res,!67,!147?54.!
ZHENG,!L.,!LI,!D.,!XIANG,!X.,!TONG,!L.,!QI,!M.,!PU,!J.,!HUANG,!K.!&!
TONG,! Q.! 2013.! Methyl! jasmonate! abolishes! the! migration,!









umbilical! vein! endothelial! cells.! Biochem% Biophys% Res%
Commun,!331,!1295?300.!
ZLOTOGORA,! J.,! ZIMMERMAN,! J.! &! RACHMILEWITZ,! D.! 1990.!
Crohn's!disease!in!Ashkenazi!Jews.!Gastroenterology,!99,!286?
7.!
ZORZI,! F.,! MONTELEONE,! I.,! SARRA,! M.,! CALABRESE,! E.,!


















BAYRAKTAR,! Y.! 2016.! The! Role! of! Fecal! Calprotectin! in!
Evaluating! Intestinal! Involvement! of! Behçet's! Disease.! Dis%
Markers,!2016,!5423043.!
!
